STMN4 | 29184442 | Other | Downregulated | Tissue | Colorectal cancer | Exome and transcriptome sequencing identifies loss of PDLIM2 in metastatic |
CLCA4 | 38809379 | Other | Unknown | Tissue | Colorectal cancer | Identification and Validation of SLC9A2 as A Potential Tumor Suppressor in |
CLCA4 | 38043836 | Other | Unknown | Tissue | Colorectal cancer | Insights into the molecular mechanisms and signalling pathways of epithelial to |
CLCA4 | 35266369 | Other | Unknown | Tissue | Colorectal cancer | <em>miR-19a</em> targeting <em>CLCA4</em> to regulate the proliferation, |
CLCA4 | 34643455 | Other | Unknown | Urine | Colorectal cancer | A systems-level analysis of bile acids effects on rat colon epithelial cells. |
CLCA4 | 34477243 | Other | Unknown | Other | Colorectal cancer | Distinguishing colorectal adenoma from hyperplastic polyp by WNT2 expression. |
CLCA4 | 38809379 | Other | Unknown | Tissue | Colon Cancer | Identification and Validation of SLC9A2 as A Potential Tumor Suppressor in |
CLCA4 | 35266369 | Other | Unknown | Tissue | Colon Cancer | <em>miR-19a</em> targeting <em>CLCA4</em> to regulate the proliferation, |
CLCA4 | 34643455 | Other | Unknown | Urine | Colon Cancer | A systems-level analysis of bile acids effects on rat colon epithelial cells. |
CLCA4 | 34477243 | Other | Unknown | Other | Colon Cancer | Distinguishing colorectal adenoma from hyperplastic polyp by WNT2 expression. |
CLCA4 | 32565987 | Other | Downregulated | Tissue | Colon Cancer | Downregulation of CLCA4 expression is associated with the development and |
GUCA2B | 38058807 | Other | Upregulated | Tissue | Colorectal cancer | A co-regulatory network of SPIB, AQP8, and GUCA2B related to immune infiltration |
GUCA2B | 35418782 | Other | Unknown | Tissue | Colorectal cancer | OTOP2, Inversely Modulated by miR-3148, Inhibits CRC Cell Migration, |
GUCA2B | 32594830 | Other | Unknown | Other | Colorectal cancer | Silencing the intestinal GUCY2C tumor suppressor axis requires APC loss of |
GUCA2B | 38058807 | Other | Upregulated | Tissue | Colon Cancer | A co-regulatory network of SPIB, AQP8, and GUCA2B related to immune infiltration |
GUCA2B | 30954025 | Other | Upregulated | Tissue | Colon Cancer | Colonic Mucosal Transcriptomic Changes in Patients with Long-Duration Ulcerative |
GUCA2B | 29246519 | Other | Unknown | Other | Colon Cancer | Hybrid Method Based on Information Gain and Support Vector Machine for Gene |
GUCA2B | 27044258 | Other | Unknown | Tissue | Colon Cancer | Cellular localization of guanylin and uroguanylin mRNAs in human and rat duodenal |
GUCA2B | 24959000 | Other | Unknown | Tissue | Colon Cancer | Gene expression profiling of colorectal tumors and normal mucosa by microarrays |
NFE2L3 | 35091681 | Other | Unknown | Tissue | Colorectal cancer | Loss of NFE2L3 protects against inflammation-induced colorectal cancer through |
NFE2L3 | 32962187 | Other | Unknown | Other | Colorectal cancer | Roles of NRF3 in the Hallmarks of Cancer: Proteasomal Inactivation of Tumor |
NFE2L3 | 32366381 | Other | Unknown | Other | Colorectal cancer | NFE2L1 and NFE2L3 Complementarily Maintain Basal Proteasome Activity in Cancer |
NFE2L3 | 32123008 | Other | Unknown | Tissue | Colorectal cancer | NRF3-POMP-20S Proteasome Assembly Axis Promotes Cancer Development via |
NFE2L3 | 31742837 | Other | Unknown | Other | Colorectal cancer | New addiction to the NRF2-related factor NRF3 in cancer cells: |
NFE2L3 | 31693889 | Other | Unknown | Tissue | Colorectal cancer | NFE2L3 Controls Colon Cancer Cell Growth through Regulation of DUX4, a CDK1 |
NFE2L3 | 31288376 | Other | Unknown | Tissue | Colorectal cancer | beta-Catenin/TCF4 Complex-Mediated Induction of the NRF3 (NFE2L3) Gene in Cancer |
NFE2L3 | 31191746 | Other | Upregulated | Tissue | Colorectal cancer | NFE2L3 Inhibition Induces Cell Cycle Arrest at the G0/G1 Phase in Colorectal |
NFE2L3 | 22321245 | Other | Unknown | Tissue | Colorectal cancer | Detection of collagen triple helix repeat containing-1 and nuclear factor |
NFE2L3 | 35323693 | Other | Unknown | Tissue | Colon Cancer | FOXO3 Expression in Macrophages Is Lowered by a High-Fat Diet and Regulates |
NFE2L3 | 35091681 | Other | Unknown | Tissue | Colon Cancer | Loss of NFE2L3 protects against inflammation-induced colorectal cancer through |
NFE2L3 | 31693889 | Other | Unknown | Tissue | Colon Cancer | NFE2L3 Controls Colon Cancer Cell Growth through Regulation of DUX4, a CDK1 |
NFE2L3 | 31288376 | Other | Unknown | Tissue | Colon Cancer | beta-Catenin/TCF4 Complex-Mediated Induction of the NRF3 (NFE2L3) Gene in Cancer |
NFE2L3 | 22321245 | Other | Unknown | Tissue | Colon Cancer | Detection of collagen triple helix repeat containing-1 and nuclear factor |
NFE2L3 | 37350063 | Other | Unknown | Other | Cancer Related Liver | NFE2L3 drives hepatocellular carcinoma cell proliferation by regulating the |
NFE2L3 | 30886504 | Other | Unknown | Tissue | Cancer Related Liver | Short hairpin RNA-mediated knockdown of nuclear factor erythroid 2-like 3 |
CDH3 | 37151391 | Other | Upregulated | Tissue | Colorectal cancer | MicroRNA 133A Regulates Cell Proliferation, Cell Migration, and Apoptosis in |
CDH3 | 36576616 | Other | Unknown | Tissue | Colorectal cancer | Weighted gene co-expression network analysis combined with machine learning |
CDH3 | 36216892 | Other | Unknown | Other | Colorectal cancer | Targeted activation in localized protein environments via deep red photoredox |
CDH3 | 35563773 | Other | Upregulated | Tissue | Colorectal cancer | P-Cadherin Regulates Intestinal Epithelial Cell Migration and Mucosal Repair, but |
CDH3 | 34589397 | Other | Unknown | Other | Colorectal cancer | The biology, function, and applications of exosomes in cancer. |
CDH3 | 32655830 | Other | Upregulated | Tissue | Colorectal cancer | Downregulated CDH3 decreases proliferation, migration, and invasion in thyroid |
CDH3 | 36216892 | Other | Unknown | Other | Colon Cancer | Targeted activation in localized protein environments via deep red photoredox |
CDH3 | 35563773 | Other | Upregulated | Tissue | Colon Cancer | P-Cadherin Regulates Intestinal Epithelial Cell Migration and Mucosal Repair, but |
CDH3 | 26137091 | Other | Unknown | Tissue | Colon Cancer | Expression changes of cell-cell adhesion-related genes in colorectal tumors. |
CDH3 | 24691442 | Other | Upregulated | Tissue | Colon Cancer | Excess PLAC8 promotes an unconventional ERK2-dependent EMT in colon cancer. |
CDH3 | 23682078 | Other | Upregulated | Tissue | Colon Cancer | Identification of putative immunologic targets for colon cancer prevention based |
CDH3 | 19528483 | Other | Unknown | Tissue | Colon Cancer | Demethylation of the CDH3 gene is frequently detected in advanced colorectal |
CDH3 | 18927117 | Other | Unknown | Tissue | Colon Cancer | Whole genome exon arrays identify differential expression of alternatively |
CDH3 | 18829530 | Other | Unknown | Other | Colon Cancer | Ectopic expression of P-cadherin correlates with promoter hypomethylation early |
CDH3 | 31182916 | Other | Downregulated | Tissue | Cancer Related Liver | KLF4-Mediated CDH3 Upregulation Suppresses Human Hepatoma Cell Growth and |
CDH3 | 21189991 | Other | Unknown | Tissue | Cancer Related Liver | CDH3/P-Cadherin regulates migration of HuCCT1 cholangiocarcinoma cells. |
GLP2R | 33112876 | Other | Unknown | Tissue | Colorectal cancer | APC mutations in human colon lead to decreased neuroendocrine maturation of ALDH+ |
GLP2R | 30529582 | Other | Unknown | Other | Colorectal cancer | Large-Scale Genome-Wide Association Study of East Asians Identifies Loci |
GLP2R | 27401218 | Other | Unknown | Tissue | Colorectal cancer | Comprehensive site-specific whole genome profiling of stromal and epithelial |
GLP2R | 33112876 | Other | Unknown | Tissue | Colon Cancer | APC mutations in human colon lead to decreased neuroendocrine maturation of ALDH+ |
GLP2R | 30529582 | Other | Unknown | Other | Colon Cancer | Large-Scale Genome-Wide Association Study of East Asians Identifies Loci |
GLP2R | 27401218 | Other | Unknown | Tissue | Colon Cancer | Comprehensive site-specific whole genome profiling of stromal and epithelial |
GLP2R | 18829546 | Other | Unknown | Urine | Colon Cancer | Glucagon-like peptide-2 does not modify the growth or survival of murine or human |
TRIP13 | 38347785 | Other | Unknown | Tissue | Colorectal cancer | TRIP13 Activates Glycolysis to Promote Cell Stemness and Strengthen Doxorubicin |
TRIP13 | 35362548 | Other | Unknown | Cell lines | Colorectal cancer | MiR-129-5p/TRIP13 affects malignant phenotypes of colorectal cancer cells. |
TRIP13 | 35347966 | Other | Unknown | Tissue | Colorectal cancer | [Screening of differentially expressed genes for colorectal cancer and prediction |
TRIP13 | 35194944 | Other | Upregulated | Cell lines | Colorectal cancer | DCZ0415, a small-molecule inhibitor targeting TRIP13, inhibits EMT and metastasis |
TRIP13 | 35075117 | Other | Downregulated | Tissue | Colorectal cancer | TRIP13, identified as a hub gene of tumor progression, is the target of |
TRIP13 | 33237662 | Other | Upregulated | Tissue | Colorectal cancer | Investigation of the expression levels of CPEB4, APC, TRIP13, EIF2S3, EIF4A1, |
TRIP13 | 33037736 | Other | Unknown | Tissue | Colorectal cancer | TRIP13 promotes metastasis of colorectal cancer regardless of p53 and |
TRIP13 | 35362548 | Other | Unknown | Cell lines | Colon Cancer | MiR-129-5p/TRIP13 affects malignant phenotypes of colorectal cancer cells. |
TRIP13 | 33237662 | Other | Upregulated | Tissue | Colon Cancer | Investigation of the expression levels of CPEB4, APC, TRIP13, EIF2S3, EIF4A1, |
TRIP13 | 27171439 | Other | Unknown | Other | Colon Cancer | Systematic Analysis of Gene Expression Alterations and Clinical Outcomes for |
TRIP13 | 36948354 | Other | Upregulated | Tissue | Cancer Related Liver | KIFC3 regulates progression of hepatocellular carcinoma via EMT and the AKT/mTOR |
TRIP13 | 33037736 | Other | Unknown | Tissue | Cancer Related Liver | TRIP13 promotes metastasis of colorectal cancer regardless of p53 and |
TRIP13 | 31533816 | Other | Unknown | Tissue | Cancer Related Liver | Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of |
TRIP13 | 30542731 | Other | Upregulated | Tissue | Cancer Related Liver | Upregulation of thyroid hormone receptor interactor 13 is associated with human |
MMP11 | 36216310 | Other | Unknown | Tissue | Colorectal cancer | Single-cell Transcriptomics Reveals Early Molecular and Immune Alterations |
MMP11 | 31157588 | Other | Unknown | Tissue | Colorectal cancer | Circular RNA 0047905 acts as a sponge for microRNA4516 and microRNA1227-5p, |
MMP11 | 38156105 | Other | Unknown | Tissue | Colon Cancer | Detection of lymph node metastasis in colon cancer by ectopically expressed |
MMP11 | 36216310 | Other | Unknown | Tissue | Colon Cancer | Single-cell Transcriptomics Reveals Early Molecular and Immune Alterations |
MMP11 | 30582284 | Other | Unknown | Other | Colon Cancer | Exosomes Derived from Human Primary and Metastatic Colorectal Cancer Cells |
MMP11 | 33369474 | Other | Unknown | Other | Cancer Related Liver | Matrix Metalloproteinase-11 Gene Polymorphisms as a Risk for Hepatocellular |
MMP11 | 32709089 | Other | Upregulated | Tissue | Cancer Related Liver | A Novel ceRNA Regulatory Network Involving the Long Non-Coding Antisense RNA |
MMP11 | 32685465 | Other | Upregulated | Cell lines | Cancer Related Liver | Apatinib Inhibits the Invasion and Metastasis of Liver Cancer Cells by |
MMP11 | 24989236 | Other | Upregulated | Tissue | Cancer Related Liver | Chloride intracellular channel 1 participates in migration and invasion of |
MMP11 | 17627864 | Other | Unknown | Urine | Cancer Related Liver | siRNA targeted against matrix metalloproteinase 11 inhibits the metastatic |
MMP11 | 7632822 | Other | Unknown | Tissue | Cancer Related Liver | Expression pattern of matrix metalloproteinases in human liver. |
SEC14L2 | 19909011 | Other | Downregulated | Tissue | Colon Cancer | Reduced expression of tocopherol-associated protein (TAP/Sec14L2) in human breast |
SLCO4A1 | 35331000 | Other | Downregulated | Tissue | Colorectal cancer | Solute carrier organic anion transporter family member 4A1 promotes colorectal |
SLCO4A1 | 33958701 | Other | Unknown | Tissue | Colorectal cancer | LncRNA SLCO4A1-AS1 modulates colon cancer stem cell properties by binding to |
SLCO4A1 | 32994815 | Other | Unknown | Other | Colorectal cancer | Two common polymorphic variants of OATP4A1 as potential risk factors for |
SLCO4A1 | 32762035 | Other | Unknown | Tissue | Colorectal cancer | SLCO4A1-AS1 promotes cell growth and induces resistance in lung adenocarcinoma by |
SLCO4A1 | 31853225 | Other | Upregulated | Tissue | Colorectal cancer | LncRNA SLCO4A1-AS1 predicts poor prognosis and promotes proliferation and |
SLCO4A1 | 31308265 | Other | Unknown | Tissue | Colorectal cancer | LncRNA SLCO4A1-AS1 promotes colorectal cancer cell proliferation by enhancing |
SLCO4A1 | 30863101 | Other | Upregulated | Tissue | Colorectal cancer | lncRNA SLCO4A1-AS1 promotes growth and invasion of bladder cancer through |
SLCO4A1 | 33958701 | Other | Unknown | Tissue | Colon Cancer | LncRNA SLCO4A1-AS1 modulates colon cancer stem cell properties by binding to |
SLCO4A1 | 22734885 | Other | Unknown | Other | Colon Cancer | Transporter function and cyclic AMP turnover in normal colonic mucosa from |
TRIB3 | 37833290 | Other | Unknown | Other | Colorectal cancer | Identification of ATF3 as a novel protective signature of quiescent colorectal |
TRIB3 | 36245025 | Other | Unknown | Tissue | Colorectal cancer | TRIB3 Interacts with STAT3 to Promote Cancer Angiogenesis. |
TRIB3 | 35119938 | Other | Unknown | Other | Colorectal cancer | The trouble with TRIBbles: TRIB3 blocks CD8 T cell homing to colorectal cancers. |
TRIB3 | 34985967 | Other | Unknown | Other | Colorectal cancer | TRIB3 reduces CD8(+) T cell infiltration and induces immune evasion by repressing |
TRIB3 | 34375482 | Other | Unknown | Other | Colorectal cancer | Tumor-associated macrophage-derived transforming growth factor-beta promotes |
TRIB3 | 34198908 | Other | Unknown | Cell lines | Colorectal cancer | Tribbles Pseudokinases in Colorectal Cancer. |
TRIB3 | 33896816 | Other | Upregulated | Tissue | Colorectal cancer | TRIB3 promotes proliferation, migration, and invasion of retinoblastoma cells by |
TRIB3 | 33717256 | Other | Unknown | Tissue | Colorectal cancer | TRIB3 promotes oral squamous cell carcinoma cell proliferation by activating the |
TRIB3 | 36245025 | Other | Unknown | Tissue | Colon Cancer | TRIB3 Interacts with STAT3 to Promote Cancer Angiogenesis. |
TRIB3 | 34198908 | Other | Unknown | Cell lines | Colon Cancer | Tribbles Pseudokinases in Colorectal Cancer. |
TRIB3 | 33793828 | Other | Unknown | Other | Colon Cancer | Hypericin-mediated photodynamic therapy for the treatment of cancer: a review. |
TRIB3 | 31562741 | Other | Unknown | Cell lines | Colon Cancer | DCLK1 integrates induction of TRIB3, EMT, drug resistance and poor prognosis in |
TRIB3 | 31548560 | Other | Unknown | Other | Colon Cancer | Concurrent targeting of BMI1 and CDK4/6 abrogates tumor growth in vitro and in |
TRIB3 | 30365932 | Other | Unknown | Tissue | Colon Cancer | TRIB3 Interacts With beta-Catenin and TCF4 to Increase Stem Cell Features of |
TRIB3 | 28392376 | Other | Unknown | Other | Colon Cancer | Endoplasmic reticulum-targeting photosensitizer Hypericin confers |
TRIB3 | 38214606 | Other | Unknown | Other | Cancer Related Liver | RBCK1 overexpression is associated with immune cell infiltration and poor |
TRIB3 | 36527874 | Other | Unknown | Other | Cancer Related Liver | The functions and molecular mechanisms of Tribbles homolog 3 (TRIB3) implicated |
TRIB3 | 34881468 | Other | Unknown | Other | Cancer Related Liver | Molecular dynamics and structural analysis of the binding of COP1 E3 ubiquitin |
TRIB3 | 32397857 | Other | Unknown | Blood | Cancer Related Liver | The anti-cancer drug ABTL0812 induces ER stress-mediated cytotoxic autophagy by |
TRIB3 | 31286822 | Other | Unknown | Tissue | Cancer Related Liver | Disrupting the TRIB3-SQSTM1 interaction reduces liver fibrosis by restoring |
TRIB3 | 30875926 | Other | Upregulated | Other | Cancer Related Liver | Cellular Gene Expression during Hepatitis C Virus Replication as Revealed by |
TRIB3 | 26517932 | Other | Unknown | Other | Cancer Related Liver | The TRIB3 Q84R polymorphism, insulin resistance and related metabolic |
TRIB3 | 23640460 | Other | Unknown | Other | Cancer Related Liver | Involvement of PPARgamma in the antitumoral action of cannabinoids on hepatocellular |
TRIB3 | 21475304 | Other | Unknown | Cell lines | Cancer Related Liver | Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of |
CEMIP | 37329550 | Other | Unknown | Tissue | Colorectal cancer | The probiotic-induced disregulation of immune-related genes in colon cells and |
CEMIP | 36849460 | Other | Unknown | Other | Colorectal cancer | CEMIP, acting as a scaffold protein for bridging GRAF1 and MIB1, promotes |
CEMIP | 36607478 | Other | Unknown | Tissue | Colorectal cancer | Downregulation of CEMIP enhances radiosensitivity by promoting DNA damage and |
CEMIP | 36596591 | Other | Downregulated | Tissue | Colorectal cancer | Tumor CEMIP drives immune evasion of colorectal cancer via MHC-I internalization |
CEMIP | 36576616 | Other | Unknown | Tissue | Colorectal cancer | Weighted gene co-expression network analysis combined with machine learning |
CEMIP | 36291875 | Other | Unknown | Other | Colorectal cancer | CEMIP, a Promising Biomarker That Promotes the Progression and Metastasis of |
CEMIP | 35303583 | Other | Upregulated | Other | Colorectal cancer | Identification of metastasis-associated exoDEPs in colorectal cancer using |
CEMIP | 34608265 | Other | Unknown | Other | Colorectal cancer | CEMIP, a novel adaptor protein of OGT, promotes colorectal cancer metastasis |
CEMIP | 37329550 | Other | Unknown | Tissue | Colon Cancer | The probiotic-induced disregulation of immune-related genes in colon cells and |
CEMIP | 36596591 | Other | Downregulated | Tissue | Colon Cancer | Tumor CEMIP drives immune evasion of colorectal cancer via MHC-I internalization |
CEMIP | 31011255 | Other | Upregulated | Tissue | Colon Cancer | Functional role of long non-coding RNA CASC19/miR-140-5p/CEMIP axis in colorectal |
CEMIP | 29915160 | Other | Unknown | Other | Colon Cancer | The Endosomal Protein CEMIP Links WNT Signaling to MEK1-ERK1/2 Activation in |
CEMIP | 28058013 | Other | Unknown | Tissue | Colon Cancer | Aging related methylation influences the gene expression of key control genes in |
CEMIP | 26009875 | Other | Upregulated | Tissue | Colon Cancer | Hypoxia promotes colon cancer dissemination through up-regulation of cell |
CEMIP | 23936024 | Other | Unknown | Cell lines | Colon Cancer | Early insights into the function of KIAA1199, a markedly overexpressed protein in |
CEMIP | 29886655 | Other | Unknown | Tissue | Cancer Related Liver | [Expression and clinical significance of KIAA1199 in primary hepatocellular |
CEMIP | 29776371 | Other | Upregulated | Tissue | Cancer Related Liver | LncRNA TUG1 promoted KIAA1199 expression via miR-600 to accelerate cell |
CEMIP | 28213952 | Other | Upregulated | Tissue | Cancer Related Liver | Down-regulation of KIAA1199/CEMIP by miR-216a suppresses tumor invasion and |
STMN2 | 38224712 | Other | Downregulated | Tissue | Cancer Related Liver | Identification of key genes and functional enrichment analysis of liver fibrosis |
STMN2 | 30870804 | Other | Unknown | Plasma | Cancer Related Liver | Cancer-related gene expression is associated with disease severity and modifiable |
STMN2 | 16712787 | Other | Unknown | Tissue | Cancer Related Liver | STMN2 is a novel target of beta-catenin/TCF-mediated transcription in human |
RERGL | 34477243 | Other | Unknown | Other | Colorectal cancer | Distinguishing colorectal adenoma from hyperplastic polyp by WNT2 expression. |
RERGL | 34308980 | Other | Unknown | Tissue | Colorectal cancer | Identification of hub genes in colorectal cancer based on weighted gene |
RERGL | 28409560 | Other | Upregulated | Other | Colorectal cancer | Identification of differentially expressed genes and their upstream regulators in |
RERGL | 24127187 | Other | Unknown | Other | Colorectal cancer | Genome-wide analysis associates familial colorectal cancer with increases in copy |
RERGL | 34477243 | Other | Unknown | Other | Colon Cancer | Distinguishing colorectal adenoma from hyperplastic polyp by WNT2 expression. |
MSX2 | 38637796 | Other | Unknown | Other | Colorectal cancer | Sparassis latifolia and exercise training as complementary medicine mitigated the |
MSX2 | 25576648 | Other | Unknown | Tissue | Colorectal cancer | Dissecting the mechanism of colorectal tumorigenesis based on RNA-sequencing |
MSX2 | 20018687 | Other | Unknown | Other | Colorectal cancer | Defined factors induce reprogramming of gastrointestinal cancer cells. |
MSX2 | 15161049 | Other | Unknown | Tissue | Colorectal cancer | Expression and localization of homeodomain proteins DLX4, HB9 and HB24 in |
MSX2 | 15161049 | Other | Unknown | Tissue | Colon Cancer | Expression and localization of homeodomain proteins DLX4, HB9 and HB24 in |
MSX2 | 21876555 | Other | Upregulated | Other | Cancer Related Liver | Normal and disease-related biological functions of Twist1 and underlying |
MSX2 | 20018687 | Other | Unknown | Other | Cancer Related Liver | Defined factors induce reprogramming of gastrointestinal cancer cells. |
MSX2 | 18349132 | Other | Unknown | Tissue | Cancer Related Liver | Up-regulation of MSX2 enhances the malignant phenotype and is associated with |
INHBA | 38588888 | Other | Upregulated | Tissue | Colorectal cancer | INHBA regulates Hippo signaling to confer 5-FU chemoresistance mediated by |
INHBA | 38062804 | Other | Unknown | Tissue | Colorectal cancer | The New Role of HNF1A-NAS1/miR-214/INHBA Signaling Axis in Colorectal Cancer. |
INHBA | 36371957 | Other | Unknown | Tissue | Colorectal cancer | Multiregion single cell analysis reveals a novel subtype of cancer-associated |
INHBA | 35909892 | Other | Upregulated | Tissue | Colorectal cancer | Long-Read Nanopore Sequencing Identifies Mismatch Repair-Deficient Related Genes |
INHBA | 38588888 | Other | Upregulated | Tissue | Colon Cancer | INHBA regulates Hippo signaling to confer 5-FU chemoresistance mediated by |
INHBA | 38062804 | Other | Unknown | Tissue | Colon Cancer | The New Role of HNF1A-NAS1/miR-214/INHBA Signaling Axis in Colorectal Cancer. |
INHBA | 35909892 | Other | Upregulated | Tissue | Colon Cancer | Long-Read Nanopore Sequencing Identifies Mismatch Repair-Deficient Related Genes |
INHBA | 34824625 | Other | Unknown | Tissue | Colon Cancer | Pilot Nanostring PanCancer pathway analysis of colon adenocarcinoma in a tertiary |
INHBA | 34130530 | Other | Upregulated | Tissue | Colon Cancer | INHBA promotes the proliferation, migration and invasion of colon cancer cells |
INHBA | 34103052 | Other | Unknown | Tissue | Colon Cancer | An immune-related model based on INHBA, JAG2 and CCL19 to predict the prognoses |
INHBA | 32600423 | Other | Unknown | Other | Colon Cancer | Prediction and identification of immune genes related to the prognosis of |
INHBA | 31286822 | Other | Unknown | Tissue | Cancer Related Liver | Disrupting the TRIB3-SQSTM1 interaction reduces liver fibrosis by restoring |
INHBA | 19389832 | Other | Unknown | Tissue | Cancer Related Liver | Activin signaling: effects on body composition and mitochondrial energy |
PLP1 | 25031414 | Other | Unknown | Other | Colorectal cancer | Progressive disorganization of paranodal junctions and compact myelin due to loss |
PLP1 | 18664355 | Other | Unknown | Other | Cancer Related Liver | [Differentially expressed genes in adrenal gland of H22 liver cancer mice with |
PCSK2 | 30439686 | Other | Unknown | Other | Colorectal cancer | Enhanced mitochondrial pyruvate transport elicits a robust ROS production to |
PCSK2 | 30439686 | Other | Unknown | Other | Colon Cancer | Enhanced mitochondrial pyruvate transport elicits a robust ROS production to |
PYY | 36628274 | Other | Unknown | Tissue | Colorectal cancer | PYY modulates the tumorigenesis and progression of colorectal cancer unveiled by |
PYY | 36367526 | Other | Unknown | Plasma | Colorectal cancer | Plasma Concentrations of Gut Hormones Acyl Ghrelin and Peptide YY and Subsequent |
PYY | 35471164 | Other | Unknown | Other | Colorectal cancer | Dietary fiber in the prevention of obesity and obesity-related chronic diseases: |
PYY | 35418782 | Other | Unknown | Tissue | Colorectal cancer | OTOP2, Inversely Modulated by miR-3148, Inhibits CRC Cell Migration, |
PYY | 35032662 | Other | Unknown | Blood | Colorectal cancer | Traditional Patchouli essential oil modulates the host's immune responses and gut |
PYY | 34796980 | Other | Unknown | Other | Colorectal cancer | Immune and stromal related genes in colon cancer: Analysis of tumour |
PYY | 38658031 | Other | Unknown | Other | Colon Cancer | Tigilanol tiglate is an oncolytic small molecule that induces immunogenic cell |
PYY | 36628274 | Other | Unknown | Tissue | Colon Cancer | PYY modulates the tumorigenesis and progression of colorectal cancer unveiled by |
PYY | 36367526 | Other | Unknown | Plasma | Colon Cancer | Plasma Concentrations of Gut Hormones Acyl Ghrelin and Peptide YY and Subsequent |
PYY | 34796980 | Other | Unknown | Other | Colon Cancer | Immune and stromal related genes in colon cancer: Analysis of tumour |
PYY | 33924402 | Other | Unknown | Tissue | Colon Cancer | Effect of Obesity on the Expression of Nutrient Receptors and Satiety Hormones in |
PYY | 33711555 | Other | Unknown | Urine | Colon Cancer | Selective release of gastrointestinal hormones induced by an orally active GPR39 |
PYY | 31499195 | Other | Unknown | Other | Colon Cancer | Mushroom polysaccharides and jiaogulan saponins exert cancer preventive effects |
PYY | 30136343 | Other | Unknown | Other | Colon Cancer | Signaling of free fatty acid receptors 2 and 3 differs in colonic mucosa |
PYY | 27169834 | Other | Unknown | Blood | Colon Cancer | Increased colonic propionate reduces anticipatory reward responses in the human |
GLTP | 30472325 | Other | Unknown | Plasma | Colorectal cancer | Upregulation of human glycolipid transfer protein (GLTP) induces necroptosis in |
GLTP | 29532406 | Other | Unknown | Tissue | Colorectal cancer | MicroRNA 196B Regulates HOXA5, HOXB6 and GLTP Expression Levels in Colorectal |
GLTP | 32339554 | Other | Unknown | Cell lines | Colon Cancer | Emerging roles for human glycolipid transfer protein superfamily members in the |
GLTP | 30472325 | Other | Unknown | Plasma | Colon Cancer | Upregulation of human glycolipid transfer protein (GLTP) induces necroptosis in |
PDX1 | 37811008 | Other | Unknown | Cell lines | Colorectal cancer | Peristalsis-Associated Mechanotransduction Drives Malignant Progression of |
PDX1 | 37247123 | Other | Unknown | Tissue | Colorectal cancer | The potential oncogenic effect of tissue-specific expression of JC polyoma T |
PDX1 | 36425530 | Other | Unknown | Other | Colorectal cancer | The roles of ING5 in cancer: A tumor suppressor. |
PDX1 | 34735515 | Other | Unknown | Tissue | Colorectal cancer | Sex-dependent development of Kras-induced anal squamous cell carcinoma in mice. |
PDX1 | 19908063 | Other | Unknown | Tissue | Colorectal cancer | Colonic carcinoma with a pancreatic acinar cell differentiation. A case report. |
PDX1 | 18855980 | Other | Unknown | Tissue | Colorectal cancer | Transcription factor PDX-1 in human colorectal adenocarcinoma: a potential tumor |
PDX1 | 28764929 | Other | Unknown | Tissue | Colon Cancer | Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma. |
PDX1 | 23118920 | Other | Downregulated | Other | Colon Cancer | Forkhead box protein A2 (FOXA2) protein stability and activity are regulated by |
PDX1 | 19908063 | Other | Unknown | Tissue | Colon Cancer | Colonic carcinoma with a pancreatic acinar cell differentiation. A case report. |
PDX1 | 18855980 | Other | Unknown | Tissue | Colon Cancer | Transcription factor PDX-1 in human colorectal adenocarcinoma: a potential tumor |
PDX1 | 17851679 | Other | Upregulated | Other | Colon Cancer | Hyperplastic polyps and sessile serrated 'adenomas' of the colon and rectum |
PDX1 | 16952033 | Other | Unknown | Other | Colon Cancer | Gastric-and-intestinal mixed-type intestinal metaplasia: aberrant expression of |
PDX1 | 11179495 | Other | Unknown | Tissue | Colon Cancer | Differential expression of Hox A5 in human colon cancer cell differentiation: a |
PDX1 | 37192689 | Other | Unknown | Other | Cancer Related Liver | Inhibition of the SLC35B2-TPST2 Axis of Tyrosine Sulfation Attenuates the Growth |
PDX1 | 36038349 | Other | Unknown | Tissue | Cancer Related Liver | [Sorafenib regulates vascular endothelial growth factor by runt-related |
PDX1 | 32999644 | Other | Unknown | Other | Cancer Related Liver | Alpha-Fetoprotein-Producing Early Gastric Cancer with Intramucosal Hepatoid and |
PDX1 | 29550076 | Other | Unknown | Tissue | Cancer Related Liver | Long-Term Correction of Diabetes in Mice by In Vivo Reprogramming of Pancreatic |
PDX1 | 27523981 | Other | Unknown | Cell lines | Cancer Related Liver | Loss of Trefoil Factor 2 From Pancreatic Duct Glands Promotes Formation of |
PDX1 | 27474396 | Other | Unknown | Tissue | Cancer Related Liver | Iterative use of nuclear receptor Nr5a2 regulates multiple stages of liver and |
PDX1 | 27375208 | Other | Unknown | Saliva | Cancer Related Liver | A SMAD4 mutation indicative of juvenile polyposis syndrome in a family previously |
PDX1 | 26098869 | Other | Unknown | Other | Cancer Related Liver | Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility |
BEST4 | 36915382 | Other | Unknown | Other | Colorectal cancer | Mechanistic insights into zearalenone-accelerated colorectal cancer in mice using |
BEST4 | 35418782 | Other | Unknown | Tissue | Colorectal cancer | OTOP2, Inversely Modulated by miR-3148, Inhibits CRC Cell Migration, |
BEST4 | 35058597 | Other | Upregulated | Other | Colorectal cancer | Oncogenic potential of BEST4 in colorectal cancer via activation of PI3K/Akt |
BEST4 | 36915382 | Other | Unknown | Other | Colon Cancer | Mechanistic insights into zearalenone-accelerated colorectal cancer in mice using |
BEST4 | 35176508 | Other | Unknown | Tissue | Colon Cancer | A Proximal-to-Distal Survey of Healthy Adult Human Small Intestine and Colon |
BEST4 | 31348891 | Other | Unknown | Other | Colon Cancer | Intra- and Inter-cellular Rewiring of the Human Colon during Ulcerative Colitis. |
RSPO2 | 38682058 | Other | Unknown | Tissue | Colorectal cancer | Investigating the therapeutic potential of Bifidobacterium breve and |
RSPO2 | 37612734 | Other | Unknown | Cell lines | Colorectal cancer | CRISPR/dCAS9-mediated DNA demethylation screen identifies functional epigenetic |
RSPO2 | 36217544 | Other | Unknown | Plasma | Colorectal cancer | RSPO2 promotes progression of ovarian cancer through dual receptor-mediated |
RSPO2 | 34663878 | Other | Unknown | Other | Colorectal cancer | The role of R-spondin proteins in cancer biology. |
RSPO2 | 34273374 | Other | Unknown | Cell lines | Colorectal cancer | RSPO2 silence inhibits tumorigenesis of nasopharyngeal carcinoma by |
RSPO2 | 37612734 | Other | Unknown | Cell lines | Colon Cancer | CRISPR/dCAS9-mediated DNA demethylation screen identifies functional epigenetic |
RSPO2 | 34663878 | Other | Unknown | Other | Colon Cancer | The role of R-spondin proteins in cancer biology. |
RSPO2 | 33320737 | Other | Upregulated | Other | Colon Cancer | R-Spondins 2 and 3 Are Overexpressed in a Subset of Human Colon and Breast |
RSPO2 | 32052185 | Other | Unknown | Other | Colon Cancer | Clinicopathological and molecular correlations in traditional serrated adenoma. |
RSPO2 | 31209633 | Other | Unknown | Other | Colon Cancer | Identification of a novel PRR15L-RSPO2 fusion transcript in a sigmoid colon |
RSPO2 | 35912232 | Other | Unknown | Other | Cancer Related Liver | Genomic Features of Organ-Specific Metastases in Lung Adenocarcinoma. |
RSPO2 | 34273374 | Other | Unknown | Cell lines | Cancer Related Liver | RSPO2 silence inhibits tumorigenesis of nasopharyngeal carcinoma by |
RSPO2 | 32581137 | Other | Unknown | Tissue | Cancer Related Liver | R-spondin2 Suppresses the Progression of Hepatocellular Carcinoma via MAPK |
RSPO2 | 31701073 | Other | Unknown | Tissue | Cancer Related Liver | R-spondin 2 Drives Liver Tumor Development in a Yes-Associated Protein-Dependent |
RSPO2 | 26052033 | Other | Upregulated | Tissue | Cancer Related Liver | Roles of miR-196a on gene regulation of neuroendocrine tumor cells. |
BMP3 | 37338022 | Other | Unknown | Blood | Colorectal cancer | Combined SEPT9 and BMP3 methylation in plasma for colorectal cancer early |
BMP3 | 35963995 | Other | Unknown | Blood | Colorectal cancer | Feasibility of quantification based on novel evaluation with stool DNA and fecal |
BMP3 | 35383606 | Other | Unknown | Other | Colorectal cancer | A Practical Overview of the Stool DNA Test for Colorectal Cancer Screening. |
BMP3 | 34621892 | Other | Unknown | Cell lines | Colorectal cancer | Multiple Biomarker-Combined Screening for Colorectal Cancer Based on Bisulfate |
BMP3 | 35963995 | Other | Unknown | Blood | Colon Cancer | Feasibility of quantification based on novel evaluation with stool DNA and fecal |
BMP3 | 31764091 | Other | Unknown | Tissue | Colon Cancer | Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer |
BMP3 | 31665064 | Other | Downregulated | Tissue | Colon Cancer | BMP3 suppresses colon tumorigenesis via ActRIIB/SMAD2-dependent and TAK1/JNK |
BMP3 | 31456088 | Other | Unknown | Other | Colon Cancer | A novel panel of stool-based DNA biomarkers for early screening of colorectal |
BMP3 | 27114416 | Other | Unknown | Tissue | Colon Cancer | Field Cancerization in Sporadic Colon Cancer. |
BMP3 | 27104828 | Other | Unknown | Tissue | Colon Cancer | DNA Methylation and Mutation of Small Colonic Neoplasms in Ulcerative Colitis and |
BMP3 | 26524859 | Other | Unknown | Blood | Colon Cancer | [Fecal Biomarker for Colorectal Cancer Diagnosis]. |
BMP3 | 31639434 | Other | Unknown | Other | Cancer Related Liver | Bile acids and bilirubin effects on osteoblastic gene profile. Implications in |
BMP3 | 27114416 | Other | Unknown | Tissue | Cancer Related Liver | Field Cancerization in Sporadic Colon Cancer. |
LRP8 | 38389136 | Other | Unknown | Cell lines | Colorectal cancer | MiR-378a-5p exerts a radiosensitizing effect on CRC through LRP8/beta-catenin axis. |
LRP8 | 37770979 | Other | Upregulated | Tissue | Colorectal cancer | Therapeutic targeting of the TPX2/TTK network in colorectal cancer. |
LRP8 | 31121307 | Other | Unknown | Tissue | Colorectal cancer | Estrogen receptor alpha regulates the Wnt/beta-catenin signaling pathway in colon |
LRP8 | 37770979 | Other | Upregulated | Tissue | Colon Cancer | Therapeutic targeting of the TPX2/TTK network in colorectal cancer. |
LRP8 | 31121307 | Other | Unknown | Tissue | Colon Cancer | Estrogen receptor alpha regulates the Wnt/beta-catenin signaling pathway in colon |
LRP8 | 32312520 | Other | Unknown | Cell lines | Cancer Related Liver | Genome-scale CRISPR activation screening identifies a role of LRP8 in Sorafenib |
LRP8 | 16973241 | Other | Unknown | Other | Cancer Related Liver | Convergence of genes implicated in Alzheimer's disease on the cerebral |
SIM2 | 29964097 | Other | Upregulated | Tissue | Colorectal cancer | Long noncoding RNA TMEM75 promotes colorectal cancer progression by activation of |
SIM2 | 25908452 | Other | Unknown | Tissue | Colorectal cancer | Identification of commonly dysregulated genes in colorectal cancer by integrating |
SIM2 | 16129820 | Other | Unknown | Other | Colorectal cancer | Inhibition of Single Minded 2 gene expression mediates tumor-selective apoptosis |
SIM2 | 12676991 | Other | Unknown | Tissue | Colorectal cancer | Identification of Down's syndrome critical locus gene SIM2-s as a drug therapy |
SIM2 | 25908452 | Other | Unknown | Tissue | Colon Cancer | Identification of commonly dysregulated genes in colorectal cancer by integrating |
SIM2 | 20448453 | Other | Downregulated | Tissue | Colon Cancer | Single minded 2-s (SIM2-s) gene is expressed in human GBM cells and involved in |
SIM2 | 16129820 | Other | Unknown | Other | Colon Cancer | Inhibition of Single Minded 2 gene expression mediates tumor-selective apoptosis |
SIM2 | 12676991 | Other | Unknown | Tissue | Colon Cancer | Identification of Down's syndrome critical locus gene SIM2-s as a drug therapy |
IL6R | 36933092 | Other | Unknown | Other | Colorectal cancer | Tumor necrosis factor-alpha induces proliferation and reduces apoptosis of colorectal |
IL6R | 36270986 | Other | Unknown | Tissue | Colorectal cancer | HDAC6-dependent deacetylation of TAK1 enhances sIL-6R release to promote |
IL6R | 35962138 | Other | Unknown | Tissue | Colorectal cancer | Effects of a novel toll-like receptor 4 antagonist IAXO-102 in a murine model of |
IL6R | 35557592 | Other | Downregulated | Tissue | Colorectal cancer | miRNA-320 inhibits colitis-associated colorectal cancer by regulating the |
IL6R | 35510373 | Other | Unknown | Blood | Colorectal cancer | A novel oncolytic virus induces a regional cytokine storm and safely eliminates |
IL6R | 34951580 | Other | Unknown | Other | Colorectal cancer | Network Pharmacology-based Prediction and Verification of Shikonin for Treating |
IL6R | 34931923 | Other | Unknown | Other | Colorectal cancer | Bioinformatics and in-silico findings reveal medical features and pharmacological |
IL6R | 36933092 | Other | Unknown | Other | Colon Cancer | Tumor necrosis factor-alpha induces proliferation and reduces apoptosis of colorectal |
IL6R | 36270986 | Other | Unknown | Tissue | Colon Cancer | HDAC6-dependent deacetylation of TAK1 enhances sIL-6R release to promote |
IL6R | 35962138 | Other | Unknown | Tissue | Colon Cancer | Effects of a novel toll-like receptor 4 antagonist IAXO-102 in a murine model of |
IL6R | 35557592 | Other | Downregulated | Tissue | Colon Cancer | miRNA-320 inhibits colitis-associated colorectal cancer by regulating the |
IL6R | 35510373 | Other | Unknown | Blood | Colon Cancer | A novel oncolytic virus induces a regional cytokine storm and safely eliminates |
IL6R | 34992417 | Other | Upregulated | Other | Colon Cancer | Lactobacillus fermentum ZS09 Mediates Epithelial-Mesenchymal Transition (EMT) by |
IL6R | 34726248 | Other | Downregulated | Other | Colon Cancer | Shikonin suppresses colon cancer cell growth and exerts synergistic effects by |
IL6R | 34125978 | Other | Unknown | Other | Colon Cancer | Phosphorylation of meprin beta controls its cell surface abundance and subsequently |
IL6R | 33923292 | Other | Unknown | Other | Colon Cancer | A Potential Role of IL-6/IL-6R in the Development and Management of Colon Cancer. |
IL6R | 33794029 | Other | Unknown | Blood | Colon Cancer | Resolvin D1 suppresses inflammation-associated tumorigenesis in the colon by |
IL6R | 38441314 | Other | Upregulated | Cell lines | Cancer Related Liver | IL-6 upregulates the expression of IL-6R through the JAK2/STAT3 signalling |
IL6R | 37108378 | Other | Upregulated | Tissue | Cancer Related Liver | Lipid-Independent Regulation of PLIN5 via IL-6 through the JAK/STAT3 Axis in |
IL6R | 35030010 | Other | Unknown | Other | Cancer Related Liver | Palladium Nanoplate-Based IL-6 Receptor Antagonists Ameliorate Cancer-Related |
IL6R | 34976809 | Other | Unknown | Other | Cancer Related Liver | IL-6/STAT3 Is a Promising Therapeutic Target for Hepatocellular Carcinoma. |
IL6R | 34405380 | Other | Unknown | Other | Cancer Related Liver | Tumor-derived exosomes encapsulating miR-34a promote apoptosis and inhibit |
IL6R | 31831556 | Other | Unknown | Other | Cancer Related Liver | Functional Genomics Identifies Hepatitis-Induced STAT3-TYRO3-STAT3 Signaling as a |
IL6R | 29621586 | Other | Unknown | Other | Cancer Related Liver | Long non-coding RNA DILC suppresses cell proliferation and metastasis in |
IL6R | 27477312 | Other | Unknown | Other | Cancer Related Liver | Hepatitis C virus suppresses Hepatocyte Nuclear Factor 4 alpha, a key regulator |
CLDN1 | 37924938 | Other | Unknown | Other | Colorectal cancer | Claudin-1 interacts with EPHA2 to promote cancer stemness and chemoresistance in |
CLDN1 | 37585503 | Other | Unknown | Other | Colorectal cancer | Phosphoproteomics of patient-derived xenografts identifies targets and markers |
CLDN1 | 37318881 | Other | Unknown | Urine | Colorectal cancer | LIN28B promotes cell invasion and colorectal cancer metastasis via CLDN1 and |
CLDN1 | 37041570 | Other | Upregulated | Urine | Colorectal cancer | Improving the response to oxaliplatin by targeting chemotherapy-induced CLDN1 in |
CLDN1 | 36925536 | Other | Unknown | Tissue | Colorectal cancer | Transcriptomics and experimental validation-based approach to understand the |
CLDN1 | 35892269 | Other | Unknown | Other | Colorectal cancer | Reliable epithelial-mesenchymal transition biomarkers for colorectal cancer |
CLDN1 | 37585503 | Other | Unknown | Other | Colon Cancer | Phosphoproteomics of patient-derived xenografts identifies targets and markers |
CLDN1 | 37318881 | Other | Unknown | Urine | Colon Cancer | LIN28B promotes cell invasion and colorectal cancer metastasis via CLDN1 and |
CLDN1 | 35248004 | Other | Unknown | Tissue | Colon Cancer | Mammary tumors alter the fecal bacteriome and permit enteric bacterial |
CLDN1 | 34880645 | Other | Upregulated | Tissue | Colon Cancer | The Differential Expression of the Inflammasomes in Adipose Tissue and Colon |
CLDN1 | 34571860 | Other | Unknown | Cell lines | Colon Cancer | A Claudin-Based Molecular Signature Identifies High-Risk, Chemoresistant |
CLDN1 | 34519940 | Other | Upregulated | Tissue | Colon Cancer | Long non-coding RNA VPS9D1-AS1 promotes growth of colon adenocarcinoma by |
CLDN1 | 37041570 | Other | Upregulated | Urine | Cancer Related Liver | Improving the response to oxaliplatin by targeting chemotherapy-induced CLDN1 in |
CLDN1 | 36786636 | Other | Unknown | Blood | Cancer Related Liver | A High-Salt Diet Exacerbates Liver Fibrosis through Enterococcus-Dependent |
CLDN1 | 36542691 | Other | Unknown | Tissue | Cancer Related Liver | A monoclonal antibody targeting nonjunctional claudin-1 inhibits fibrosis in |
CLDN1 | 36063450 | Other | Unknown | Other | Cancer Related Liver | Effect of Helicobacter pylori infection and its eradication on the expression of |
CLDN1 | 33465371 | Other | Unknown | Tissue | Cancer Related Liver | Protective Functions of ZO-2/Tjp2 Expressed in Hepatocytes and Cholangiocytes |
CLDN1 | 33416138 | Other | Downregulated | Other | Cancer Related Liver | p53‑p72‑Delta225‑331‑V31I identified in a cholangiocarcinoma cell line promotes |
ESM1 | 37715566 | Other | Unknown | Other | Colorectal cancer | Novel specific anti-ESM1 antibodies overcome tumor bevacizumab resistance by |
ESM1 | 37100467 | Other | Unknown | Cell lines | Colorectal cancer | ESM1 promotes angiogenesis in colorectal cancer by activating PI3K/Akt/mTOR |
ESM1 | 28409560 | Other | Upregulated | Other | Colorectal cancer | Identification of differentially expressed genes and their upstream regulators in |
ESM1 | 25575808 | Other | Unknown | Tissue | Colon Cancer | The non glycanated endocan polypeptide slows tumor growth by inducing stromal |
ESM1 | 24416777 | Other | Unknown | Other | Colon Cancer | Butyrate suppresses proliferation and migration of RKO colon cancer cells though |
ESM1 | 18680240 | Other | Unknown | Tissue | Colon Cancer | Correlation between expression and differentiation of endocan in colorectal |
ESM1 | 34500557 | Other | Unknown | Other | Cancer Related Liver | Anticancer Effect of Benzimidazole Derivatives, Especially Mebendazole, on |
ESM1 | 26894862 | Other | Upregulated | Tissue | Cancer Related Liver | HULC long noncoding RNA silencing suppresses angiogenesis by regulating ESM-1 via |
ESM1 | 25666192 | Other | Unknown | Tissue | Cancer Related Liver | Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular |
ESM1 | 24465615 | Other | Upregulated | Tissue | Cancer Related Liver | Genome-wide analysis of long noncoding RNA (lncRNA) expression in hepatoblastoma |
ESM1 | 20515564 | Other | Unknown | Tissue | Cancer Related Liver | Over-expression of the Endocan gene in endothelial cells from hepatocellular |
FOXQ1 | 38682953 | Other | Unknown | Other | Colorectal cancer | Resveratrol triggers autophagy-related apoptosis to inhibit the progression of |
FOXQ1 | 38609520 | Other | Unknown | Other | Colorectal cancer | Evaluation of EGFR and COX pathway inhibition in human colon organoids of |
FOXQ1 | 38432629 | Other | Unknown | Cell lines | Colorectal cancer | The tumor suppressor p53 is a negative regulator of the carcinoma-associated |
FOXQ1 | 36841801 | Other | Unknown | Tissue | Colorectal cancer | LINC00543 promotes colorectal cancer metastasis by driving EMT and inducing the |
FOXQ1 | 36576616 | Other | Unknown | Tissue | Colorectal cancer | Weighted gene co-expression network analysis combined with machine learning |
FOXQ1 | 36457036 | Other | Unknown | Other | Colorectal cancer | MicroRNA-378a-3p prevents initiation and growth of colorectal cancer by fine |
FOXQ1 | 36124643 | Other | Unknown | Cell lines | Colorectal cancer | The oncogenic transcription factor FOXQ1 is a differential regulator of Wnt |
FOXQ1 | 35633908 | Other | Unknown | Tissue | Colorectal cancer | Forkhead Box q1 promotes invasion and metastasis in colorectal cancer by |
FOXQ1 | 35600345 | Other | Downregulated | Tissue | Colorectal cancer | The Novel lncRNA RP9P Promotes Colorectal Cancer Progression by Modulating |
FOXQ1 | 38609520 | Other | Unknown | Other | Colon Cancer | Evaluation of EGFR and COX pathway inhibition in human colon organoids of |
FOXQ1 | 38156105 | Other | Unknown | Tissue | Colon Cancer | Detection of lymph node metastasis in colon cancer by ectopically expressed |
FOXQ1 | 33174020 | Other | Unknown | Other | Colon Cancer | Cooperation between ETS transcription factor ETV1 and histone demethylase JMJD1A |
FOXQ1 | 20145154 | Other | Upregulated | Blood | Colon Cancer | FOXQ1 is overexpressed in colorectal cancer and enhances tumorigenicity and tumor |
FOXQ1 | 37875474 | Other | Unknown | Tissue | Cancer Related Liver | FOXQ1 promotes pancreatic cancer cell proliferation, tumor stemness, invasion and |
FOXQ1 | 24211718 | Other | Unknown | Other | Cancer Related Liver | Effects of lentiviral-mediated Foxp1 and Foxq1 RNAi on the hepatocarcinoma cell. |
FOXQ1 | 23196670 | Other | Unknown | Tissue | Cancer Related Liver | AhR-mediated changes in global gene expression in rat liver progenitor cells. |
FOXQ1 | 18813803 | Other | Unknown | Tissue | Cancer Related Liver | Integrative genomic analyses on GLI2: mechanism of Hedgehog priming through basal |
VWA2 | 26474385 | Other | Unknown | Tissue | Colorectal cancer | Novel RNA variants in colorectal cancers. |
KRT80 | 37791824 | Other | Upregulated | Tissue | Colorectal cancer | Identification of autophagy and angiogenesis modulators in colorectal cancer |
KRT80 | 36232922 | Other | Unknown | Tissue | Colorectal cancer | Molecular Pathogenesis of Colorectal Cancer: Impact of Oncogenic Targets |
KRT80 | 33101466 | Other | Upregulated | Tissue | Colorectal cancer | Small interfering RNA-mediated knockdown of KRT80 suppresses colorectal cancer |
SCARA5 | 37150230 | Other | Unknown | Other | Colorectal cancer | SCARA5 in bone marrow stromal cell-derived exosomes inhibits colorectal cancer |
SCARA5 | 34417976 | Other | Unknown | Cell lines | Colorectal cancer | Tumor suppressive effect of scavenger receptor class A member 5 overexpression in |
SCARA5 | 29184442 | Other | Downregulated | Tissue | Colorectal cancer | Exome and transcriptome sequencing identifies loss of PDLIM2 in metastatic |
SCARA5 | 22399497 | Other | Unknown | Tissue | Colorectal cancer | Screening for epigenetically masked genes in colorectal cancer Using |
SCARA5 | 33247676 | Other | Unknown | Tissue | Colon Cancer | Pan-Cancer Multiomics Analysis of TC2N Gene Suggests its Important Role(s) in |
SCARA5 | 29019900 | Other | Unknown | Tissue | Cancer Related Liver | Methylation analysis of p16, SLIT2, SCARA5, and Runx3 genes in hepatocellular |
SCARA5 | 23627007 | Other | Unknown | Blood | Cancer Related Liver | Role of scavenger receptors in the pathophysiology of chronic liver diseases. |
GFRA2 | 31341364 | Other | Unknown | Other | Colorectal cancer | Identification of differentially expressed genes regulated by methylation in |
GFRA2 | 29184442 | Other | Downregulated | Tissue | Colorectal cancer | Exome and transcriptome sequencing identifies loss of PDLIM2 in metastatic |
GFRA2 | 31341364 | Other | Unknown | Other | Colon Cancer | Identification of differentially expressed genes regulated by methylation in |
CA7 | 29885515 | Other | Unknown | Other | Colorectal cancer | Human colorectal cancer initiation is bidirectional, and cell growth, metabolic |
CA7 | 24959000 | Other | Unknown | Tissue | Colorectal cancer | Gene expression profiling of colorectal tumors and normal mucosa by microarrays |
CA7 | 12910694 | Other | Unknown | Tissue | Colorectal cancer | [Detection of point mutation in p53 gene by capillary electrophoresis-PCR-SSCP |
CA7 | 29885515 | Other | Unknown | Other | Colon Cancer | Human colorectal cancer initiation is bidirectional, and cell growth, metabolic |
CA7 | 24959000 | Other | Unknown | Tissue | Colon Cancer | Gene expression profiling of colorectal tumors and normal mucosa by microarrays |
CA7 | 12910694 | Other | Unknown | Tissue | Colon Cancer | [Detection of point mutation in p53 gene by capillary electrophoresis-PCR-SSCP |
CA7 | 12057899 | Other | Unknown | Other | Colon Cancer | Endometrial and colorectal tumors from patients with hereditary nonpolyposis |
CA7 | 11709519 | Other | Unknown | Blood | Colon Cancer | Bile acid metabolism by fresh human colonic contents: a comparison of caecal |
CST1 | 36633774 | Other | Unknown | Tissue | Colorectal cancer | Circ_0001821 Potentiates Cell Growth, Metastasis, and Stemness in Colorectal |
CST1 | 29845224 | Other | Upregulated | Tissue | Colorectal cancer | Let‑7d inhibits colorectal cancer cell proliferation through the CST1/p65 |
CST1 | 28300829 | Other | Unknown | Saliva | Colorectal cancer | Cystatin SN inhibits auranofin-induced cell death by autophagic induction and ROS |
CST1 | 25577248 | Other | Unknown | Tissue | Colorectal cancer | Identification of cystatin SN as a novel biomarker for pancreatic cancer. |
CST1 | 24357805 | Other | Unknown | Tissue | Colorectal cancer | Cystatin SN neutralizes the inhibitory effect of cystatin C on cathepsin B |
CST1 | 15455346 | Other | Unknown | Urine | Colorectal cancer | Transcriptome analysis of a human colorectal cancer cell line shows molecular |
CST1 | 29845224 | Other | Upregulated | Tissue | Colon Cancer | Let‑7d inhibits colorectal cancer cell proliferation through the CST1/p65 |
CST1 | 24357805 | Other | Unknown | Tissue | Colon Cancer | Cystatin SN neutralizes the inhibitory effect of cystatin C on cathepsin B |
CST1 | 15455346 | Other | Unknown | Urine | Colon Cancer | Transcriptome analysis of a human colorectal cancer cell line shows molecular |
CST1 | 29720474 | Other | Unknown | Other | Cancer Related Liver | Functional and genomic characterisation of a xenograft model system for the study |
EPHX4 | 25929336 | Other | Unknown | Tissue | Colorectal cancer | Global gene expression in pseudomyxoma peritonei, with parallel development of |
EPHX4 | 25929336 | Other | Unknown | Tissue | Colon Cancer | Global gene expression in pseudomyxoma peritonei, with parallel development of |
ETV4 | 38200223 | Other | Unknown | Other | Colorectal cancer | Profiling the heterogeneity of colorectal cancer consensus molecular subtypes |
ETV4 | 38032469 | Other | Upregulated | Tissue | Colorectal cancer | Integration of single-cell transcriptomics and epigenetic analysis reveals |
ETV4 | 37478614 | Other | Unknown | Other | Colorectal cancer | Transcriptomic analysis reveals immune infiltration status and potential |
ETV4 | 36538275 | Other | Unknown | Other | Colorectal cancer | Cell cycle protein BORA is associated with colorectal cancer progression by |
ETV4 | 35892269 | Other | Unknown | Other | Colorectal cancer | Reliable epithelial-mesenchymal transition biomarkers for colorectal cancer |
ETV4 | 34824625 | Other | Unknown | Tissue | Colorectal cancer | Pilot Nanostring PanCancer pathway analysis of colon adenocarcinoma in a tertiary |
ETV4 | 38032469 | Other | Upregulated | Tissue | Colon Cancer | Integration of single-cell transcriptomics and epigenetic analysis reveals |
ETV4 | 34824625 | Other | Unknown | Tissue | Colon Cancer | Pilot Nanostring PanCancer pathway analysis of colon adenocarcinoma in a tertiary |
ETV4 | 34270850 | Other | Unknown | Tissue | Colon Cancer | ETV4 transcriptionally activates HES1 and promotes Stat3 phosphorylation to |
ETV4 | 32631391 | Other | Unknown | Tissue | Colon Cancer | Dysregulation of cancer genes by recurrent intergenic fusions. |
ETV4 | 37474643 | Other | Upregulated | Tissue | Cancer Related Liver | Heat shock protein family A member 8 serving as a co-activator of transcriptional |
ETV4 | 35296440 | Other | Unknown | Other | Cancer Related Liver | ETV4 potentiates nuclear YAP retention and activities to enhance the progression |
ETV4 | 35121725 | Other | Upregulated | Tissue | Cancer Related Liver | HBx increases chromatin accessibility and ETV4 expression to regulate |
ETV4 | 29251790 | Other | Unknown | Other | Cancer Related Liver | Capicua suppresses hepatocellular carcinoma progression by controlling the |
CPNE7 | 38526029 | Other | Unknown | Tissue | Colorectal cancer | Depletion of CPNE7 sensitizes colorectal cancer to 5-fluorouracil by |
CPNE7 | 37469397 | Other | Downregulated | Other | Colorectal cancer | Copine 7 promotes colorectal cancer proliferation through PKM2 interaction and |
TMIGD1 | 37087524 | Other | Unknown | Tissue | Colorectal cancer | TMIGD1: Emerging functions of a tumor supressor and adhesion receptor. |
TMIGD1 | 34477243 | Other | Unknown | Other | Colorectal cancer | Distinguishing colorectal adenoma from hyperplastic polyp by WNT2 expression. |
TMIGD1 | 33129760 | Other | Unknown | Other | Colorectal cancer | Transmembrane and Immunoglobulin Domain Containing 1, a Putative Tumor |
TMIGD1 | 35117711 | Other | Unknown | Other | Colorectal cancer | Identification of biomarkers for the diagnosis and treatment of primary |
TMIGD1 | 25929336 | Other | Unknown | Tissue | Colorectal cancer | Global gene expression in pseudomyxoma peritonei, with parallel development of |
TMIGD1 | 21538994 | Other | Unknown | Tissue | Colorectal cancer | Preinvasive colorectal lesion transcriptomes correlate with endoscopic morphology |
TMIGD1 | 34477243 | Other | Unknown | Other | Colon Cancer | Distinguishing colorectal adenoma from hyperplastic polyp by WNT2 expression. |
TMIGD1 | 33129760 | Other | Unknown | Other | Colon Cancer | Transmembrane and Immunoglobulin Domain Containing 1, a Putative Tumor |
TMIGD1 | 32303178 | Other | Downregulated | Plasma | Colon Cancer | The mitochondrial outer membrane protein SYNJ2BP interacts with the cell adhesion |
TMIGD1 | 25929336 | Other | Unknown | Tissue | Colon Cancer | Global gene expression in pseudomyxoma peritonei, with parallel development of |
OTOP3 | 34477243 | Other | Unknown | Other | Colorectal cancer | Distinguishing colorectal adenoma from hyperplastic polyp by WNT2 expression. |
OTOP3 | 34477243 | Other | Unknown | Other | Colon Cancer | Distinguishing colorectal adenoma from hyperplastic polyp by WNT2 expression. |
OTOP2 | 35418782 | Other | Unknown | Tissue | Colorectal cancer | OTOP2, Inversely Modulated by miR-3148, Inhibits CRC Cell Migration, |
OTOP2 | 30954025 | Other | Upregulated | Tissue | Colorectal cancer | Colonic Mucosal Transcriptomic Changes in Patients with Long-Duration Ulcerative |
OTOP2 | 30652071 | Other | Unknown | Tissue | Colorectal cancer | Wild-type p53 regulates OTOP2 transcription through DNA loop alteration of the |
OTOP2 | 30954025 | Other | Upregulated | Tissue | Colon Cancer | Colonic Mucosal Transcriptomic Changes in Patients with Long-Duration Ulcerative |
OTOP2 | 30814735 | Other | Unknown | Other | Colon Cancer | Colonic epithelial cell diversity in health and inflammatory bowel disease. |
SFTA2 | 36064367 | Other | Unknown | Other | Colorectal cancer | Identification of genes with high heterogeneity of expression as a predictor of |
S100A2 | 37647260 | Other | Unknown | Other | Colorectal cancer | Sinapine thiocyanate exhibited anti-colorectal cancer effects by inhibiting |
S100A2 | 34802034 | Other | Unknown | Other | Colorectal cancer | The interaction between S100A2 and KPNA2 mediates NFYA nuclear import and is a |
S100A2 | 32816365 | Other | Upregulated | Tissue | Colorectal cancer | S100A2 promotes glycolysis and proliferation via GLUT1 regulation in colorectal |
S100A2 | 26474385 | Other | Unknown | Tissue | Colorectal cancer | Novel RNA variants in colorectal cancers. |
S100A2 | 35114371 | Other | Upregulated | Cell lines | Colon Cancer | 3,5-Bis(trifluoromethyl)phenylsulfonamides, a novel pancreatic cancer active |
S100A2 | 11510959 | Other | Unknown | Tissue | Colon Cancer | Development and progression of malignancy in human colon tissues are correlated |
BLACAT1 | 34321169 | Other | Unknown | Other | Colorectal cancer | Oncogenic roles of lncRNA BLACAT1 and its related mechanisms in human cancers. |
BLACAT1 | 33376405 | Other | Unknown | Tissue | Colorectal cancer | LncRNA BLACAT1/miR-519d-3p/CREB1 Axis Mediates Proliferation, Apoptosis, |
BLACAT1 | 35116731 | Other | Unknown | Tissue | Colorectal cancer | Overexpression of the long non-coding RNA BLACAT1 promotes cell proliferation and |
BLACAT1 | 30453959 | Other | Unknown | Tissue | Colorectal cancer | Genomic analyses based on pulmonary adenocarcinoma in situ reveal early lung |
BLACAT1 | 35116731 | Other | Unknown | Tissue | Colon Cancer | Overexpression of the long non-coding RNA BLACAT1 promotes cell proliferation and |
DBF4 | 35282117 | Other | Upregulated | Other | Esophageal cancer | Analysis of cancer-promoting genes related to chemotherapy resistance in |
DBF4 | 35282117 | Other | Upregulated | Other | Esophageal Adenocarcinoma | Analysis of cancer-promoting genes related to chemotherapy resistance in |
DBF4 | 35282117 | Other | Upregulated | Other | Esophageal Squamous Cell Carcinoma | Analysis of cancer-promoting genes related to chemotherapy resistance in |
DBF4 | 35282117 | Other | Upregulated | Other | Cancer Related Esophageal | Analysis of cancer-promoting genes related to chemotherapy resistance in |
TYMP | 27222202 | Other | Upregulated | Tissue | Esophageal cancer | Genome-wide analysis of the effect of esophageal squamous cell carcinoma on human |
TYMP | 26416564 | Other | Unknown | Other | Esophageal cancer | Biomodulation of capecitabine by paclitaxel and carboplatin in advanced solid |
TYMP | 26416564 | Other | Unknown | Other | Esophageal Adenocarcinoma | Biomodulation of capecitabine by paclitaxel and carboplatin in advanced solid |
TYMP | 27222202 | Other | Upregulated | Tissue | Esophageal Squamous Cell Carcinoma | Genome-wide analysis of the effect of esophageal squamous cell carcinoma on human |
HOXC8 | 32158227 | Other | Unknown | Other | Esophageal cancer | LncRNA SNHG1 Regulates the Progression of Esophageal Squamous Cell Cancer by the |
HOXC8 | 31389660 | Other | Unknown | Tissue | Esophageal cancer | Down-regulation of long non-coding RNA HOTAIR inhibits invasion and migration of |
HOXC8 | 17659465 | Other | Unknown | Cell lines | Esophageal cancer | [Expression of 39 HOX genes in esophageal cancer cell lines]. |
HOXC8 | 31389660 | Other | Unknown | Tissue | Esophageal Squamous Cell Carcinoma | Down-regulation of long non-coding RNA HOTAIR inhibits invasion and migration of |
HOXC8 | 17659465 | Other | Unknown | Cell lines | Esophageal Squamous Cell Carcinoma | [Expression of 39 HOX genes in esophageal cancer cell lines]. |
HOXC8 | 17659465 | Other | Unknown | Cell lines | Cancer Related Esophageal | [Expression of 39 HOX genes in esophageal cancer cell lines]. |
TRIP13 | 38274384 | Other | Unknown | Other | Esophageal cancer | RIOK1 synergizes with TRIP13 by regulating the E2F-Rb signaling pathway to |
TRIP13 | 35601150 | Other | Unknown | Other | Esophageal cancer | TRIP13 Induces Nedaplatin Resistance in Esophageal Squamous Cell Carcinoma by |
TRIP13 | 35601150 | Other | Unknown | Other | Esophageal Squamous Cell Carcinoma | TRIP13 Induces Nedaplatin Resistance in Esophageal Squamous Cell Carcinoma by |
BIRC5 | 34517565 | Other | Upregulated | Other | Esophageal cancer | Upregulation of BIRC5 plays essential role in esophageal squamous cell carcinoma. |
BIRC5 | 34121605 | Other | Unknown | Tissue | Esophageal cancer | RELT promotes the growth of esophageal squamous cell carcinoma by activating the |
BIRC5 | 33737385 | Other | Unknown | Other | Esophageal cancer | Mutant p53 regulates Survivin to foster lung metastasis. |
BIRC5 | 32846774 | Other | Unknown | Tissue | Esophageal cancer | Expression of SIRT1 and survivin correlates with poor prognosis in esophageal |
BIRC5 | 32673063 | Other | Upregulated | Tissue | Esophageal cancer | Identification of KHSRP-Regulated RNAs in Esophageal Cancer by Integrated |
BIRC5 | 29473241 | Other | Upregulated | Tissue | Esophageal Adenocarcinoma | Immunohistochemical assessment of Survivin and Bcl3 expression as potential |
BIRC5 | 20235790 | Other | Unknown | Blood | Esophageal Adenocarcinoma | Preoperative survivin mRNA detection in peripheral blood is an independent |
BIRC5 | 19653263 | Other | Unknown | Blood | Esophageal Adenocarcinoma | Quantitative analysis of survivin RNA expression in blood as a non-invasive |
BIRC5 | 19352701 | Other | Unknown | Tissue | Esophageal Adenocarcinoma | Polymorphisms of survivin promoter are associated with risk of esophageal |
BIRC5 | 34517565 | Other | Upregulated | Other | Esophageal Squamous Cell Carcinoma | Upregulation of BIRC5 plays essential role in esophageal squamous cell carcinoma. |
BIRC5 | 34121605 | Other | Unknown | Tissue | Esophageal Squamous Cell Carcinoma | RELT promotes the growth of esophageal squamous cell carcinoma by activating the |
BIRC5 | 33737385 | Other | Unknown | Other | Esophageal Squamous Cell Carcinoma | Mutant p53 regulates Survivin to foster lung metastasis. |
BIRC5 | 32846774 | Other | Unknown | Tissue | Esophageal Squamous Cell Carcinoma | Expression of SIRT1 and survivin correlates with poor prognosis in esophageal |
BIRC5 | 30075571 | Other | Unknown | Tissue | Esophageal Squamous Cell Carcinoma | Excision repair cross-complementing group 1 (ERCC1) overexpression inhibits cell |
BIRC5 | 29523849 | Other | Unknown | Other | Esophageal Squamous Cell Carcinoma | p63 is a key regulator of iRHOM2 signalling in the keratinocyte stress response. |
BIRC5 | 34517565 | Other | Upregulated | Other | Cancer Related Esophageal | Upregulation of BIRC5 plays essential role in esophageal squamous cell carcinoma. |
BIRC5 | 34121605 | Other | Unknown | Tissue | Cancer Related Esophageal | RELT promotes the growth of esophageal squamous cell carcinoma by activating the |
BIRC5 | 22646166 | Other | Unknown | Cell lines | Cancer Related Esophageal | The RNA-binding protein CUG-BP1 increases survivin expression in oesophageal |
BIRC5 | 21443519 | Other | Unknown | Other | Cancer Related Esophageal | The RNA-binding protein HuR stabilizes survivin mRNA in human oesophageal |
HNRNPC | 37417427 | Other | Unknown | Other | Esophageal cancer | Circular RNA circ-FIRRE interacts with HNRNPC to promote esophageal squamous cell |
HNRNPC | 33748145 | Other | Unknown | Other | Esophageal cancer | m6A Regulators Is Differently Expressed and Correlated With Immune Response of |
HNRNPC | 30824187 | Other | Unknown | Tissue | Esophageal cancer | LBX2-AS1 is activated by ZEB1 and promotes the development of esophageal squamous |
HNRNPC | 37417427 | Other | Unknown | Other | Esophageal Squamous Cell Carcinoma | Circular RNA circ-FIRRE interacts with HNRNPC to promote esophageal squamous cell |
HNRNPC | 30824187 | Other | Unknown | Tissue | Esophageal Squamous Cell Carcinoma | LBX2-AS1 is activated by ZEB1 and promotes the development of esophageal squamous |
HNRNPC | 30824187 | Other | Unknown | Tissue | Cancer Related Esophageal | LBX2-AS1 is activated by ZEB1 and promotes the development of esophageal squamous |
IL11 | 36873192 | Other | Unknown | Other | Esophageal cancer | PAFR/Stat3 axis maintains the symbiotic ecosystem between tumor and stroma to |
IL11 | 31544245 | Other | Unknown | Cell lines | Esophageal cancer | miR-204-5p regulates cell proliferation, invasion, and apoptosis by targeting |
IL11 | 30954889 | Other | Unknown | Tissue | Esophageal cancer | IL-11 activated by lnc-ATB promotes cell proliferation and invasion in esophageal |
IL11 | 36873192 | Other | Unknown | Other | Esophageal Squamous Cell Carcinoma | PAFR/Stat3 axis maintains the symbiotic ecosystem between tumor and stroma to |
IL11 | 31544245 | Other | Unknown | Cell lines | Esophageal Squamous Cell Carcinoma | miR-204-5p regulates cell proliferation, invasion, and apoptosis by targeting |
IL11 | 30954889 | Other | Unknown | Tissue | Esophageal Squamous Cell Carcinoma | IL-11 activated by lnc-ATB promotes cell proliferation and invasion in esophageal |
IL11 | 36873192 | Other | Unknown | Other | Cancer Related Esophageal | PAFR/Stat3 axis maintains the symbiotic ecosystem between tumor and stroma to |
IL11 | 31544245 | Other | Unknown | Cell lines | Cancer Related Esophageal | miR-204-5p regulates cell proliferation, invasion, and apoptosis by targeting |
MMP11 | 12680208 | Other | Unknown | Tissue | Esophageal cancer | Transcriptional gene expression profiles of oesophageal adenocarcinoma and normal |
MMP11 | 12680208 | Other | Unknown | Tissue | Esophageal Adenocarcinoma | Transcriptional gene expression profiles of oesophageal adenocarcinoma and normal |
MMP11 | 12680208 | Other | Unknown | Tissue | Cancer Related Esophageal | Transcriptional gene expression profiles of oesophageal adenocarcinoma and normal |
PSMA7 | 38173490 | Other | Unknown | Tissue | Esophageal cancer | PSMA7 promotes the malignant proliferation of esophageal cancer. |
CDC25B | 33442418 | Other | Unknown | Tissue | Esophageal cancer | LncRNA FAM83A-AS1 promotes ESCC progression by regulating miR-214/CDC25B axis. |
CDC25B | 28954387 | Other | Unknown | Tissue | Esophageal cancer | MiR-214 inhibits the proliferation and invasion of esophageal squamous cell |
CDC25B | 23605218 | Other | Unknown | Other | Esophageal cancer | Biomarkers for predicting the response of esophageal squamous cell carcinoma to |
CDC25B | 18722351 | Other | Unknown | Tissue | Esophageal cancer | Proteomics-based identification of autoantibody against CDC25B as a novel serum |
CDC25B | 12680208 | Other | Unknown | Tissue | Esophageal Adenocarcinoma | Transcriptional gene expression profiles of oesophageal adenocarcinoma and normal |
CDC25B | 33442418 | Other | Unknown | Tissue | Esophageal Squamous Cell Carcinoma | LncRNA FAM83A-AS1 promotes ESCC progression by regulating miR-214/CDC25B axis. |
CDC25B | 28954387 | Other | Unknown | Tissue | Esophageal Squamous Cell Carcinoma | MiR-214 inhibits the proliferation and invasion of esophageal squamous cell |
CDC25B | 23605218 | Other | Unknown | Other | Esophageal Squamous Cell Carcinoma | Biomarkers for predicting the response of esophageal squamous cell carcinoma to |
CDC25B | 18722351 | Other | Unknown | Tissue | Esophageal Squamous Cell Carcinoma | Proteomics-based identification of autoantibody against CDC25B as a novel serum |
CDC25B | 18559558 | Other | Unknown | Tissue | Esophageal Squamous Cell Carcinoma | Overexpression of CDC25B and LAMC2 mRNA and protein in esophageal squamous cell |
CDC25B | 17187659 | Other | Unknown | Tissue | Esophageal Squamous Cell Carcinoma | Tissue microarray analysis reveals a tight correlation between protein expression |
CDC25B | 33442418 | Other | Unknown | Tissue | Cancer Related Esophageal | LncRNA FAM83A-AS1 promotes ESCC progression by regulating miR-214/CDC25B axis. |
CDC25B | 18559558 | Other | Unknown | Tissue | Cancer Related Esophageal | Overexpression of CDC25B and LAMC2 mRNA and protein in esophageal squamous cell |
CDC25B | 17187659 | Other | Unknown | Tissue | Cancer Related Esophageal | Tissue microarray analysis reveals a tight correlation between protein expression |
CDC25B | 12680208 | Other | Unknown | Tissue | Cancer Related Esophageal | Transcriptional gene expression profiles of oesophageal adenocarcinoma and normal |
CDC25B | 11705871 | Other | Unknown | Tissue | Cancer Related Esophageal | Profiling of differentially expressed cancer-related genes in esophageal squamous |
PDAP1 | 26750096 | Other | Unknown | Other | Esophageal cancer | Quantitative Profiling of the Activity of Protein Lysine Methyltransferase SMYD2 |
PDAP1 | 26750096 | Other | Unknown | Other | Esophageal Squamous Cell Carcinoma | Quantitative Profiling of the Activity of Protein Lysine Methyltransferase SMYD2 |
LIMK1 | 30551528 | Other | Unknown | Other | Esophageal cancer | MicroRNA-384 inhibits the progression of esophageal squamous cell carcinoma |
LIMK1 | 30551528 | Other | Unknown | Other | Esophageal Squamous Cell Carcinoma | MicroRNA-384 inhibits the progression of esophageal squamous cell carcinoma |
LIMK1 | 30551528 | Other | Unknown | Other | Cancer Related Esophageal | MicroRNA-384 inhibits the progression of esophageal squamous cell carcinoma |
RFC3 | 25351503 | Other | Unknown | Other | Esophageal cancer | Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive |
RFC3 | 25351503 | Other | Unknown | Other | Esophageal Adenocarcinoma | Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive |
MMP3 | 38296593 | Other | Unknown | Blood | Esophageal cancer | Sulforaphane activates CD8(+) T cells antitumor response through |
MMP3 | 37551683 | Other | Unknown | Other | Esophageal cancer | MMP-3 -1171 5A/6A promoter polymorphism and cancer susceptibility: an updated |
MMP3 | 34646138 | Other | Unknown | Other | Esophageal cancer | Five-Decade Update on Chemopreventive and Other Pharmacological Potential of |
MMP3 | 34559117 | Other | Unknown | Tissue | Esophageal cancer | Polymorphisms of matrix metalloproteinases affect the susceptibility of |
MMP3 | 32850952 | Other | Upregulated | Other | Esophageal cancer | Silencing of Long Non-coding RNA NEAT1 Upregulates miR-195a to Attenuate |
MMP3 | 32825936 | Other | Unknown | Tissue | Esophageal cancer | Identification of methylated-differentially expressed genes and pathways in |
MMP3 | 32711119 | Other | Unknown | Cell lines | Esophageal cancer | TWIST1 upregulates matrix metalloproteinase (MMP) genes family in esophageal |
MMP3 | 22422400 | Other | Unknown | Other | Esophageal Adenocarcinoma | Single nucleotide polymorphisms in the matrix metalloproteinase gene family and |
MMP3 | 19321798 | Other | Unknown | Other | Esophageal Adenocarcinoma | Matrix metalloproteinase 1, 3 and 12 polymorphisms and esophageal adenocarcinoma |
MMP3 | 15319302 | Other | Unknown | Other | Esophageal Adenocarcinoma | The functional SNP in the matrix metalloproteinase-3 promoter modifies |
MMP3 | 32850952 | Other | Upregulated | Other | Esophageal Squamous Cell Carcinoma | Silencing of Long Non-coding RNA NEAT1 Upregulates miR-195a to Attenuate |
MMP3 | 32825936 | Other | Unknown | Tissue | Esophageal Squamous Cell Carcinoma | Identification of methylated-differentially expressed genes and pathways in |
MMP3 | 32711119 | Other | Unknown | Cell lines | Esophageal Squamous Cell Carcinoma | TWIST1 upregulates matrix metalloproteinase (MMP) genes family in esophageal |
MMP3 | 30969151 | Other | Upregulated | Cell lines | Esophageal Squamous Cell Carcinoma | CCAAT/Enhancer Binding Protein beta-Mediated MMP3 Upregulation Promotes Esophageal |
MMP3 | 29916547 | Other | Unknown | Tissue | Esophageal Squamous Cell Carcinoma | XBP1 promotes tumor invasion and is associated with poor prognosis in oral |
MMP3 | 29763634 | Other | Upregulated | Tissue | Esophageal Squamous Cell Carcinoma | Novel long noncoding RNA NMR promotes tumor progression via NSUN2 and BPTF in |
MMP3 | 32850952 | Other | Upregulated | Other | Cancer Related Esophageal | Silencing of Long Non-coding RNA NEAT1 Upregulates miR-195a to Attenuate |
MMP3 | 32711119 | Other | Unknown | Cell lines | Cancer Related Esophageal | TWIST1 upregulates matrix metalloproteinase (MMP) genes family in esophageal |
MMP3 | 28209530 | Other | Unknown | Tissue | Cancer Related Esophageal | Solute Carrier Family 39 Member 6 Gene Promotes Aggressiveness of Esophageal |
MMP3 | 23644699 | Other | Unknown | Other | Cancer Related Esophageal | Association between promoters polymorphisms of matrix metalloproteinases and risk |
MMP3 | 22422400 | Other | Unknown | Other | Cancer Related Esophageal | Single nucleotide polymorphisms in the matrix metalloproteinase gene family and |
MMP3 | 19321798 | Other | Unknown | Other | Cancer Related Esophageal | Matrix metalloproteinase 1, 3 and 12 polymorphisms and esophageal adenocarcinoma |
TDO2 | 30134247 | Other | Unknown | Tissue | Esophageal cancer | TDO2 Overexpression Is Associated with Cancer Stem Cells and Poor Prognosis in |
TDO2 | 30134247 | Other | Unknown | Tissue | Esophageal Squamous Cell Carcinoma | TDO2 Overexpression Is Associated with Cancer Stem Cells and Poor Prognosis in |
MAGOH | 12821948 | Other | Unknown | Other | Esophageal cancer | Physical and transcript map of the minimally deleted region III on 17p implicated |
MAGOH | 12821948 | Other | Unknown | Other | Esophageal Adenocarcinoma | Physical and transcript map of the minimally deleted region III on 17p implicated |
ESM1 | 20139130 | Other | Downregulated | Cell lines | Esophageal cancer | An integrative genomic approach in oesophageal cells identifies TRB3 as a bile |
ESM1 | 20139130 | Other | Downregulated | Cell lines | Esophageal Adenocarcinoma | An integrative genomic approach in oesophageal cells identifies TRB3 as a bile |
MCM7 | 35711839 | Other | Upregulated | Blood | Esophageal cancer | 3,3'-Diindolylmethane plus Eflornithine suppress DNA Replication and Cell Cycle |
MCM7 | 32913912 | Other | Unknown | Other | Esophageal cancer | Proteomic variations of esophageal squamous cell carcinoma revealed by combining |
MCM7 | 32884453 | Other | Unknown | Other | Esophageal cancer | Good or not good: Role of miR-18a in cancer biology. |
MCM7 | 28498460 | Other | Unknown | Other | Esophageal cancer | MCM7 amplification and overexpression promote cell proliferation, colony |
MCM7 | 19422085 | Other | Upregulated | Tissue | Esophageal cancer | The miR-106b-25 polycistron, activated by genomic amplification, functions as an |
MCM7 | 32884453 | Other | Unknown | Other | Esophageal Adenocarcinoma | Good or not good: Role of miR-18a in cancer biology. |
MCM7 | 19422085 | Other | Upregulated | Tissue | Esophageal Adenocarcinoma | The miR-106b-25 polycistron, activated by genomic amplification, functions as an |
MCM7 | 19167610 | Other | Unknown | Other | Esophageal Adenocarcinoma | Array comparative genomic hybridization, expression array, and protein analysis |
MCM7 | 35711839 | Other | Upregulated | Blood | Esophageal Squamous Cell Carcinoma | 3,3'-Diindolylmethane plus Eflornithine suppress DNA Replication and Cell Cycle |
MCM7 | 32913912 | Other | Unknown | Other | Esophageal Squamous Cell Carcinoma | Proteomic variations of esophageal squamous cell carcinoma revealed by combining |
MCM7 | 32884453 | Other | Unknown | Other | Esophageal Squamous Cell Carcinoma | Good or not good: Role of miR-18a in cancer biology. |
MCM7 | 28498460 | Other | Unknown | Other | Esophageal Squamous Cell Carcinoma | MCM7 amplification and overexpression promote cell proliferation, colony |
MCM7 | 32913912 | Other | Unknown | Other | Cancer Related Esophageal | Proteomic variations of esophageal squamous cell carcinoma revealed by combining |
MCM7 | 32884453 | Other | Unknown | Other | Cancer Related Esophageal | Good or not good: Role of miR-18a in cancer biology. |
CXCL8 | 38091397 | Other | Unknown | Other | Esophageal cancer | Comprehensive single-cell analysis demonstrates radiotherapy-induced infiltration |
CXCL8 | 36134663 | Other | Unknown | Other | Esophageal cancer | AI-assisted discovery of an ethnicity-influenced driver of cell transformation in |
CXCL8 | 35688292 | Other | Unknown | Other | Esophageal cancer | Insulin receptor substrate 1(IRS1) is related with lymph node metastases and |
CXCL8 | 35479061 | Other | Upregulated | Tissue | Esophageal cancer | Esophageal squamous cell carcinoma: Integrated bioinformatics analysis for |
CXCL8 | 36134663 | Other | Unknown | Other | Esophageal Adenocarcinoma | AI-assisted discovery of an ethnicity-influenced driver of cell transformation in |
CXCL8 | 33441691 | Other | Unknown | Tissue | Esophageal Adenocarcinoma | Lipid droplet biogenesis and COX-2 pathway activation are triggered by Barrett's |
CXCL8 | 33290281 | Other | Unknown | Tissue | Esophageal Adenocarcinoma | Immune determinants of Barrett's progression to esophageal adenocarcinoma. |
CXCL8 | 30998992 | Other | Unknown | Tissue | Esophageal Adenocarcinoma | High-Fat Diet Accelerates Carcinogenesis in a Mouse Model of Barrett's Esophagus |
CXCL8 | 28586026 | Other | Unknown | Cell lines | Esophageal Adenocarcinoma | Effects of galectin-9 on apoptosis, cell cycle and autophagy in human esophageal |
CXCL8 | 20334899 | Other | Unknown | Blood | Esophageal Adenocarcinoma | Expression of angiostatic platelet factor-4var/CXCL4L1 counterbalances angiogenic |
CXCL8 | 38091397 | Other | Unknown | Other | Esophageal Squamous Cell Carcinoma | Comprehensive single-cell analysis demonstrates radiotherapy-induced infiltration |
CXCL8 | 36142285 | Other | Upregulated | Plasma | Esophageal Squamous Cell Carcinoma | Inflammatory and Proliferative Pathway Activation in Human Esophageal |
CXCL8 | 35688292 | Other | Unknown | Other | Esophageal Squamous Cell Carcinoma | Insulin receptor substrate 1(IRS1) is related with lymph node metastases and |
CXCL8 | 35479061 | Other | Upregulated | Tissue | Esophageal Squamous Cell Carcinoma | Esophageal squamous cell carcinoma: Integrated bioinformatics analysis for |
CXCL8 | 33441691 | Other | Unknown | Tissue | Esophageal Squamous Cell Carcinoma | Lipid droplet biogenesis and COX-2 pathway activation are triggered by Barrett's |
CXCL8 | 35688292 | Other | Unknown | Other | Cancer Related Esophageal | Insulin receptor substrate 1(IRS1) is related with lymph node metastases and |
CXCL8 | 35174914 | Other | Unknown | Other | Cancer Related Esophageal | Network pharmacology reveals potential functional components and underlying |
CXCL8 | 31488216 | Other | Unknown | Tissue | Cancer Related Esophageal | Phase I trial of HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, in |
CXCL8 | 29520695 | Other | Unknown | Blood | Cancer Related Esophageal | AKIP1 promotes angiogenesis and tumor growth by upregulating CXC-chemokines in |
CXCL8 | 28586026 | Other | Unknown | Cell lines | Cancer Related Esophageal | Effects of galectin-9 on apoptosis, cell cycle and autophagy in human esophageal |
HOXC9 | 17659465 | Other | Unknown | Cell lines | Esophageal cancer | [Expression of 39 HOX genes in esophageal cancer cell lines]. |
HOXC9 | 17659465 | Other | Unknown | Cell lines | Esophageal Squamous Cell Carcinoma | [Expression of 39 HOX genes in esophageal cancer cell lines]. |
HOXC9 | 17659465 | Other | Unknown | Cell lines | Cancer Related Esophageal | [Expression of 39 HOX genes in esophageal cancer cell lines]. |
KPNA2 | 31695414 | Other | Upregulated | Tissue | Esophageal cancer | SNHG8 is upregulated in esophageal squamous cell carcinoma and directly sponges |
KPNA2 | 25109899 | Other | Unknown | Tissue | Esophageal cancer | KPNA2 is a promising biomarker candidate for esophageal squamous cell carcinoma |
KPNA2 | 16487489 | Other | Unknown | Tissue | Esophageal cancer | Polo-like kinase and survivin are esophageal tumor-specific promoters. |
KPNA2 | 34785905 | Other | Upregulated | Other | Esophageal Squamous Cell Carcinoma | SNHG8 is Upregulated in Esophageal Squamous Cell Carcinoma and Directly Sponges |
KPNA2 | 31695414 | Other | Upregulated | Tissue | Esophageal Squamous Cell Carcinoma | SNHG8 is upregulated in esophageal squamous cell carcinoma and directly sponges |
KPNA2 | 25109899 | Other | Unknown | Tissue | Esophageal Squamous Cell Carcinoma | KPNA2 is a promising biomarker candidate for esophageal squamous cell carcinoma |
ISG15 | 38781019 | Other | Unknown | Tissue | Esophageal cancer | ISG15-GRAIL1-CD3 axis influences survival of esophageal adenocarcinoma patients. |
ISG15 | 38091397 | Other | Unknown | Other | Esophageal cancer | Comprehensive single-cell analysis demonstrates radiotherapy-induced infiltration |
ISG15 | 32010432 | Other | Unknown | Other | Esophageal cancer | Correction: UBE2L6/UBCH8 and ISG15 attenuate autophagy in esophageal cancer |
ISG15 | 28186990 | Other | Unknown | Cell lines | Esophageal cancer | UBE2L6/UBCH8 and ISG15 attenuate autophagy in esophageal cancer cells. |
ISG15 | 16101138 | Other | Unknown | Cell lines | Esophageal cancer | 5-Fluorouracil up-regulates interferon pathway gene expression in esophageal |
ISG15 | 38781019 | Other | Unknown | Tissue | Esophageal Adenocarcinoma | ISG15-GRAIL1-CD3 axis influences survival of esophageal adenocarcinoma patients. |
ISG15 | 38091397 | Other | Unknown | Other | Esophageal Squamous Cell Carcinoma | Comprehensive single-cell analysis demonstrates radiotherapy-induced infiltration |
ISG15 | 16101138 | Other | Unknown | Cell lines | Esophageal Squamous Cell Carcinoma | 5-Fluorouracil up-regulates interferon pathway gene expression in esophageal |
ISG15 | 38781019 | Other | Unknown | Tissue | Cancer Related Esophageal | ISG15-GRAIL1-CD3 axis influences survival of esophageal adenocarcinoma patients. |
ISG15 | 16101138 | Other | Unknown | Cell lines | Cancer Related Esophageal | 5-Fluorouracil up-regulates interferon pathway gene expression in esophageal |
SUMO2 | 36915458 | Other | Unknown | Other | Esophageal cancer | Network and pathway-based analysis of candidate genes associated with esophageal |
SUMO2 | 34185429 | Other | Unknown | Tissue | Esophageal cancer | Aberrant MCM10 SUMOylation induces genomic instability mediated by a genetic |
SUMO2 | 32945483 | Other | Unknown | Tissue | Esophageal cancer | SUMOylation of HSP27 regulates PKM2 to promote esophageal squamous cell carcinoma |
SUMO2 | 36915458 | Other | Unknown | Other | Esophageal Adenocarcinoma | Network and pathway-based analysis of candidate genes associated with esophageal |
SUMO2 | 34185429 | Other | Unknown | Tissue | Esophageal Squamous Cell Carcinoma | Aberrant MCM10 SUMOylation induces genomic instability mediated by a genetic |
SUMO2 | 32945483 | Other | Unknown | Tissue | Esophageal Squamous Cell Carcinoma | SUMOylation of HSP27 regulates PKM2 to promote esophageal squamous cell carcinoma |
SUMO2 | 36915458 | Other | Unknown | Other | Cancer Related Esophageal | Network and pathway-based analysis of candidate genes associated with esophageal |
SUMO2 | 32945483 | Other | Unknown | Tissue | Cancer Related Esophageal | SUMOylation of HSP27 regulates PKM2 to promote esophageal squamous cell carcinoma |
SEMA3F | 37599522 | Other | Unknown | Tissue | Hepatocellular Carcinoma | Advances in SEMA3F regulation of clinically high-incidence cancers. |
SEMA3F | 34238242 | Other | Unknown | Tissue | Hepatocellular Carcinoma | Genetic expression and mutational profile analysis in different pathologic stages |
SEMA3F | 34026328 | Other | Unknown | Tissue | Hepatocellular Carcinoma | ncRNAs-mediated high expression of SEMA3F correlates with poor prognosis and |
SEMA3F | 31968181 | Other | Upregulated | Tissue | Hepatocellular Carcinoma | SEMA3F Promotes Liver Hepatocellular Carcinoma Metastasis by Activating Focal |
SEMA3F | 38034016 | Other | Unknown | Tissue | Liver Cancer | Proteome profiling identifies circulating biomarkers associated with hepatic |
SEMA3F | 37599522 | Other | Unknown | Tissue | Liver Cancer | Advances in SEMA3F regulation of clinically high-incidence cancers. |
SEMA3F | 34238242 | Other | Unknown | Tissue | Liver Cancer | Genetic expression and mutational profile analysis in different pathologic stages |
SEMA3F | 31968181 | Other | Upregulated | Tissue | Liver Cancer | SEMA3F Promotes Liver Hepatocellular Carcinoma Metastasis by Activating Focal |
SEMA3F | 26447612 | Other | Unknown | Tissue | Liver Cancer | The axon guidance molecule semaphorin 3F is a negative regulator of tumor |
SEMA3F | 25866254 | Other | Unknown | Tissue | Liver Cancer | SEMA3F prevents metastasis of colorectal cancer by PI3K-AKT-dependent |
SEMA3F | 21349996 | Other | Unknown | Tissue | Liver Cancer | Endogenous axon guiding chemorepulsant semaphorin-3F inhibits the growth and |
SEMA3F | 20664165 | Other | Upregulated | Other | Liver Cancer | Semaphorin 3E, an exception to the rule. |
SEMA3F | 8786119 | Other | Unknown | Tissue | Liver Cancer | Isolation of the human semaphorin III/F gene (SEMA3F) at chromosome 3p21, a |
SEMA3F | 38034016 | Other | Unknown | Tissue | Cancer Related Liver | Proteome profiling identifies circulating biomarkers associated with hepatic |
SEMA3F | 37599522 | Other | Unknown | Tissue | Cancer Related Liver | Advances in SEMA3F regulation of clinically high-incidence cancers. |
SEMA3F | 34238242 | Other | Unknown | Tissue | Cancer Related Liver | Genetic expression and mutational profile analysis in different pathologic stages |
SEMA3F | 8786119 | Other | Unknown | Tissue | Cancer Related Liver | Isolation of the human semaphorin III/F gene (SEMA3F) at chromosome 3p21, a |
MARCO | 38801968 | Other | Unknown | Other | Hepatocellular Carcinoma | A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection |
MARCO | 38771633 | Other | Unknown | Other | Hepatocellular Carcinoma | Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular |
MARCO | 38426262 | Other | Unknown | Other | Hepatocellular Carcinoma | Characteristics and outcome of anti-hepatitis D virus positive patients with |
MARCO | 38398400 | Other | Unknown | Other | Hepatocellular Carcinoma | Aging with a Liver Graft: Analysis of Very Long-Term Survivors after Liver |
MARCO | 38065400 | Other | Unknown | Other | Hepatocellular Carcinoma | Blocking MARCO(+) tumor-associated macrophages improves anti-PD-L1 therapy of |
MARCO | 38780693 | Other | Unknown | Other | Liver Cancer | Radiologic Occult Metastases in Pancreatic Cancer: Analysis of Risk Factors and |
MARCO | 38771633 | Other | Unknown | Other | Liver Cancer | Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular |
MARCO | 38674284 | Other | Unknown | Other | Liver Cancer | Management of Malignant Gastric Outlet Obstruction: A Comprehensive Review on the |
MARCO | 38458884 | Other | Unknown | Other | Liver Cancer | Artificial Intelligence-assisted colonoscopy and colorectal cancer screening: |
MARCO | 38426262 | Other | Unknown | Other | Liver Cancer | Characteristics and outcome of anti-hepatitis D virus positive patients with |
MARCO | 38345714 | Other | Unknown | Tissue | Liver Cancer | High dose proton and photon-based radiation therapy for 213 liver lesions: a |
MARCO | 36980187 | Other | Unknown | Other | Bile duct cancer | Heterogeneity of Cholangiocarcinoma Immune Biology. |
MARCO | 35896070 | Other | Unknown | Other | Bile duct cancer | [Clinicopathological profile of patients with hepatobiliary cancers at two main |
MARCO | 35200376 | Other | Unknown | Tissue | Bile duct cancer | Electrical Impedance-Based Characterization of Hepatic Tissue with Early-Stage |
MARCO | 32333323 | Other | Unknown | Other | Bile duct cancer | The robotic-assisted approach for left-side predominance hilar |
MARCO | 28943450 | Other | Upregulated | Other | Bile duct cancer | Pathological features of primary sclerosing cholangitis identified by bile |
MARCO | 38345714 | Other | Unknown | Tissue | Cholangiocarcinoma | High dose proton and photon-based radiation therapy for 213 liver lesions: a |
MARCO | 37681152 | Other | Unknown | Other | Cholangiocarcinoma | Fibroblast growth factor receptors as targets for anticancer therapy in |
MARCO | 36980187 | Other | Unknown | Other | Cholangiocarcinoma | Heterogeneity of Cholangiocarcinoma Immune Biology. |
MARCO | 34198568 | Other | Unknown | Other | Cholangiocarcinoma | Cutaneous Metastases from Primary Liver Cancers: The Need for Knowledge and |
MARCO | 38771633 | Other | Unknown | Other | Cancer Related Liver | Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular |
MARCO | 38426262 | Other | Unknown | Other | Cancer Related Liver | Characteristics and outcome of anti-hepatitis D virus positive patients with |
MARCO | 38147598 | Other | Unknown | Other | Cancer Related Liver | Upper Gastrointestinal Endoscopy Quality in Italy: A Nationwide Study. |
MARCO | 38065400 | Other | Unknown | Other | Cancer Related Liver | Blocking MARCO(+) tumor-associated macrophages improves anti-PD-L1 therapy of |
MARCO | 37787706 | Other | Unknown | Other | Cancer Related Liver | Palliative Care Nursing Case Management in Young Adults With Advanced Rare |
NOX4 | 38103659 | Other | Unknown | Tissue | Hepatocellular Carcinoma | Impact of amino acid substitutions in hepatitis C virus core region on the severe |
NOX4 | 38045041 | Other | Unknown | Tissue | Hepatocellular Carcinoma | Remodeling of the liver fibrosis microenvironment based on nilotinib-loaded |
NOX4 | 37463530 | Other | Unknown | Other | Hepatocellular Carcinoma | Dissecting the role of the NADPH oxidase NOX4 in TGF-beta signaling in |
NOX4 | 36964576 | Other | Upregulated | Other | Hepatocellular Carcinoma | Mitochondrial ROS driven by NOX4 upregulation promotes hepatocellular carcinoma |
NOX4 | 36004692 | Other | Unknown | Tissue | Hepatocellular Carcinoma | ciRS-7 Enhances the Progression of Hepatocellular Carcinoma through miR-944/NOX4 |
NOX4 | 35413508 | Other | Unknown | Cell lines | Hepatocellular Carcinoma | Combined Levo-tetrahydropalmatine and diphenyleneiodonium chloride enhances |
NOX4 | 34939720 | Other | Unknown | Other | Hepatocellular Carcinoma | Capsaicin inhibits cell proliferation by enhancing oxidative stress and apoptosis |
NOX4 | 34204571 | Other | Unknown | Other | Hepatocellular Carcinoma | The Role of Oxidative Stress in NAFLD-NASH-HCC Transition-Focus on NADPH |
NOX4 | 38258487 | Other | Unknown | Other | Liver Cancer | NADPH oxidase 1 promotes hepatic steatosis in obese mice and is abrogated by |
NOX4 | 38103659 | Other | Unknown | Tissue | Liver Cancer | Impact of amino acid substitutions in hepatitis C virus core region on the severe |
NOX4 | 37562703 | Other | Unknown | Tissue | Liver Cancer | Promising influences of zingerone against natural and chemical toxins: A |
NOX4 | 37463530 | Other | Unknown | Other | Liver Cancer | Dissecting the role of the NADPH oxidase NOX4 in TGF-beta signaling in |
NOX4 | 36964576 | Other | Upregulated | Other | Liver Cancer | Mitochondrial ROS driven by NOX4 upregulation promotes hepatocellular carcinoma |
NOX4 | 36723726 | Other | Unknown | Tissue | Liver Cancer | The Effect and Mechanism of Syringa pinnatifolia Hemsl. Ligans on Cerebral |
NOX4 | 36290761 | Other | Unknown | Other | Liver Cancer | NOX as a Therapeutic Target in Liver Disease. |
NOX4 | 36004692 | Other | Unknown | Tissue | Liver Cancer | ciRS-7 Enhances the Progression of Hepatocellular Carcinoma through miR-944/NOX4 |
NOX4 | 38103659 | Other | Unknown | Tissue | Cancer Related Liver | Impact of amino acid substitutions in hepatitis C virus core region on the severe |
NOX4 | 37562703 | Other | Unknown | Tissue | Cancer Related Liver | Promising influences of zingerone against natural and chemical toxins: A |
NOX4 | 37463530 | Other | Unknown | Other | Cancer Related Liver | Dissecting the role of the NADPH oxidase NOX4 in TGF-beta signaling in |
NOX4 | 37174663 | Other | Unknown | Other | Cancer Related Liver | LKB1 Regulates Inflammation of Fibroblast-like Synoviocytes from Patients with |
NOX4 | 36964576 | Other | Upregulated | Other | Cancer Related Liver | Mitochondrial ROS driven by NOX4 upregulation promotes hepatocellular carcinoma |
NOX4 | 36723726 | Other | Unknown | Tissue | Cancer Related Liver | The Effect and Mechanism of Syringa pinnatifolia Hemsl. Ligans on Cerebral |
NOX4 | 36290761 | Other | Unknown | Other | Cancer Related Liver | NOX as a Therapeutic Target in Liver Disease. |
NOX4 | 35700820 | Other | Unknown | Other | Cancer Related Liver | Fangchinoline inhibits non-small cell lung cancer metastasis by reversing |
PHACTR3 | 36827016 | Other | Downregulated | Tissue | Hepatocellular Carcinoma | Integrated analysis of RNA-seq in hepatocellular carcinoma reveals competing |
PHACTR3 | 36827016 | Other | Downregulated | Tissue | Liver Cancer | Integrated analysis of RNA-seq in hepatocellular carcinoma reveals competing |
PHACTR3 | 36827016 | Other | Downregulated | Tissue | Cancer Related Liver | Integrated analysis of RNA-seq in hepatocellular carcinoma reveals competing |
SLC5A1 | 31540429 | Other | Unknown | Cell lines | Hepatocellular Carcinoma | Trilobatin, a Novel SGLT1/2 Inhibitor, Selectively Induces the Proliferation of |
SLC5A1 | 27178057 | Other | Unknown | Tissue | Hepatocellular Carcinoma | FLIP(L) is critical for aerobic glycolysis in hepatocellular carcinoma. |
SLC5A1 | 31540429 | Other | Unknown | Cell lines | Liver Cancer | Trilobatin, a Novel SGLT1/2 Inhibitor, Selectively Induces the Proliferation of |
SLC5A1 | 30118349 | Other | Upregulated | Other | Liver Cancer | Inhibition of autotaxin alleviates inflammation and increases the expression of |
SLC5A1 | 29162437 | Other | Unknown | Tissue | Liver Cancer | Mouse Model of Alagille Syndrome and Mechanisms of Jagged1 Missense Mutations. |
SLC5A1 | 27178057 | Other | Unknown | Tissue | Liver Cancer | FLIP(L) is critical for aerobic glycolysis in hepatocellular carcinoma. |
SLC5A1 | 26658676 | Other | Unknown | Other | Liver Cancer | SGLT-1 Transport and Deglycosylation inside Intestinal Cells Are Key Steps in the |
SLC5A1 | 18556422 | Other | Upregulated | Other | Liver Cancer | Luminal regulation of normal and neoplastic human EC cell serotonin release is |
SLC5A1 | 17686765 | Other | Unknown | Plasma | Liver Cancer | Tripeptides of RS1 (RSC1A1) inhibit a monosaccharide-dependent exocytotic pathway |
SLC5A1 | 11509120 | Other | Unknown | Tissue | Liver Cancer | SGLT gene expression in primary lung cancers and their metastatic lesions. |
SLC5A1 | 29162437 | Other | Unknown | Tissue | Bile duct cancer | Mouse Model of Alagille Syndrome and Mechanisms of Jagged1 Missense Mutations. |
SLC5A1 | 11509120 | Other | Unknown | Tissue | Cancer Related Liver | SGLT gene expression in primary lung cancers and their metastatic lesions. |
RASD2 | 35461072 | Other | Unknown | Tissue | Liver Cancer | RASD2 promotes the development and metastasis of uveal melanoma via enhancing |
RASD2 | 35461072 | Other | Unknown | Tissue | Cancer Related Liver | RASD2 promotes the development and metastasis of uveal melanoma via enhancing |
CDKN3 | 37393234 | Other | Upregulated | Other | Hepatocellular Carcinoma | A systematic study on the treatment of hepatitis B-related hepatocellular |
CDKN3 | 36786134 | Other | Unknown | Other | Hepatocellular Carcinoma | Identification of Drug Targets and Agents Associated with Hepatocellular |
CDKN3 | 36716957 | Other | Upregulated | Other | Hepatocellular Carcinoma | Identification and validation of functional roles for three MYC-associated genes |
CDKN3 | 35944363 | Other | Unknown | Other | Hepatocellular Carcinoma | Identification of cell cycle-associated and -unassociated regulators for |
CDKN3 | 33917186 | Other | Upregulated | Tissue | Hepatocellular Carcinoma | Systematic Analysis of the Transcriptome Profiles and Co-Expression Networks of |
CDKN3 | 37393234 | Other | Upregulated | Other | Liver Cancer | A systematic study on the treatment of hepatitis B-related hepatocellular |
CDKN3 | 36786134 | Other | Unknown | Other | Liver Cancer | Identification of Drug Targets and Agents Associated with Hepatocellular |
CDKN3 | 36716957 | Other | Upregulated | Other | Liver Cancer | Identification and validation of functional roles for three MYC-associated genes |
CDKN3 | 35944363 | Other | Unknown | Other | Liver Cancer | Identification of cell cycle-associated and -unassociated regulators for |
CDKN3 | 33917186 | Other | Upregulated | Tissue | Liver Cancer | Systematic Analysis of the Transcriptome Profiles and Co-Expression Networks of |
CDKN3 | 37393234 | Other | Upregulated | Other | Cancer Related Liver | A systematic study on the treatment of hepatitis B-related hepatocellular |
CDKN3 | 36786134 | Other | Unknown | Other | Cancer Related Liver | Identification of Drug Targets and Agents Associated with Hepatocellular |
CDKN3 | 36716957 | Other | Upregulated | Other | Cancer Related Liver | Identification and validation of functional roles for three MYC-associated genes |
CDKN3 | 33917186 | Other | Upregulated | Tissue | Cancer Related Liver | Systematic Analysis of the Transcriptome Profiles and Co-Expression Networks of |
CDKN3 | 33688500 | Other | Upregulated | Tissue | Cancer Related Liver | Identification and Validation of Key Genes in Hepatocellular Carcinoma by |
CDKN3 | 29962817 | Other | Unknown | Other | Cancer Related Liver | Bioinformatics analysis of aberrantly methylated-differentially expressed genes |
CLEC4M | 34277395 | Other | Unknown | Other | Hepatocellular Carcinoma | Identification and Validation of Hub Genes Associated With Hepatocellular |
CLEC4M | 32705212 | Other | Unknown | Other | Hepatocellular Carcinoma | CLEC4M overexpression inhibits progression and is associated with a favorable |
CLEC4M | 24766301 | Other | Unknown | Other | Hepatocellular Carcinoma | Role of N-linked glycans in the interactions of recombinant HCV envelope |
CLEC4M | 16894195 | Other | Unknown | Other | Hepatocellular Carcinoma | L-SIGN (CD209L) isoforms differently mediate trans-infection of hepatoma cells by |
CLEC4M | 38320121 | Other | Unknown | Blood | Liver Cancer | A genetic association study of circulating coagulation factor VIII and von |
CLEC4M | 38074511 | Other | Upregulated | Tissue | Liver Cancer | SARS-CoV-2 receptor ACE2 is upregulated by fatty acids in human MASH. |
CLEC4M | 34277395 | Other | Unknown | Other | Liver Cancer | Identification and Validation of Hub Genes Associated With Hepatocellular |
CLEC4M | 32970391 | Other | Unknown | Tissue | Liver Cancer | An investigation into the molecular basis of cancer comorbidities in coronavirus |
CLEC4M | 32705212 | Other | Unknown | Other | Liver Cancer | CLEC4M overexpression inhibits progression and is associated with a favorable |
CLEC4M | 32116021 | Other | Unknown | Blood | Liver Cancer | Unraveling the transcriptional determinants of liver sinusoidal endothelial cell |
CLEC4M | 33247676 | Other | Unknown | Tissue | Cholangiocarcinoma | Pan-Cancer Multiomics Analysis of TC2N Gene Suggests its Important Role(s) in |
CLEC4M | 38074511 | Other | Upregulated | Tissue | Cancer Related Liver | SARS-CoV-2 receptor ACE2 is upregulated by fatty acids in human MASH. |
CLEC4M | 32970391 | Other | Unknown | Tissue | Cancer Related Liver | An investigation into the molecular basis of cancer comorbidities in coronavirus |
CLEC4M | 32705212 | Other | Unknown | Other | Cancer Related Liver | CLEC4M overexpression inhibits progression and is associated with a favorable |
CLEC4M | 32116021 | Other | Unknown | Blood | Cancer Related Liver | Unraveling the transcriptional determinants of liver sinusoidal endothelial cell |
CLEC4M | 15111305 | Other | Unknown | Tissue | Cancer Related Liver | Dynamic populations of dendritic cell-specific ICAM-3 grabbing |
CLEC4M | 12152166 | Other | Unknown | Other | Cancer Related Liver | Expression of human immunodeficiency virus (HIV)-binding lectin DC-SIGNR: |
THBS4 | 37965158 | Other | Upregulated | Tissue | Hepatocellular Carcinoma | B4GALNT1 promotes hepatocellular carcinoma stemness and progression via integrin |
THBS4 | 32567740 | Other | Unknown | Tissue | Hepatocellular Carcinoma | THBS4 promotes HCC progression by regulating ITGB1 via FAK/PI3K/AKT pathway. |
THBS4 | 28177895 | Other | Unknown | Tissue | Hepatocellular Carcinoma | Over-expression of Thrombospondin 4 correlates with loss of miR-142 and |
THBS4 | 27769059 | Other | Unknown | Tissue | Hepatocellular Carcinoma | Microarray analysis on the lncRNA expression profile in male hepatocelluar |
THBS4 | 17202846 | Other | Unknown | Other | Hepatocellular Carcinoma | Association of common promoter polymorphisms of MCP1 with hepatitis B virus |
THBS4 | 32899998 | Other | Unknown | Tissue | Liver Cancer | Potential Role of PDGFRbeta-Associated THBS4 in Colorectal Cancer Development. |
THBS4 | 32567740 | Other | Unknown | Tissue | Liver Cancer | THBS4 promotes HCC progression by regulating ITGB1 via FAK/PI3K/AKT pathway. |
THBS4 | 28177895 | Other | Unknown | Tissue | Liver Cancer | Over-expression of Thrombospondin 4 correlates with loss of miR-142 and |
THBS4 | 27769059 | Other | Unknown | Tissue | Liver Cancer | Microarray analysis on the lncRNA expression profile in male hepatocelluar |
THBS4 | 17202846 | Other | Unknown | Other | Liver Cancer | Association of common promoter polymorphisms of MCP1 with hepatitis B virus |
THBS4 | 32567740 | Other | Unknown | Tissue | Cancer Related Liver | THBS4 promotes HCC progression by regulating ITGB1 via FAK/PI3K/AKT pathway. |
SCAMP3 | 36627007 | Other | Unknown | Other | Hepatocellular Carcinoma | SCAMP3 promotes breast cancer progression through the c-MYC-beta-Catenin-SQSTM1 |
SCAMP3 | 35035772 | Other | Unknown | Other | Hepatocellular Carcinoma | SCAMP3 is regulated by miR-128-3p and promotes the metastasis of hepatocellular |
SCAMP3 | 27519163 | Other | Unknown | Tissue | Hepatocellular Carcinoma | Quantitative proteome analysis reveals the correlation between |
SCAMP3 | 18277965 | Other | Upregulated | Other | Hepatocellular Carcinoma | Gene expression profiling in hepatocellular carcinoma: upregulation of genes in |
SCAMP3 | 37860266 | Other | Unknown | Other | Liver Cancer | miR-3200 accelerates the growth of liver cancer cells by enhancing Rab7A. |
SCAMP3 | 27519163 | Other | Unknown | Tissue | Liver Cancer | Quantitative proteome analysis reveals the correlation between |
SCAMP3 | 18277965 | Other | Upregulated | Other | Liver Cancer | Gene expression profiling in hepatocellular carcinoma: upregulation of genes in |
SCAMP3 | 37860266 | Other | Unknown | Other | Cancer Related Liver | miR-3200 accelerates the growth of liver cancer cells by enhancing Rab7A. |
PLVAP | 38168935 | Other | Unknown | Other | Hepatocellular Carcinoma | Presence of onco-fetal neighborhoods in hepatocellular carcinoma is associated |
PLVAP | 35494789 | Other | Unknown | Tissue | Hepatocellular Carcinoma | A hybrid feature selection algorithm and its application in bioinformatics. |
PLVAP | 34079085 | Other | Unknown | Tissue | Hepatocellular Carcinoma | Plasmalemma vesicle-associated protein promotes angiogenesis in |
PLVAP | 33767421 | Other | Unknown | Other | Hepatocellular Carcinoma | A new perspective on the immune escape mechanism in HCC: onco-foetal |
PLVAP | 32976798 | Other | Unknown | Other | Hepatocellular Carcinoma | Onco-fetal Reprogramming of Endothelial Cells Drives Immunosuppressive |
PLVAP | 25376302 | Other | Unknown | Tissue | Hepatocellular Carcinoma | Plasmalemmal Vesicle Associated Protein (PLVAP) as a therapeutic target for |
PLVAP | 38168935 | Other | Unknown | Other | Liver Cancer | Presence of onco-fetal neighborhoods in hepatocellular carcinoma is associated |
PLVAP | 37810232 | Other | Unknown | Tissue | Liver Cancer | The senescent secretome drives PLVAP expression in cultured human hepatic |
PLVAP | 35494789 | Other | Unknown | Tissue | Liver Cancer | A hybrid feature selection algorithm and its application in bioinformatics. |
PLVAP | 34079085 | Other | Unknown | Tissue | Liver Cancer | Plasmalemma vesicle-associated protein promotes angiogenesis in |
PLVAP | 33767421 | Other | Unknown | Other | Liver Cancer | A new perspective on the immune escape mechanism in HCC: onco-foetal |
PLVAP | 32976798 | Other | Unknown | Other | Liver Cancer | Onco-fetal Reprogramming of Endothelial Cells Drives Immunosuppressive |
PLVAP | 31597160 | Other | Unknown | Blood | Liver Cancer | Resolving the fibrotic niche of human liver cirrhosis at single-cell level. |
PLVAP | 31540222 | Other | Unknown | Other | Liver Cancer | Differential Consequences of Bmp9 Deletion on Sinusoidal Endothelial Cell |
PLVAP | 34079085 | Other | Unknown | Tissue | Bile duct cancer | Plasmalemma vesicle-associated protein promotes angiogenesis in |
PLVAP | 34079085 | Other | Unknown | Tissue | Cholangiocarcinoma | Plasmalemma vesicle-associated protein promotes angiogenesis in |
PLVAP | 34079085 | Other | Unknown | Tissue | Cancer Related Liver | Plasmalemma vesicle-associated protein promotes angiogenesis in |
ANGPTL6 | 36777503 | Other | Upregulated | Blood | Hepatocellular Carcinoma | Decision tree algorithm predicts hepatocellular carcinoma among chronic hepatitis |
ANGPTL6 | 31146977 | Other | Unknown | Cell lines | Hepatocellular Carcinoma | ANGPTL6-mediated angiogenesis promotes alpha fetoprotein-producing gastric cancer |
ANGPTL6 | 36777503 | Other | Upregulated | Blood | Liver Cancer | Decision tree algorithm predicts hepatocellular carcinoma among chronic hepatitis |
ANGPTL6 | 31146977 | Other | Unknown | Cell lines | Liver Cancer | ANGPTL6-mediated angiogenesis promotes alpha fetoprotein-producing gastric cancer |
B4GALNT1 | 37965158 | Other | Upregulated | Tissue | Hepatocellular Carcinoma | B4GALNT1 promotes hepatocellular carcinoma stemness and progression via integrin |
STAB2 | 36059952 | Other | Unknown | Tissue | Hepatocellular Carcinoma | The expression and significance of efferocytosis and immune checkpoint related |
STAB2 | 34277395 | Other | Unknown | Other | Hepatocellular Carcinoma | Identification and Validation of Hub Genes Associated With Hepatocellular |
STAB2 | 23870052 | Other | Unknown | Tissue | Hepatocellular Carcinoma | Endothelial transdifferentiation in hepatocellular carcinoma: loss of Stabilin-2 |
STAB2 | 38320121 | Other | Unknown | Blood | Liver Cancer | A genetic association study of circulating coagulation factor VIII and von |
STAB2 | 36325910 | Other | Unknown | Tissue | Liver Cancer | Targeting of Scavenger Receptors Stabilin-1 and Stabilin-2 Ameliorates |
STAB2 | 36059952 | Other | Unknown | Tissue | Liver Cancer | The expression and significance of efferocytosis and immune checkpoint related |
STAB2 | 35776660 | Other | Upregulated | Blood | Liver Cancer | ALK1 controls hepatic vessel formation, angiodiversity, and angiocrine functions |
STAB2 | 34816100 | Other | Unknown | Blood | Liver Cancer | Stabilin receptors clear LPS and control systemic inflammation. |
STAB2 | 34277395 | Other | Unknown | Other | Liver Cancer | Identification and Validation of Hub Genes Associated With Hepatocellular |
STAB2 | 31783007 | Other | Unknown | Other | Liver Cancer | Angiocrine Hepatocyte Growth Factor Signaling Controls Physiological Organ and |
STAB2 | 30964206 | Other | Unknown | Tissue | Liver Cancer | Bone Morphogenetic Protein 9 Is a Paracrine Factor Controlling Liver Sinusoidal |
STAB2 | 30124466 | Other | Unknown | Plasma | Liver Cancer | The endothelial cell receptor stabilin-2 regulates VWF-FVIII complex half-life |
STAB2 | 29603397 | Other | Unknown | Other | Liver Cancer | Role of miR-31 and SATB2 in arsenic-induced malignant BEAS-2B cell |
STAB2 | 33247676 | Other | Unknown | Tissue | Cholangiocarcinoma | Pan-Cancer Multiomics Analysis of TC2N Gene Suggests its Important Role(s) in |
STAB2 | 36059952 | Other | Unknown | Tissue | Cancer Related Liver | The expression and significance of efferocytosis and immune checkpoint related |
STAB2 | 34816100 | Other | Unknown | Blood | Cancer Related Liver | Stabilin receptors clear LPS and control systemic inflammation. |
ARHGEF39 | 29382922 | Other | Unknown | Other | Hepatocellular Carcinoma | ARHGEF39 promotes tumor progression via activation of Rac1/P38 MAPK/ATF2 |
ARHGEF39 | 28871449 | Other | Upregulated | Tissue | Hepatocellular Carcinoma | ARHGEF39 promotes gastric cancer cell proliferation and migration via Akt |
ARHGEF39 | 38463168 | Other | Unknown | Other | Liver Cancer | DeepCBS: shedding light on the impact of mutations occurring at CTCF binding |
TRPC6 | 37132400 | Other | Unknown | Other | Hepatocellular Carcinoma | The synthesis and effects of a novel TRPC6 inhibitor, BP3112, on hepatocellular |
TRPC6 | 30136057 | Other | Unknown | Other | Hepatocellular Carcinoma | A novel TRPC6-dependent mechanism of TGF-beta-induced migration and invasion of |
TRPC6 | 29500176 | Other | Upregulated | Tissue | Hepatocellular Carcinoma | The NCX1/TRPC6 Complex Mediates TGFbeta-Driven Migration and Invasion of Human |
TRPC6 | 27011063 | Other | Unknown | Other | Hepatocellular Carcinoma | Regulation of Multi-drug Resistance in hepatocellular carcinoma cells is |
TRPC6 | 25960236 | Other | Unknown | Other | Hepatocellular Carcinoma | Silencing of TRPC1 regulates store-operated calcium entry and proliferation in |
TRPC6 | 25845497 | Other | Upregulated | Other | Hepatocellular Carcinoma | Receptor channel TRPC6 orchestrate the activation of human hepatic stellate cell |
TRPC6 | 25842354 | Other | Unknown | Tissue | Hepatocellular Carcinoma | Differential Expression of Ion Channels and Transporters During Hepatocellular |
TRPC6 | 21290321 | Other | Unknown | Cell lines | Hepatocellular Carcinoma | Expression and function of TRP channels in liver cells. |
TRPC6 | 18506892 | Other | Unknown | Cell lines | Hepatocellular Carcinoma | Capacitative calcium entry and transient receptor potential canonical 6 |
TRPC6 | 37132400 | Other | Unknown | Other | Liver Cancer | The synthesis and effects of a novel TRPC6 inhibitor, BP3112, on hepatocellular |
TRPC6 | 30136057 | Other | Unknown | Other | Liver Cancer | A novel TRPC6-dependent mechanism of TGF-beta-induced migration and invasion of |
TRPC6 | 29500176 | Other | Upregulated | Tissue | Liver Cancer | The NCX1/TRPC6 Complex Mediates TGFbeta-Driven Migration and Invasion of Human |
TRPC6 | 28430609 | Other | Unknown | Blood | Liver Cancer | Characterization of pressure-mediated vascular tone in resistance arteries from |
TRPC6 | 27011063 | Other | Unknown | Other | Liver Cancer | Regulation of Multi-drug Resistance in hepatocellular carcinoma cells is |
TRPC6 | 25960236 | Other | Unknown | Other | Liver Cancer | Silencing of TRPC1 regulates store-operated calcium entry and proliferation in |
TRPC6 | 25845497 | Other | Upregulated | Other | Liver Cancer | Receptor channel TRPC6 orchestrate the activation of human hepatic stellate cell |
TRPC6 | 25842354 | Other | Unknown | Tissue | Liver Cancer | Differential Expression of Ion Channels and Transporters During Hepatocellular |
TRPC6 | 21290321 | Other | Unknown | Cell lines | Liver Cancer | Expression and function of TRP channels in liver cells. |
TRPC6 | 18506892 | Other | Unknown | Cell lines | Liver Cancer | Capacitative calcium entry and transient receptor potential canonical 6 |
TRPC6 | 28430609 | Other | Unknown | Blood | Bile duct cancer | Characterization of pressure-mediated vascular tone in resistance arteries from |
TRPC6 | 21290321 | Other | Unknown | Cell lines | Cancer Related Liver | Expression and function of TRP channels in liver cells. |
CEP131 | 32218865 | Other | Unknown | Cell lines | Hepatocellular Carcinoma | CEP131 knockdown inhibits cell proliferation by inhibiting the ERK and AKT |
PPOX | 36642627 | Other | Unknown | Urine | Hepatocellular Carcinoma | AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic |
PPOX | 36245063 | Other | Unknown | Tissue | Hepatocellular Carcinoma | Heterogeneous molecular behavior in liver tumors (HCC and CCA) of two patients |
PPOX | 23409300 | Other | Unknown | Urine | Hepatocellular Carcinoma | Variegate Porphyria. |
PPOX | 27040643 | Other | Upregulated | Tissue | Hepatocellular Carcinoma | Systems biology analysis of hepatitis C virus infection reveals the role of copy |
PPOX | 25445397 | Other | Unknown | Tissue | Hepatocellular Carcinoma | Biallelic inactivation of protoporphyrinogen oxidase and hydroxymethylbilane |
PPOX | 20814629 | Other | Unknown | Other | Hepatocellular Carcinoma | Hepatocellular carcinoma in variegate porphyria: a serious complication. |
PPOX | 19350426 | Other | Unknown | Other | Hepatocellular Carcinoma | Porphyria in Switzerland, 15 years experience. |
PPOX | 15482256 | Other | Unknown | Other | Hepatocellular Carcinoma | Examination of mitochondrial protein targeting of haem synthetic enzymes: in vivo |
PPOX | 36642627 | Other | Unknown | Urine | Liver Cancer | AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic |
PPOX | 36245063 | Other | Unknown | Tissue | Liver Cancer | Heterogeneous molecular behavior in liver tumors (HCC and CCA) of two patients |
PPOX | 27040643 | Other | Upregulated | Tissue | Liver Cancer | Systems biology analysis of hepatitis C virus infection reveals the role of copy |
PPOX | 25445397 | Other | Unknown | Tissue | Liver Cancer | Biallelic inactivation of protoporphyrinogen oxidase and hydroxymethylbilane |
PPOX | 20814629 | Other | Unknown | Other | Liver Cancer | Hepatocellular carcinoma in variegate porphyria: a serious complication. |
PPOX | 19350426 | Other | Unknown | Other | Liver Cancer | Porphyria in Switzerland, 15 years experience. |
PPOX | 15482256 | Other | Unknown | Other | Liver Cancer | Examination of mitochondrial protein targeting of haem synthetic enzymes: in vivo |
PPOX | 9250538 | Other | Unknown | Other | Liver Cancer | Evaluation of the porphyrinogenic risk of antineoplastics. |
PPOX | 36245063 | Other | Unknown | Tissue | Cholangiocarcinoma | Heterogeneous molecular behavior in liver tumors (HCC and CCA) of two patients |
PRCC | 33024658 | Other | Unknown | Other | Hepatocellular Carcinoma | c-Met expression in renal cell carcinoma with bone metastases. |
PRCC | 31303768 | Other | Unknown | Other | Hepatocellular Carcinoma | Bioinformatics analysis of molecular genetic targets and key pathways for |
PRCC | 34088935 | Other | Unknown | Other | Liver Cancer | The first competing risk survival nomogram in patients with papillary renal cell |
PRCC | 33475752 | Other | Unknown | Other | Liver Cancer | Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma |
PRCC | 33109495 | Other | Unknown | Other | Liver Cancer | The Impact of Histological Subtype on the Incidence, Timing, and Patterns of |
PRCC | 32458743 | Other | Unknown | Other | Liver Cancer | Activity of lenvatinib plus everolimus combination in a heavily pretreated |
PRCC | 31852068 | Other | Unknown | Other | Liver Cancer | Heterogeneous response to target therapy in metastatic papillary renal cell |
PRCC | 20723433 | Other | Unknown | Other | Liver Cancer | [Clinicopathologic analysis of papillary renal cell carcinoma]. |
PRCC | 34088935 | Other | Unknown | Other | Cancer Related Liver | The first competing risk survival nomogram in patients with papillary renal cell |
PRCC | 15723337 | Other | Unknown | Tissue | Cancer Related Liver | Molecular cloning and characterization of FBXO47, a novel gene containing an |
CXCL14 | 38823657 | Other | Unknown | Tissue | Hepatocellular Carcinoma | Qizhu anticancer prescription enhances immunosurveillance of liver cancer cells |
CXCL14 | 36722664 | Other | Unknown | Other | Hepatocellular Carcinoma | Targetable Brg1-CXCL14 axis contributes to alcoholic liver injury by driving |
CXCL14 | 34704819 | Other | Unknown | Tissue | Hepatocellular Carcinoma | MiR-3188 regulates the proliferation and apoptosis of hepatocellular carcinoma |
CXCL14 | 33445170 | Other | Unknown | Tissue | Hepatocellular Carcinoma | Apobec1 complementation factor overexpression promotes hepatic steatosis, |
CXCL14 | 33108937 | Other | Upregulated | Tissue | Hepatocellular Carcinoma | CXCL14 inhibits the growth and promotes apoptosis of hepatocellular carcinoma |
CXCL14 | 38823657 | Other | Unknown | Tissue | Liver Cancer | Qizhu anticancer prescription enhances immunosurveillance of liver cancer cells |
CXCL14 | 38003215 | Other | Unknown | Other | Liver Cancer | Data Mining Suggests That CXCL14 Gene Silencing in Colon Cancer Is Due to |
CXCL14 | 37563546 | Other | Unknown | Plasma | Liver Cancer | Comprehensive analysis of CXCL14 uncovers its role during liver metastasis in |
CXCL14 | 34704819 | Other | Unknown | Tissue | Liver Cancer | MiR-3188 regulates the proliferation and apoptosis of hepatocellular carcinoma |
CXCL14 | 33445170 | Other | Unknown | Tissue | Liver Cancer | Apobec1 complementation factor overexpression promotes hepatic steatosis, |
CXCL14 | 33326461 | Other | Unknown | Other | Liver Cancer | The pharmacodynamic and differential gene expression analysis of PPAR alpha/delta agonist |
CXCL14 | 38823657 | Other | Unknown | Tissue | Cancer Related Liver | Qizhu anticancer prescription enhances immunosurveillance of liver cancer cells |
CXCL14 | 38003215 | Other | Unknown | Other | Cancer Related Liver | Data Mining Suggests That CXCL14 Gene Silencing in Colon Cancer Is Due to |
CXCL14 | 35751868 | Other | Unknown | Tissue | Cancer Related Liver | Brown adipose tissue activation with ginsenoside compound K ameliorates |
CXCL14 | 31849533 | Other | Unknown | Tissue | Cancer Related Liver | Suppressed Expression of CXCL14 in Hepatocellular Carcinoma Tissues and Its |
CXCL14 | 31417300 | Other | Unknown | Tissue | Cancer Related Liver | ELR positive CXCL chemokines are highly expressed in an animal model of |
CXCL14 | 30700932 | Other | Unknown | Other | Cancer Related Liver | Identification of liver metastasis-associated genes in human colon carcinoma by |
CXCL14 | 30481877 | Other | Unknown | Other | Cancer Related Liver | [Genes and molecular mechanisms affecting the correlation between liver cancer |
FBXO43 | 38604312 | Other | Unknown | Other | Hepatocellular Carcinoma | FBXO43 promotes cell cycle progression in cancer cells through stabilizing SKP2. |
FBXO43 | 37250703 | Other | Unknown | Tissue | Hepatocellular Carcinoma | Clinical significance of FBXO43 in hepatocellular carcinoma and its impact on |
FBXO43 | 36765911 | Other | Upregulated | Tissue | Hepatocellular Carcinoma | F-Box Protein 43, Stabilized by N6-Methyladenosine Methylation, Enhances |
FBXO43 | 37250703 | Other | Unknown | Tissue | Liver Cancer | Clinical significance of FBXO43 in hepatocellular carcinoma and its impact on |
FCN2 | 34277395 | Other | Unknown | Other | Hepatocellular Carcinoma | Identification and Validation of Hub Genes Associated With Hepatocellular |
FCN2 | 30747617 | Other | Unknown | Other | Hepatocellular Carcinoma | Expression of human ficolin-2 in hepatocytes confers resistance to infection by |
FCN2 | 25550913 | Other | Unknown | Other | Hepatocellular Carcinoma | Regulation of gene expression in HBV- and HCV-related hepatocellular carcinoma: |
FCN2 | 22140517 | Other | Unknown | Blood | Hepatocellular Carcinoma | Ficolin-2 levels and FCN2 haplotypes influence hepatitis B infection outcome in |
FCN2 | 34277395 | Other | Unknown | Other | Liver Cancer | Identification and Validation of Hub Genes Associated With Hepatocellular |
FCN2 | 33446637 | Other | Unknown | Other | Liver Cancer | PU.1 drives specification of pluripotent stem cell-derived endothelial cells to |
FCN2 | 30747617 | Other | Unknown | Other | Liver Cancer | Expression of human ficolin-2 in hepatocytes confers resistance to infection by |
FCN2 | 9508159 | Other | Unknown | Other | Liver Cancer | Causes of declining life expectancy in Russia. |
FCN2 | 9508159 | Other | Unknown | Other | Cancer Related Liver | Causes of declining life expectancy in Russia. |
FLAD1 | 31848930 | Other | Unknown | Tissue | Hepatocellular Carcinoma | Multiple novel hepatocellular carcinoma signature genes are commonly controlled |
FLAD1 | 31848930 | Other | Unknown | Tissue | Liver Cancer | Multiple novel hepatocellular carcinoma signature genes are commonly controlled |
BMP10 | 31417183 | Other | Downregulated | Blood | Hepatocellular Carcinoma | BMP10 suppresses hepatocellular carcinoma progression via PTPRS-STAT3 axis. |
BMP10 | 31188741 | Other | Downregulated | Tissue | Hepatocellular Carcinoma | TMEM100 expression suppresses metastasis and enhances sensitivity to chemotherapy |
BMP10 | 35776660 | Other | Upregulated | Blood | Liver Cancer | ALK1 controls hepatic vessel formation, angiodiversity, and angiocrine functions |
BMP10 | 31417183 | Other | Downregulated | Blood | Liver Cancer | BMP10 suppresses hepatocellular carcinoma progression via PTPRS-STAT3 axis. |
BMP10 | 29789425 | Other | Unknown | Blood | Liver Cancer | A heterodimer formed by bone morphogenetic protein 9 (BMP9) and BMP10 provides |
BMP10 | 31417183 | Other | Downregulated | Blood | Cancer Related Liver | BMP10 suppresses hepatocellular carcinoma progression via PTPRS-STAT3 axis. |
PYGO2 | 36404439 | Other | Unknown | Cell lines | Hepatocellular Carcinoma | Interference of EFNA4 suppresses cell proliferation, invasion and angiogenesis in |
PYGO2 | 35023882 | Other | Unknown | Tissue | Hepatocellular Carcinoma | Nuclear Expression of Pygo2 Correlates with Poorly Differentiated State Involving |
PYGO2 | 25871475 | Other | Unknown | Other | Hepatocellular Carcinoma | Pygopus-2 promotes invasion and metastasis of hepatic carcinoma cell by |
PYGO2 | 25545771 | Other | Unknown | Tissue | Hepatocellular Carcinoma | Abnormal nuclear expression of Pygopus-2 in human primary hepatocellular |
PYGO2 | 18277965 | Other | Upregulated | Other | Hepatocellular Carcinoma | Gene expression profiling in hepatocellular carcinoma: upregulation of genes in |
PYGO2 | 36404439 | Other | Unknown | Cell lines | Liver Cancer | Interference of EFNA4 suppresses cell proliferation, invasion and angiogenesis in |
PYGO2 | 25871475 | Other | Unknown | Other | Liver Cancer | Pygopus-2 promotes invasion and metastasis of hepatic carcinoma cell by |
PYGO2 | 25545771 | Other | Unknown | Tissue | Liver Cancer | Abnormal nuclear expression of Pygopus-2 in human primary hepatocellular |
PYGO2 | 18277965 | Other | Upregulated | Other | Liver Cancer | Gene expression profiling in hepatocellular carcinoma: upregulation of genes in |
EBF1 | 34233610 | Other | Unknown | Other | Hepatocellular Carcinoma | DeepHBV: a deep learning model to predict hepatitis B virus (HBV) integration |
EBF1 | 34233610 | Other | Unknown | Other | Liver Cancer | DeepHBV: a deep learning model to predict hepatitis B virus (HBV) integration |
EBF1 | 33686952 | Other | Unknown | Other | Liver Cancer | Transcriptome profiling reveals target in primary myelofibrosis together with |
EBF1 | 29169115 | Other | Unknown | Tissue | Liver Cancer | Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition |
EBF1 | 17511028 | Other | Unknown | Cell lines | Liver Cancer | Expression of SNC73, a transcript of the immunoglobulin alpha-1 gene, in human |
EBF1 | 12717432 | Other | Unknown | Other | Liver Cancer | Bcl11a is essential for normal lymphoid development. |
EBF1 | 33854627 | Other | Unknown | Tissue | Bile duct cancer | Promoter hypermethylation of early B cell factor 1 (EBF1) is associated with |
EBF1 | 29169115 | Other | Unknown | Tissue | Bile duct cancer | Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition |
EBF1 | 23863747 | Other | Unknown | Other | Bile duct cancer | Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for |
EBF1 | 33854627 | Other | Unknown | Tissue | Cholangiocarcinoma | Promoter hypermethylation of early B cell factor 1 (EBF1) is associated with |
EBF1 | 29169115 | Other | Unknown | Tissue | Cholangiocarcinoma | Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition |
EBF1 | 23863747 | Other | Unknown | Other | Cholangiocarcinoma | Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for |
EBF1 | 34233610 | Other | Unknown | Other | Cancer Related Liver | DeepHBV: a deep learning model to predict hepatitis B virus (HBV) integration |
EBF1 | 33686952 | Other | Unknown | Other | Cancer Related Liver | Transcriptome profiling reveals target in primary myelofibrosis together with |
BMPER | 25785048 | Other | Upregulated | Tissue | Hepatocellular Carcinoma | Upregulated MiR-1269 in hepatocellular carcinoma and its clinical significance. |
BMPER | 37260544 | Other | Unknown | Tissue | Liver Cancer | The developmental gene Chordin is amplified and expressed in human cancers. |
APLN | 38087672 | Other | Unknown | Blood | Hepatocellular Carcinoma | Apelin and the gut microbiome: Potential interaction in human MASLD. |
APLN | 34636395 | Other | Unknown | Tissue | Hepatocellular Carcinoma | Long non-coding RNA BACE1-AS plays an oncogenic role in hepatocellular carcinoma |
APLN | 27083318 | Other | Unknown | Tissue | Hepatocellular Carcinoma | Apelin/APJ system and cancer. |
APLN | 25275024 | Other | Unknown | Other | Hepatocellular Carcinoma | The apelin-APJ system induces tumor arteriogenesis in hepatocellular carcinoma. |
APLN | 23684136 | Other | Unknown | Cell lines | Hepatocellular Carcinoma | Hepatocellular carcinoma cells cause different responses in expressions of |
APLN | 38087672 | Other | Unknown | Blood | Liver Cancer | Apelin and the gut microbiome: Potential interaction in human MASLD. |
APLN | 35837318 | Other | Unknown | Tissue | Liver Cancer | Abdominopelvic Lymphatic Drainage Area Irradiation for Consolidative Radiotherapy |
APLN | 34636395 | Other | Unknown | Tissue | Liver Cancer | Long non-coding RNA BACE1-AS plays an oncogenic role in hepatocellular carcinoma |
APLN | 27894959 | Other | Unknown | Tissue | Liver Cancer | Inhibition of the apelin/apelin receptor axis decreases cholangiocarcinoma |
APLN | 25275024 | Other | Unknown | Other | Liver Cancer | The apelin-APJ system induces tumor arteriogenesis in hepatocellular carcinoma. |
APLN | 23684136 | Other | Unknown | Cell lines | Liver Cancer | Hepatocellular carcinoma cells cause different responses in expressions of |
APLN | 22739041 | Other | Unknown | Cell lines | Liver Cancer | Cancer-associated fibroblasts up-regulate CCL2, CCL26, IL6 and LOXL2 genes |
APLN | 27894959 | Other | Unknown | Tissue | Bile duct cancer | Inhibition of the apelin/apelin receptor axis decreases cholangiocarcinoma |
APLN | 27894959 | Other | Unknown | Tissue | Cholangiocarcinoma | Inhibition of the apelin/apelin receptor axis decreases cholangiocarcinoma |
APLN | 27894959 | Other | Unknown | Tissue | Cancer Related Liver | Inhibition of the apelin/apelin receptor axis decreases cholangiocarcinoma |
APLN | 22739041 | Other | Unknown | Cell lines | Cancer Related Liver | Cancer-associated fibroblasts up-regulate CCL2, CCL26, IL6 and LOXL2 genes |
CD34 | 38737403 | Other | Unknown | Blood | Hepatocellular Carcinoma | Hepatic arterial infusion of autologous CD34(+) cells for hepatitis C |
CD34 | 38673992 | Other | Unknown | Tissue | Hepatocellular Carcinoma | Role of Epiregulin on Lipopolysaccharide-Induced Hepatocarcinogenesis as a |
CD34 | 38358197 | Other | Unknown | Blood | Hepatocellular Carcinoma | Clinicopathological analysis of sclerosing angiomatoid nodular transformation in |
CD34 | 38303298 | Other | Unknown | Other | Hepatocellular Carcinoma | [A Case of Primary Liver Cancer and Gastric Glomus Tumor Diagnosed Preoperatively |
CD34 | 38175402 | Other | Unknown | Other | Hepatocellular Carcinoma | Indolent T-lymphoblastic proliferation involving hepatocellular |
CD34 | 37926787 | Other | Unknown | Tissue | Hepatocellular Carcinoma | Stem cell therapy for hepatocellular carcinoma and end-stage liver disease. |
CD34 | 37882154 | Other | Unknown | Tissue | Hepatocellular Carcinoma | Primary hepatic undiferentiated pleomorphic sarcoma co-existed with |
CD34 | 37681334 | Other | Unknown | Tissue | Hepatocellular Carcinoma | Bulk RNA-Seq Combined with Single-Cell Transcriptome Sequencing Reveals the |
CD34 | 38737403 | Other | Unknown | Blood | Liver Cancer | Hepatic arterial infusion of autologous CD34(+) cells for hepatitis C |
CD34 | 38735984 | Other | Unknown | Blood | Liver Cancer | Hepatic hemangioma in a simple liver cyst mimicking biliary cystic neoplasm. |
CD34 | 38711024 | Other | Unknown | Tissue | Liver Cancer | A case study of a liver transplant-treated patient with glycogen storage disease |
CD34 | 38678462 | Other | Unknown | Other | Liver Cancer | Ex-vivo expanded CD34(+) cell transplantation alleviates fibrotic liver injury |
CD34 | 38673992 | Other | Unknown | Tissue | Liver Cancer | Role of Epiregulin on Lipopolysaccharide-Induced Hepatocarcinogenesis as a |
CD34 | 38563707 | Other | Unknown | Tissue | Liver Cancer | TFE3 rearranged epithelioid hemangioendothelioma of the lymph node: A rare |
CD34 | 38358197 | Other | Unknown | Blood | Liver Cancer | Clinicopathological analysis of sclerosing angiomatoid nodular transformation in |
CD34 | 38735984 | Other | Unknown | Blood | Bile duct cancer | Hepatic hemangioma in a simple liver cyst mimicking biliary cystic neoplasm. |
CD34 | 36899823 | Other | Unknown | Cell lines | Bile duct cancer | Sulforaphane Potentiates Gemcitabine-Mediated Anti-Cancer Effects against |
CD34 | 36871865 | Other | Unknown | Other | Bile duct cancer | Liver pathology in retinal vasculopathy with cerebral leukoencephalopathy and |
CD34 | 33685048 | Other | Unknown | Tissue | Bile duct cancer | [Angiopoietin-2 regulates vessels encapsulated by tumor clusters positive |
CD34 | 31742878 | Other | Unknown | Tissue | Bile duct cancer | Autologous Adipose Tissue-Derived Mesenchymal Stem Cells Introduced by Biliary |
CD34 | 30172911 | Other | Unknown | Other | Bile duct cancer | Immunohistochemical characterization of cancer-associated fibroblasts at the |
CD34 | 27535234 | Other | Unknown | Other | Bile duct cancer | Double primary hepatic cancer (hepatocellular carcinoma and intrahepatic |
CD34 | 37900849 | Other | Unknown | Other | Cholangiocarcinoma | Epithelioid Hemangioendothelioma of the Liver Showing Spontaneous Complete |
CD34 | 36899823 | Other | Unknown | Cell lines | Cholangiocarcinoma | Sulforaphane Potentiates Gemcitabine-Mediated Anti-Cancer Effects against |
CD34 | 35435387 | Other | Unknown | Other | Cholangiocarcinoma | Hepatic epithelioid hemangioendothelioma-report of three cases of a puzzling |
CD34 | 35350570 | Other | Unknown | Tissue | Cholangiocarcinoma | Characteristic of Perineural Invasion in Hilar Cholangiocarcinoma Based on |
CD34 | 38737403 | Other | Unknown | Blood | Cancer Related Liver | Hepatic arterial infusion of autologous CD34(+) cells for hepatitis C |
CD34 | 38735984 | Other | Unknown | Blood | Cancer Related Liver | Hepatic hemangioma in a simple liver cyst mimicking biliary cystic neoplasm. |
CD34 | 38673992 | Other | Unknown | Tissue | Cancer Related Liver | Role of Epiregulin on Lipopolysaccharide-Induced Hepatocarcinogenesis as a |
CD34 | 38499049 | Other | Unknown | Other | Cancer Related Liver | Efficacy and safety of cladribine in combination with busulfan and |
CD34 | 38178742 | Other | Unknown | Tissue | Cancer Related Liver | [Clinicopathological features of intravascular large B-cell lymphoma and |
CD34 | 38074511 | Other | Upregulated | Tissue | Cancer Related Liver | SARS-CoV-2 receptor ACE2 is upregulated by fatty acids in human MASH. |
CD34 | 37833210 | Other | Unknown | Tissue | Cancer Related Liver | A case of a motor vehicle collision suspected as associated with development of |
CD34 | 37657739 | Other | Unknown | Blood | Cancer Related Liver | Comprehensive Characterization and Global Transcriptome Analysis of Human Fetal |
GBA | 37469132 | Other | Unknown | Other | Hepatocellular Carcinoma | LAMP2A, LAMP2B and LAMP2C: similar structures, divergent roles. |
GBA | 36958408 | Other | Unknown | Tissue | Hepatocellular Carcinoma | A novel lonidamine derivative targeting mitochondria to eliminate cancer stem |
GBA | 36870542 | Other | Unknown | Tissue | Hepatocellular Carcinoma | Hydroxyethyl starch stabilized copper-diethyldithiocarbamate nanocrystals for |
GBA | 36510170 | Other | Unknown | Other | Hepatocellular Carcinoma | Renal and hepatic artery embolization with Pickering gel emulsion of lipiodol in |
GBA | 35524631 | Other | Unknown | Urine | Hepatocellular Carcinoma | Reducing Postoperative Recurrence of Early-Stage Hepatocellular Carcinoma by a |
GBA | 34085419 | Other | Unknown | Other | Hepatocellular Carcinoma | Hyperbaric Oxygen Boosts PD-1 Antibody Delivery and T Cell Infiltration for |
GBA | 38674014 | Other | Unknown | Blood | Liver Cancer | Gut Bacteria Provide Genetic and Molecular Reporter Systems to Identify Specific |
GBA | 38496007 | Other | Unknown | Tissue | Liver Cancer | Acceleration of benzo(a)pyrene-induced colon carcinogenesis by Western diet in a |
GBA | 37968095 | Other | Unknown | Tissue | Liver Cancer | Spatial transcriptomics reveals a low extent of transcriptionally active |
GBA | 37487315 | Other | Unknown | Other | Liver Cancer | The potential therapeutic effects of Galbanic acid on cancer. |
GBA | 37469132 | Other | Unknown | Other | Liver Cancer | LAMP2A, LAMP2B and LAMP2C: similar structures, divergent roles. |
GBA | 36958408 | Other | Unknown | Tissue | Liver Cancer | A novel lonidamine derivative targeting mitochondria to eliminate cancer stem |
GBA | 35557587 | Other | Unknown | Tissue | Cholangiocarcinoma | Biliary cancer brain metastases: a multi-institution case series with case |
GBA | 38674014 | Other | Unknown | Blood | Cancer Related Liver | Gut Bacteria Provide Genetic and Molecular Reporter Systems to Identify Specific |
GBA | 38496007 | Other | Unknown | Tissue | Cancer Related Liver | Acceleration of benzo(a)pyrene-induced colon carcinogenesis by Western diet in a |
GBA | 37469132 | Other | Unknown | Other | Cancer Related Liver | LAMP2A, LAMP2B and LAMP2C: similar structures, divergent roles. |
GBA | 36958408 | Other | Unknown | Tissue | Cancer Related Liver | A novel lonidamine derivative targeting mitochondria to eliminate cancer stem |
GBA | 36918575 | Other | Unknown | Blood | Cancer Related Liver | Mechano-boosting nanomedicine antitumour efficacy by blocking the |
GBA | 36870542 | Other | Unknown | Tissue | Cancer Related Liver | Hydroxyethyl starch stabilized copper-diethyldithiocarbamate nanocrystals for |
GBA | 35637196 | Other | Downregulated | Tissue | Cancer Related Liver | GBA1-dependent membrane glucosylceramide reprogramming promotes liver cancer |
CHRM2 | 35429253 | Other | Unknown | Tissue | Hepatocellular Carcinoma | The role of bile acids in carcinogenesis. |
CHRM2 | 31848930 | Other | Unknown | Tissue | Hepatocellular Carcinoma | Multiple novel hepatocellular carcinoma signature genes are commonly controlled |
CHRM2 | 35429253 | Other | Unknown | Tissue | Liver Cancer | The role of bile acids in carcinogenesis. |
CHRM2 | 31848930 | Other | Unknown | Tissue | Liver Cancer | Multiple novel hepatocellular carcinoma signature genes are commonly controlled |
CHRM2 | 28882624 | Other | Unknown | Other | Liver Cancer | Network pharmacology analysis of the anti-cancer pharmacological mechanisms of |
CHRM2 | 28882624 | Other | Unknown | Other | Cancer Related Liver | Network pharmacology analysis of the anti-cancer pharmacological mechanisms of |
GJC1 | 30078215 | Other | Unknown | Other | Liver Cancer | High glucose stimulates proliferative capacity of liver cancer cells possibly via |
COLEC10 | 33565325 | Other | Upregulated | Other | Hepatocellular Carcinoma | MiR-452-5p mediates the proliferation, migration and invasion of hepatocellular |
COLEC10 | 32311840 | Other | Unknown | Tissue | Hepatocellular Carcinoma | Identification of cancer stem cell characteristics in liver hepatocellular |
COLEC10 | 33565325 | Other | Upregulated | Other | Liver Cancer | MiR-452-5p mediates the proliferation, migration and invasion of hepatocellular |
COLEC10 | 32311840 | Other | Unknown | Tissue | Liver Cancer | Identification of cancer stem cell characteristics in liver hepatocellular |
COLEC10 | 30108587 | Other | Unknown | Tissue | Liver Cancer | CL-L1 and CL-K1 Exhibit Widespread Tissue Distribution With High and Co-Localized |
COLEC10 | 27341702 | Other | Unknown | Other | Liver Cancer | Collectin Liver 1 and Collectin Kidney 1 of the Lectin Complement Pathway Are |
COLEC10 | 25710878 | Other | Unknown | Tissue | Liver Cancer | Genetic variation of COLEC10 and COLEC11 and association with serum levels of |
COLEC10 | 32311840 | Other | Unknown | Tissue | Cancer Related Liver | Identification of cancer stem cell characteristics in liver hepatocellular |
C14orf180 | 36860864 | Other | Unknown | Tissue | Liver Cancer | Research into the characteristic molecules significantly affecting liver cancer |
C14orf180 | 36860864 | Other | Unknown | Tissue | Cancer Related Liver | Research into the characteristic molecules significantly affecting liver cancer |
GABRD | 31277598 | Other | Upregulated | Other | Hepatocellular Carcinoma | Novel significant stage-specific differentially expressed genes in hepatocellular |
GABRD | 31277598 | Other | Upregulated | Other | Liver Cancer | Novel significant stage-specific differentially expressed genes in hepatocellular |
COL15A1 | 37742474 | Other | Unknown | Tissue | Hepatocellular Carcinoma | COL15A1 interacts with P4HB to regulate the growth and malignancy of |
COL15A1 | 36388672 | Other | Downregulated | Other | Hepatocellular Carcinoma | Collagen XV mediated the epithelial-mesenchymal transition to inhibit |
COL15A1 | 35493106 | Other | Unknown | Other | Hepatocellular Carcinoma | Uncovering N4-Acetylcytidine-Related mRNA Modification Pattern and Landscape of |
COL15A1 | 26293333 | Other | Unknown | Tissue | Hepatocellular Carcinoma | Human collagen XV is a prominent histopathological component of sinusoidal |
COL15A1 | 37742474 | Other | Unknown | Tissue | Liver Cancer | COL15A1 interacts with P4HB to regulate the growth and malignancy of |
COL15A1 | 36388672 | Other | Downregulated | Other | Liver Cancer | Collagen XV mediated the epithelial-mesenchymal transition to inhibit |
COL15A1 | 26293333 | Other | Unknown | Tissue | Liver Cancer | Human collagen XV is a prominent histopathological component of sinusoidal |
COL15A1 | 37742474 | Other | Unknown | Tissue | Cancer Related Liver | COL15A1 interacts with P4HB to regulate the growth and malignancy of |
COL15A1 | 36388672 | Other | Downregulated | Other | Cancer Related Liver | Collagen XV mediated the epithelial-mesenchymal transition to inhibit |
MXD3 | 36524545 | Other | Unknown | Other | Hepatocellular Carcinoma | Systemic analysis identifying PVT1/DUSP13 axis for microvascular invasion in |
MXD3 | 34943942 | Other | Unknown | Blood | Hepatocellular Carcinoma | MXD3 Promotes Obesity and the Androgen Receptor Signaling Pathway in |
MXD3 | 36524545 | Other | Unknown | Other | Liver Cancer | Systemic analysis identifying PVT1/DUSP13 axis for microvascular invasion in |
MXD3 | 34943942 | Other | Unknown | Blood | Liver Cancer | MXD3 Promotes Obesity and the Androgen Receptor Signaling Pathway in |
MXD3 | 36524545 | Other | Unknown | Other | Cancer Related Liver | Systemic analysis identifying PVT1/DUSP13 axis for microvascular invasion in |
MXD3 | 34943942 | Other | Unknown | Blood | Cancer Related Liver | MXD3 Promotes Obesity and the Androgen Receptor Signaling Pathway in |
SLC26A6 | 19940027 | Other | Downregulated | Other | Liver Cancer | Mechanisms of transcriptional modulation of the human anion exchanger SLC26A3 |
SLC26A6 | 19940027 | Other | Downregulated | Other | Cancer Related Liver | Mechanisms of transcriptional modulation of the human anion exchanger SLC26A3 |
TERT | 38825912 | Other | Unknown | Other | Hepatocellular Carcinoma | [Hepatoid carcinoma of the ovary: report of a case]. |
TERT | 38769666 | Other | Downregulated | Other | Hepatocellular Carcinoma | Therapeutic targeting of PLK1 in TERT promoter-mutant hepatocellular carcinoma. |
TERT | 38746245 | Other | Unknown | Other | Hepatocellular Carcinoma | Integrative multi-omics characterization of hepatocellular carcinoma in Hispanic |
TERT | 38577190 | Other | Unknown | Other | Hepatocellular Carcinoma | Telomerase-related advances in hepatocellular carcinoma: A bibliometric and |
TERT | 38572921 | Other | Unknown | Other | Hepatocellular Carcinoma | Identification of molecular characteristics of hepatocellular carcinoma with |
TERT | 38538923 | Other | Unknown | Other | Hepatocellular Carcinoma | Fructose-1,6-bisphosphatase 1 dephosphorylates and inhibits TERT for tumor |
TERT | 38417600 | Other | Unknown | Tissue | Hepatocellular Carcinoma | Investigating the molecular mechanism of Qizhu anticancer prescription in |
TERT | 38825912 | Other | Unknown | Other | Liver Cancer | [Hepatoid carcinoma of the ovary: report of a case]. |
TERT | 38769666 | Other | Downregulated | Other | Liver Cancer | Therapeutic targeting of PLK1 in TERT promoter-mutant hepatocellular carcinoma. |
TERT | 38746245 | Other | Unknown | Other | Liver Cancer | Integrative multi-omics characterization of hepatocellular carcinoma in Hispanic |
TERT | 38742815 | Other | Unknown | Other | Liver Cancer | Pharmaceutical Properties and Phytochemical Profile of Extract Derived from |
TERT | 38577190 | Other | Unknown | Other | Liver Cancer | Telomerase-related advances in hepatocellular carcinoma: A bibliometric and |
TERT | 38572921 | Other | Unknown | Other | Liver Cancer | Identification of molecular characteristics of hepatocellular carcinoma with |
TERT | 38538923 | Other | Unknown | Other | Liver Cancer | Fructose-1,6-bisphosphatase 1 dephosphorylates and inhibits TERT for tumor |
TERT | 37903726 | Other | Unknown | Other | Bile duct cancer | Multiregional analysis of combined hepatocellular-cholangiocarcinoma reveals |
TERT | 37337460 | Other | Unknown | Tissue | Bile duct cancer | Genomic profiling, prognosis, and potential interventional targets in young and |
TERT | 37140546 | Other | Unknown | Other | Bile duct cancer | Bile duct adenoma and small-sized small duct type intrahepatic cholangiocarcinoma |
TERT | 36462464 | Other | Unknown | Other | Bile duct cancer | Pan-tumor landscape of fibroblast growth factor receptor 1-4 genomic alterations. |
TERT | 36123506 | Other | Unknown | Tissue | Bile duct cancer | Analysis of viral integration reveals new insights of oncogenic mechanism in |
TERT | 35675577 | Other | Unknown | Other | Bile duct cancer | Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer |
TERT | 34949765 | Other | Unknown | Other | Bile duct cancer | Molecular features of primary hepatic undifferentiated carcinoma. |
TERT | 34478159 | Other | Unknown | Other | Bile duct cancer | Comprehensive characterization of viral integrations and genomic aberrations in |
TERT | 37903726 | Other | Unknown | Other | Cholangiocarcinoma | Multiregional analysis of combined hepatocellular-cholangiocarcinoma reveals |
TERT | 37337460 | Other | Unknown | Tissue | Cholangiocarcinoma | Genomic profiling, prognosis, and potential interventional targets in young and |
TERT | 37140546 | Other | Unknown | Other | Cholangiocarcinoma | Bile duct adenoma and small-sized small duct type intrahepatic cholangiocarcinoma |
TERT | 36462464 | Other | Unknown | Other | Cholangiocarcinoma | Pan-tumor landscape of fibroblast growth factor receptor 1-4 genomic alterations. |
TERT | 36123506 | Other | Unknown | Tissue | Cholangiocarcinoma | Analysis of viral integration reveals new insights of oncogenic mechanism in |
TERT | 35675577 | Other | Unknown | Other | Cholangiocarcinoma | Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer |
TERT | 38746245 | Other | Unknown | Other | Cancer Related Liver | Integrative multi-omics characterization of hepatocellular carcinoma in Hispanic |
TERT | 38742815 | Other | Unknown | Other | Cancer Related Liver | Pharmaceutical Properties and Phytochemical Profile of Extract Derived from |
TERT | 38577190 | Other | Unknown | Other | Cancer Related Liver | Telomerase-related advances in hepatocellular carcinoma: A bibliometric and |
TERT | 38395437 | Other | Unknown | Other | Cancer Related Liver | HBV integrations reshaping genomic structures promote hepatocellular carcinoma. |
TERT | 38381705 | Other | Unknown | Other | Cancer Related Liver | Genome-wide association study identifies high-impact susceptibility loci for HCC |
TERT | 38344447 | Other | Unknown | Other | Cancer Related Liver | HBV DNA Integration into Telomerase or MLL4 Genes and TERT Promoter Point |
TERT | 38244516 | Other | Unknown | Tissue | Cancer Related Liver | Activation of APE1 modulates Nrf2 protected against acute liver injury by inhibit |
TERT | 38184822 | Other | Unknown | Cell lines | Cancer Related Liver | Establishment and characterization of a highly metastatic hepatocellular |
TERT | 38110948 | Other | Unknown | Other | Cancer Related Liver | A secreted form of chorismate mutase (Rv1885c) in Mycobacterium bovis BCG |
ZIC2 | 26318045 | Other | Unknown | Cell lines | Pancreatic Cancer | Addiction of pancreatic cancer cells to zinc-finger transcription factor ZIC2. |
ZIC2 | 26318045 | Other | Unknown | Cell lines | Pancreatic Ductal Adenocarcinoma | Addiction of pancreatic cancer cells to zinc-finger transcription factor ZIC2. |
SPI1 | 33099939 | Other | Unknown | Other | Pancreatic Cancer | Time series expression patterns reveal the molecular processes of pancreatic |
FXYD3 | 35371992 | Other | Unknown | Plasma | Pancreatic Cancer | Displacement of Native FXYD Protein From Na(+)/K(+)-ATPase With Novel FXYD |
FXYD3 | 26090296 | Other | Unknown | Other | Pancreatic Cancer | Estrogen and tamoxifen up-regulate FXYD3 on breast cancer cells: assessing the |
FXYD3 | 21288909 | Other | Unknown | Tissue | Pancreatic Cancer | Structural analysis of the cancer-specific promoter in mesothelin and in other |
FXYD3 | 20364041 | Other | Unknown | Other | Pancreatic Cancer | Expression and significance of FXYD-3 protein in gastric adenocarcinoma. |
FXYD3 | 16003754 | Other | Unknown | Tissue | Pancreatic Cancer | FXYD3 is overexpressed in pancreatic ductal adenocarcinoma and influences |
FXYD3 | 16003754 | Other | Unknown | Tissue | Pancreatic Ductal Adenocarcinoma | FXYD3 is overexpressed in pancreatic ductal adenocarcinoma and influences |
HMOX1 | 38127054 | Other | Unknown | Tissue | Pancreatic Cancer | Integrative transcriptome and single-cell sequencing technology analysis of the |
HMOX1 | 38115220 | Other | Upregulated | Other | Pancreatic Cancer | Myoglobin improves doxycycline sensitivity in pancreatic cancer through promoting |
HMOX1 | 37685961 | Other | Upregulated | Cell lines | Pancreatic Cancer | Targeting AHR Increases Pancreatic Cancer Cell Sensitivity to Gemcitabine through |
HMOX1 | 37488674 | Other | Unknown | Other | Pancreatic Cancer | Isoliquiritigenin induces HMOX1 and GPX4-mediated ferroptosis in gallbladder |
HMOX1 | 37094356 | Other | Unknown | Other | Pancreatic Cancer | Ferroptosis model system by the re-expression of BACH1. |
HMOX1 | 36727657 | Other | Upregulated | Urine | Pancreatic Cancer | Systemic deuteration of SCID mice using the water-isotopologue deuterium oxide |
HMOX1 | 36453019 | Other | Upregulated | Other | Pancreatic Cancer | Ryanodine receptor 2 promotes colorectal cancer metastasis by the ROS/BACH1 axis. |
HMOX1 | 36089650 | Other | Unknown | Other | Pancreatic Cancer | Photothermal Nanozymatic Nanoparticles Induce Ferroptosis and Apoptosis through |
HMOX1 | 35915609 | Other | Unknown | Other | Pancreatic Cancer | Vitamin C Sensitizes Pancreatic Cancer Cells to Erastin-Induced Ferroptosis by |
HMOX1 | 37685961 | Other | Upregulated | Cell lines | Pancreatic Ductal Adenocarcinoma | Targeting AHR Increases Pancreatic Cancer Cell Sensitivity to Gemcitabine through |
HMOX1 | 37094356 | Other | Unknown | Other | Pancreatic Ductal Adenocarcinoma | Ferroptosis model system by the re-expression of BACH1. |
HMOX1 | 36727657 | Other | Upregulated | Urine | Pancreatic Ductal Adenocarcinoma | Systemic deuteration of SCID mice using the water-isotopologue deuterium oxide |
HMOX1 | 33546433 | Other | Upregulated | Urine | Pancreatic Ductal Adenocarcinoma | Deuterium Oxide (D(2)O) Induces Early Stress Response Gene Expression and Impairs |
HMOX1 | 32629871 | Other | Upregulated | Cell lines | Pancreatic Ductal Adenocarcinoma | NRF2 Knockdown Resensitizes 5-Fluorouracil-Resistant Pancreatic Cancer Cells by |
HMOX1 | 31243599 | Other | Unknown | Other | Pancreatic Ductal Adenocarcinoma | JNK inhibition blocks piperlongumine-induced cell death and transcriptional |
HMOX1 | 29328656 | Other | Unknown | Cell lines | Pancreatic Ductal Adenocarcinoma | Design and Synthesis of Novel Reactive Oxygen Species Inducers for the Treatment |
HMOX1 | 28880262 | Other | Upregulated | Urine | Pancreatic Ductal Adenocarcinoma | Acceleration of pancreatic tumorigenesis under immunosuppressive microenvironment |
HMOX1 | 26675757 | Other | Unknown | Tissue | Pancreatic Ductal Adenocarcinoma | HuR mediated post-transcriptional regulation as a new potential adjuvant |
HMOX1 | 32629871 | Other | Upregulated | Cell lines | Cancer Related Pancreas | NRF2 Knockdown Resensitizes 5-Fluorouracil-Resistant Pancreatic Cancer Cells by |
HMOX1 | 19403515 | Other | Unknown | Tissue | Cancer Related Pancreas | Proteomic characterisation of pancreatic islet beta-cells stimulated with |
PDYN | 25070369 | Other | Unknown | Other | Pancreatic Cancer | LKB1 and AMPK differentially regulate pancreatic beta-cell identity. |
HCK | 36223746 | Other | Unknown | Other | Pancreatic Cancer | Inhibition of HCK in myeloid cells restricts pancreatic tumor growth and |
HCK | 33233470 | Other | Unknown | Other | Pancreatic Cancer | Emerging Kinase Therapeutic Targets in Pancreatic Ductal Adenocarcinoma and |
HCK | 33213062 | Other | Unknown | Tissue | Pancreatic Cancer | Kinome Array Profiling of Patient-Derived Pancreatic Ductal Adenocarcinoma |
HCK | 31381571 | Other | Unknown | Other | Pancreatic Cancer | Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome |
HCK | 24763074 | Other | Unknown | Cell lines | Pancreatic Cancer | The inhibition of SRC family kinase suppresses pancreatic cancer cell |
HCK | 24145282 | Other | Unknown | Other | Pancreatic Cancer | Antitumor effects of immunotoxins are enhanced by lowering HCK or treatment with |
HCK | 17233815 | Other | Unknown | Other | Pancreatic Cancer | Genome-wide array-based comparative genomic hybridization analysis of pancreatic |
HCK | 36223746 | Other | Unknown | Other | Pancreatic Ductal Adenocarcinoma | Inhibition of HCK in myeloid cells restricts pancreatic tumor growth and |
HCK | 33233470 | Other | Unknown | Other | Pancreatic Ductal Adenocarcinoma | Emerging Kinase Therapeutic Targets in Pancreatic Ductal Adenocarcinoma and |
HCK | 33213062 | Other | Unknown | Tissue | Pancreatic Ductal Adenocarcinoma | Kinome Array Profiling of Patient-Derived Pancreatic Ductal Adenocarcinoma |
HCK | 31381571 | Other | Unknown | Other | Pancreatic Ductal Adenocarcinoma | Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome |
HCK | 24763074 | Other | Unknown | Cell lines | Cancer Related Pancreas | The inhibition of SRC family kinase suppresses pancreatic cancer cell |
FAM83D | 33571515 | Other | Unknown | Tissue | Pancreatic Cancer | Fam83D promotes tumorigenesis and gemcitabine resistance of pancreatic |
FAM83D | 27769048 | Other | Unknown | Tissue | Pancreatic Cancer | FAM83D associates with high tumor recurrence after liver transplantation |
FAM83D | 26125229 | Other | Upregulated | Other | Pancreatic Cancer | Upregulation of FAM83D affects the proliferation and invasion of hepatocellular |
CD33 | 38650005 | Other | Unknown | Tissue | Pancreatic Cancer | Heterodimerization of T cell engaging bispecific antibodies to enhance |
CD33 | 37740463 | Other | Unknown | Other | Pancreatic Cancer | Uncovering therapeutic opportunities in the clinical development of antibody-drug |
CD33 | 36633260 | Other | Unknown | Tissue | Pancreatic Cancer | Nicotinamide N -methyltransferase promotes M2 macrophage polarization by IL6 and |
CD33 | 34525267 | Other | Unknown | Tissue | Pancreatic Cancer | CCL2 produced by pancreatic ductal adenocarcinoma is essential for the |
CD33 | 32581043 | Other | Unknown | Tissue | Pancreatic Cancer | CD200 promotes immunosuppression in the pancreatic tumor microenvironment. |
CD33 | 38650005 | Other | Unknown | Tissue | Pancreatic Ductal Adenocarcinoma | Heterodimerization of T cell engaging bispecific antibodies to enhance |
CD33 | 34525267 | Other | Unknown | Tissue | Pancreatic Ductal Adenocarcinoma | CCL2 produced by pancreatic ductal adenocarcinoma is essential for the |
CD33 | 32581043 | Other | Unknown | Tissue | Pancreatic Ductal Adenocarcinoma | CD200 promotes immunosuppression in the pancreatic tumor microenvironment. |
CD33 | 28344866 | Other | Unknown | Tissue | Pancreatic Ductal Adenocarcinoma | CD13(hi) Neutrophil-like myeloid-derived suppressor cells exert immune |
CD33 | 25827621 | Other | Upregulated | Tissue | Pancreatic Ductal Adenocarcinoma | Inflammatory features of pancreatic cancer highlighted by monocytes/macrophages |
CD33 | 24089656 | Other | Unknown | Blood | Pancreatic Ductal Adenocarcinoma | A Study of Zoledronic Acid as Neo-Adjuvant, Perioperative Therapy in Patients |
CD33 | 23894703 | Other | Unknown | Blood | Pancreatic Ductal Adenocarcinoma | The S100A8/A9 complex reduces CTLA4 expression by immature myeloid cells: |
KLF1 | 34669363 | Other | Unknown | Tissue | Pancreatic Cancer | Kruppel-like factor 1 serves as a facilitator in gastric cancer progression via |
GPRC5D | 25621293 | Other | Unknown | Other | Pancreatic Cancer | The emerging roles of GPRC5A in diseases. |
GPRC5D | 37467514 | Other | Unknown | Tissue | Cancer Related Pancreas | The G protein-coupled receptor GPRC5A-a phorbol ester and retinoic acid-induced |
NCF2 | 36879118 | Other | Unknown | Other | Pancreatic Cancer | Retraction Note: LINC01410-miR-532-NCF2-NF-kB feedback loop promotes gastric |
NCF2 | 29483646 | Other | Unknown | Other | Pancreatic Cancer | LINC01410-miR-532-NCF2-NF-kB feedback loop promotes gastric cancer angiogenesis |
TNFAIP3 | 26758190 | Other | Unknown | Tissue | Pancreatic Cancer | MiR-125a regulates chemo-sensitivity to gemcitabine in human pancreatic cancer |
TNFAIP3 | 22461193 | Other | Unknown | Tissue | Pancreatic Cancer | Expression of A20 is reduced in pancreatic cancer tissues. |
TNFAIP3 | 12446608 | Other | Unknown | Other | Pancreatic Cancer | 1,25-dihydroxyvitamin D3 protects RINm5F and human islet cells against |
TNFAIP3 | 26758190 | Other | Unknown | Tissue | Pancreatic Ductal Adenocarcinoma | MiR-125a regulates chemo-sensitivity to gemcitabine in human pancreatic cancer |
SPDEF | 38464029 | Other | Unknown | Cell lines | Pancreatic Cancer | Oncogenic GNAS drives a gastric pylorus program in intraductal papillary mucinous |
SPDEF | 38262672 | Other | Unknown | Urine | Pancreatic Cancer | A mucus production programme promotes classical pancreatic ductal adenocarcinoma. |
SPDEF | 28255028 | Other | Unknown | Other | Pancreatic Cancer | Gene signature driving invasive mucinous adenocarcinoma of the lung. |
SPDEF | 38464029 | Other | Unknown | Cell lines | Pancreatic Ductal Adenocarcinoma | Oncogenic GNAS drives a gastric pylorus program in intraductal papillary mucinous |
SPDEF | 38262672 | Other | Unknown | Urine | Pancreatic Ductal Adenocarcinoma | A mucus production programme promotes classical pancreatic ductal adenocarcinoma. |
SIGLEC9 | 33692781 | Other | Unknown | Blood | Pancreatic Cancer | Increased Frequency of Dysfunctional Siglec-7(-)CD57(+)PD-1(+) Natural Killer |
SIGLEC9 | 33627655 | Other | Unknown | Other | Pancreatic Cancer | Sialic acids in pancreatic cancer cells drive tumour-associated macrophage |
SIGLEC9 | 33627655 | Other | Unknown | Other | Pancreatic Ductal Adenocarcinoma | Sialic acids in pancreatic cancer cells drive tumour-associated macrophage |
SIGLEC9 | 24045940 | Other | Unknown | Tissue | Cancer Related Pancreas | Binding of the sialic acid-binding lectin, Siglec-9, to the membrane mucin, MUC1, |
SIGLEC9 | 15361709 | Other | Upregulated | Tissue | Cancer Related Pancreas | Molecular cloning of a new gene which is differentially expressed in breast and |
PYY | 38833137 | Other | Unknown | Other | Pancreatic Cancer | The Clinicopathological Significance of Tumor Cell Subtyping in Appendiceal |
PYY | 34041698 | Other | Unknown | Other | Pancreatic Cancer | Middle Ear "Adenoma": a Neuroendocrine Tumor with Predominant L Cell |
PYY | 33459181 | Other | Unknown | Blood | Pancreatic Cancer | Differential effects of bile acids on the postprandial secretion of gut hormones: |
PYY | 28912908 | Other | Unknown | Blood | Pancreatic Cancer | Gastrin-Releasing Peptide and Glucose Metabolism Following Pancreatitis. |
PYY | 27117413 | Other | Unknown | Other | Pancreatic Cancer | PYY-Dependent Restoration of Impaired Insulin and Glucagon Secretion in Type 2 |
PYY | 26683796 | Other | Unknown | Tissue | Pancreatic Cancer | Obesity: An overview of possible role(s) of gut hormones, lipid sensing and gut |
PYY | 26291794 | Other | Unknown | Other | Pancreatic Cancer | Changes in Metabolic Hormones in Malaysian Young Adults following Helicobacter |
PYY | 11331476 | Other | Unknown | Other | Pancreatic Ductal Adenocarcinoma | Synthetic peptide YY analog binds to a cell membrane receptor and delivers |
PYY | 10816343 | Other | Unknown | Other | Pancreatic Ductal Adenocarcinoma | Peptide YY and vitamin E inhibit hormone-sensitive and -insensitive breast cancer |
PYY | 10644462 | Other | Unknown | Cell lines | Pancreatic Ductal Adenocarcinoma | Peptide YY augments gross inhibition by vitamin E succinate of human pancreatic |
PYY | 10090823 | Other | Unknown | Other | Pancreatic Ductal Adenocarcinoma | Peptide YY inhibits growth of human breast cancer in vitro and in vivo. |
PYY | 8554139 | Other | Unknown | Other | Pancreatic Ductal Adenocarcinoma | Adjuvant hormonal treatment with peptide YY or its analog decreases human |
PYY | 7791350 | Other | Unknown | Tissue | Pancreatic Ductal Adenocarcinoma | Human pancreatic cancer growth is inhibited by peptide YY and BIM-43004-1. |
PYY | 11331476 | Other | Unknown | Other | Pancreatic Exocrine Cancer | Synthetic peptide YY analog binds to a cell membrane receptor and delivers |
PYY | 7638738 | Other | Unknown | Other | Pancreatic Exocrine Cancer | Y2 receptors decrease human pancreatic cancer growth and intracellular cyclic |
PYY | 7791350 | Other | Unknown | Tissue | Pancreatic Exocrine Cancer | Human pancreatic cancer growth is inhibited by peptide YY and BIM-43004-1. |
PYY | 2080016 | Other | Unknown | Cell lines | Pancreatic Exocrine Cancer | Neuropeptide Y and peptide YY stimulate the growth of exocrine pancreatic |
PYY | 23507937 | Other | Unknown | Other | Cancer Related Pancreas | Accurate histological terminology for small intestine carcinoid tumors. |
PYY | 18641782 | Other | Unknown | Other | Cancer Related Pancreas | [Surgical treatment [corrected] of type 2 diabetes. Neuroendocrine basis in |
PYY | 15125025 | Other | Unknown | Other | Cancer Related Pancreas | Cytological and immunocytochemical characterization of the insulin secreting |
DDC | 38623945 | Other | Unknown | Tissue | Pancreatic Cancer | Deletion of Tgm2 suppresses BMP-mediated hepatocyte-to-cholangiocyte metaplasia |
DDC | 37294165 | Other | Unknown | Plasma | Pancreatic Cancer | Rapid Chemical Synthesis of Serine Protease Inhibitor Kazal-type 13 (SPINK13) |
DDC | 34974990 | Other | Unknown | Other | Pancreatic Cancer | Idiopathic chronic pancreatitis treated with ivacaftor in a CFTR carrier with |
DDC | 30267751 | Other | Unknown | Cell lines | Pancreatic Cancer | Pancreatic cancer stem cell proliferation is strongly inhibited by |
DDC | 30074477 | Other | Unknown | Other | Pancreatic Cancer | HNF1A is a novel oncogene that regulates human pancreatic cancer stem cell |
DDC | 28664225 | Other | Unknown | Blood | Pancreatic Cancer | Does "OPTINAB" strategy ("stop-and-go") work in treatment of advanced pancreatic |
DDC | 30267751 | Other | Unknown | Cell lines | Pancreatic Ductal Adenocarcinoma | Pancreatic cancer stem cell proliferation is strongly inhibited by |
DDC | 30074477 | Other | Unknown | Other | Pancreatic Ductal Adenocarcinoma | HNF1A is a novel oncogene that regulates human pancreatic cancer stem cell |
DDC | 23269448 | Other | Unknown | Tissue | Cancer Related Pancreas | Cancer transmission from organ donors-unavoidable but low risk. |
ERN2 | 38262672 | Other | Unknown | Urine | Pancreatic Cancer | A mucus production programme promotes classical pancreatic ductal adenocarcinoma. |
ERN2 | 22189555 | Other | Unknown | Other | Pancreatic Cancer | Pancreatic beta-cells depend on basal expression of active ATF6alpha-p50 for cell |
ERN2 | 21704586 | Other | Unknown | Other | Pancreatic Cancer | Extensive pancreas regeneration following acinar-specific disruption of Xbp1 in |
ERN2 | 21419040 | Other | Unknown | Other | Pancreatic Cancer | [Oxidative damage to the endoplasmic reticulum stress pathway of |
ERN2 | 38262672 | Other | Unknown | Urine | Pancreatic Ductal Adenocarcinoma | A mucus production programme promotes classical pancreatic ductal adenocarcinoma. |
ERN2 | 21704586 | Other | Unknown | Other | Pancreatic Exocrine Cancer | Extensive pancreas regeneration following acinar-specific disruption of Xbp1 in |
ERN2 | 21419040 | Other | Unknown | Other | Cancer Related Pancreas | [Oxidative damage to the endoplasmic reticulum stress pathway of |
SOX3 | 12165811 | Other | Unknown | Tissue | Pancreatic Cancer | Expression of human SOX18 in normal tissues and tumors. |
NPL | 37637662 | Other | Unknown | Blood | Pancreatic Cancer | Perioperative Outcomes of Systematic Mesopancreas Dissection for Pancreatic and |
NPL | 35898377 | Other | Unknown | Other | Pancreatic Cancer | The Role of Type 2 Diabetes in Pancreatic Cancer. |
NPL | 34912651 | Other | Unknown | Tissue | Pancreatic Cancer | Arterial Divestment and Resection in Post-neoadjuvant Pancreatic Adenocarcinoma. |
NPL | 34367843 | Other | Unknown | Other | Pancreatic Cancer | Magic of a Common Sugar Pill in Cancer: Can Metformin Raise Survival in |
NPL | 33290836 | Other | Unknown | Blood | Pancreatic Cancer | Hyaluronan synthesis inhibition impairs antigen presentation and delays |
NPL | 32075738 | Other | Downregulated | Blood | Pancreatic Cancer | The Natural Metabolite 4-Cresol Improves Glucose Homeostasis and Enhances beta-Cell |
NPL | 36320800 | Other | Unknown | Other | Pancreatic Ductal Adenocarcinoma | Strategies in the Management of Pancreatic Ductal Adenocarcinoma Involving |
NPL | 35898377 | Other | Unknown | Other | Pancreatic Ductal Adenocarcinoma | The Role of Type 2 Diabetes in Pancreatic Cancer. |
NPL | 34912651 | Other | Unknown | Tissue | Pancreatic Ductal Adenocarcinoma | Arterial Divestment and Resection in Post-neoadjuvant Pancreatic Adenocarcinoma. |
GYPC | 27432216 | Other | Unknown | Blood | Pancreatic Cancer | MINDEC-An Enhanced Negative Depletion Strategy for Circulating Tumour Cell |
GYPC | 25831262 | Other | Unknown | Blood | Pancreatic Cancer | Anti-Ge2: further evidence for lack of clinical significance. |
FHDC1 | 15375526 | Other | Unknown | Tissue | Pancreatic Cancer | Identification and characterization of CDC50A, CDC50B and CDC50C genes in silico. |
ARRB2 | 22472349 | Other | Unknown | Tissue | Pancreatic Cancer | Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in |
MYO1F | 38097912 | Other | Unknown | Other | Pancreatic Cancer | A jack of all trades - ADAM8 as a signaling hub in inflammation and cancer. |
ABCA12 | 35783291 | Other | Unknown | Tissue | Pancreatic Cancer | ABCA12 Promotes Proliferation and Migration and Inhibits Apoptosis of Pancreatic |
ABCA12 | 28468577 | Other | Upregulated | Tissue | Pancreatic Cancer | ABC gene expression profiles have clinical importance and possibly form a new |
ABCA12 | 21616586 | Other | Unknown | Cell lines | Pancreatic Cancer | Alpha-fetoprotein-producing pancreatic cancer cells possess cancer stem cell |
PTPRO | 35003364 | Other | Unknown | Blood | Pancreatic Cancer | PTPRO is a therapeutic target and correlated with immune infiltrates in |
C1QC | 38817876 | Other | Unknown | Tissue | Pancreatic Cancer | Identification of crucial genes through WGCNA in the progression of gastric |
C1QC | 37383234 | Other | Unknown | Cell lines | Pancreatic Cancer | Single-cell RNA sequencing highlights the role of PVR/PVRL2 in the |
C1QC | 37187751 | Other | Upregulated | Tissue | Pancreatic Cancer | Identification of TREM2-positive tumor-associated macrophages in esophageal |
CYP3A4 | 37920921 | Other | Unknown | Other | Pancreatic Cancer | Protocol of the IntenSify-Trial: An open-label phase I trial of the CYP3A |
CYP3A4 | 37710176 | Other | Unknown | Other | Pancreatic Cancer | Quercetin inhibits the metabolism of arachidonic acid by inhibiting the activity |
CYP3A4 | 37679568 | Other | Unknown | Tissue | Pancreatic Cancer | Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant |
CYP3A4 | 37638428 | Other | Unknown | Other | Pancreatic Cancer | In vitro simulation of the liver first-pass effect with |
CYP3A4 | 37143385 | Other | Unknown | Other | Pancreatic Cancer | Rapid high performance liquid chromatography method for erlotinib quantification |
CYP3A4 | 37081969 | Other | Downregulated | Other | Pancreatic Cancer | Metabolomics-based discovery of XHP as a CYP3A4 inhibitor against pancreatic |
CYP3A4 | 36446317 | Other | Unknown | Other | Pancreatic Cancer | Drug Interactions Causing Warfarin Overdose in a Patient with Pancreatic Cancer: |
CYP3A4 | 36002285 | Other | Unknown | Other | Pancreatic Cancer | HIF1 inhibition of the biflavonoids against pancreas cancer: drug-likeness, |
CYP3A4 | 37920921 | Other | Unknown | Other | Pancreatic Ductal Adenocarcinoma | Protocol of the IntenSify-Trial: An open-label phase I trial of the CYP3A |
CYP3A4 | 37679568 | Other | Unknown | Tissue | Pancreatic Ductal Adenocarcinoma | Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant |
CYP3A4 | 26907883 | Other | Unknown | Other | Pancreatic Ductal Adenocarcinoma | Pancreatic cancer: CYP3A5 contributes to PDAC chemoresistance. |
CYP3A4 | 26855150 | Other | Unknown | Other | Pancreatic Ductal Adenocarcinoma | CYP3A5 mediates basal and acquired therapy resistance in different subtypes of |
CYP3A4 | 12435864 | Other | Unknown | Tissue | Pancreatic Ductal Adenocarcinoma | Expression of drug-metabolizing enzymes in the pancreas of hamster, mouse, and |
CYP3A4 | 26855150 | Other | Unknown | Other | Pancreatic Exocrine Cancer | CYP3A5 mediates basal and acquired therapy resistance in different subtypes of |
CYP3A4 | 16375696 | Other | Unknown | Other | Cancer Related Pancreas | Hormonal effects on drug metabolism through the CYP system: perspectives on their |
CYP3A4 | 15180491 | Other | Unknown | Other | Cancer Related Pancreas | Cytochrome P450 gene polymorphism and cancer. |
CYP3A4 | 8501544 | Other | Unknown | Other | Cancer Related Pancreas | Induction of drug-metabolizing enzymes in human pancreatic cancer and chronic |
LAIR1 | 36810933 | Other | Unknown | Other | Pancreatic Cancer | A novel mechanism of cannabidiol in suppressing ovarian cancer through LAIR-1 |
LAIR1 | 32628130 | Other | Unknown | Other | Pancreatic Cancer | LAIR-1 suppresses cell growth of ovarian cancer cell via the PI3K-AKT-mTOR |
SIGLEC7 | 38594506 | Other | Unknown | Cell lines | Pancreatic Cancer | Pancreatic cancer-associated fibroblasts modulate macrophage differentiation via |
SIGLEC7 | 34198593 | Other | Unknown | Tissue | Pancreatic Cancer | Phenotypic Characterization by Single-Cell Mass Cytometry of Human Intrahepatic |
SIGLEC7 | 33692781 | Other | Unknown | Blood | Pancreatic Cancer | Increased Frequency of Dysfunctional Siglec-7(-)CD57(+)PD-1(+) Natural Killer |
SIGLEC7 | 33627655 | Other | Unknown | Other | Pancreatic Cancer | Sialic acids in pancreatic cancer cells drive tumour-associated macrophage |
SIGLEC7 | 28378743 | Other | Unknown | Other | Pancreatic Cancer | Siglec-7 restores beta-cell function and survival and reduces inflammation in |
SIGLEC7 | 38594506 | Other | Unknown | Cell lines | Pancreatic Ductal Adenocarcinoma | Pancreatic cancer-associated fibroblasts modulate macrophage differentiation via |
SIGLEC7 | 33627655 | Other | Unknown | Other | Pancreatic Ductal Adenocarcinoma | Sialic acids in pancreatic cancer cells drive tumour-associated macrophage |
FPR1 | 38200229 | Other | Unknown | Cell lines | Pancreatic Cancer | A therapeutic antibody targeting annexin-A1 inhibits cancer cell growth in vitro |
FPR1 | 25510623 | Other | Unknown | Tissue | Pancreatic Cancer | Role of intracellular and extracellular annexin A1 in migration and invasion of |
C1QB | 38817876 | Other | Unknown | Tissue | Pancreatic Cancer | Identification of crucial genes through WGCNA in the progression of gastric |
C1QB | 37187751 | Other | Upregulated | Tissue | Pancreatic Cancer | Identification of TREM2-positive tumor-associated macrophages in esophageal |
C1QB | 35604302 | Other | Unknown | Other | Pancreatic Cancer | Molecular Subgroups of Intrahepatic Cholangiocarcinoma Discovered by Single-Cell |
C1QB | 33782087 | Other | Unknown | Blood | Pancreatic Cancer | Pancreatic cancer is marked by complement-high blood monocytes and |
C1QB | 33782087 | Other | Unknown | Blood | Pancreatic Ductal Adenocarcinoma | Pancreatic cancer is marked by complement-high blood monocytes and |
EPHB3 | 31807514 | Other | Unknown | Tissue | Pancreatic Cancer | Fibroblast activation protein alpha-positive pancreatic stellate cells promote the |
EPHB3 | 14697287 | Other | Unknown | Cell lines | Pancreatic Cancer | The efficacy of tyrosine kinase inhibitors on human pancreatic cancer cell lines. |
EPHB3 | 16596241 | Other | Unknown | Tissue | Cancer Related Pancreas | Comparative integromics on Eph family. |
KEL | 25609199 | Other | Unknown | Other | Pancreatic Cancer | Radiotherapy combined with TLR7/8 activation induces strong immune responses |
FCGR3A | 38710118 | Other | Unknown | Other | Pancreatic Cancer | The immune cells have complex causal regulation effects on cancers. |
FCGR3A | 31424423 | Other | Unknown | Other | Pancreatic Cancer | Antibodies targeting sialyl Lewis A mediate tumor clearance through distinct |
FCGR3A | 30596643 | Other | Unknown | Cell lines | Pancreatic Cancer | Anti-CD137 monoclonal antibody enhances trastuzumab-induced, natural killer |
FCGR3A | 23209031 | Other | Unknown | Other | Pancreatic Cancer | GA201 (RG7160): a novel, humanized, glycoengineered anti-EGFR antibody with |
GRIN2B | 29606348 | Other | Unknown | Other | Pancreatic Cancer | GKAP Acts as a Genetic Modulator of NMDAR Signaling to Govern Invasive Tumor |
GRIN2B | 29606348 | Other | Unknown | Other | Pancreatic Ductal Adenocarcinoma | GKAP Acts as a Genetic Modulator of NMDAR Signaling to Govern Invasive Tumor |
MUSK | 32972439 | Other | Unknown | Other | Rectal Cancer | Exercise and colorectal cancer: a systematic review and meta-analysis of exercise |
MUSK | 32972439 | Other | Unknown | Other | Rectum Cancer | Exercise and colorectal cancer: a systematic review and meta-analysis of exercise |
NFE2L3 | 32123008 | Other | Unknown | Tissue | Rectal Cancer | NRF3-POMP-20S Proteasome Assembly Axis Promotes Cancer Development via |
NFE2L3 | 35091681 | Other | Unknown | Tissue | Rectum Cancer | Loss of NFE2L3 protects against inflammation-induced colorectal cancer through |
NFE2L3 | 32123008 | Other | Unknown | Tissue | Rectum Cancer | NRF3-POMP-20S Proteasome Assembly Axis Promotes Cancer Development via |
CDH3 | 19528483 | Other | Unknown | Tissue | Rectum Cancer | Demethylation of the CDH3 gene is frequently detected in advanced colorectal |
GLP2R | 27401218 | Other | Unknown | Tissue | Rectal Cancer | Comprehensive site-specific whole genome profiling of stromal and epithelial |
GLP2R | 27401218 | Other | Unknown | Tissue | Rectum Cancer | Comprehensive site-specific whole genome profiling of stromal and epithelial |
SALL4 | 37527983 | Other | Unknown | Blood | Rectal Cancer | [Clinicopathological features of rectal adenocarcinoma with enteroblastic |
SALL4 | 37527983 | Other | Unknown | Blood | Rectum Cancer | [Clinicopathological features of rectal adenocarcinoma with enteroblastic |
SALL4 | 30766756 | Other | Unknown | Other | Rectum Cancer | Multidisciplinary team for the diagnosis and treatment of 2 cases of primary |
COL7A1 | 28454466 | Other | Upregulated | Tissue | Rectal Cancer | Identification of molecular characteristics induced by radiotherapy in rectal |
TGFBI | 32224706 | Other | Unknown | Tissue | Rectal Cancer | Comprehensive analysis of long non-coding RNA and mRNA expression profile in |
TGFBI | 32224706 | Other | Unknown | Tissue | Rectum Cancer | Comprehensive analysis of long non-coding RNA and mRNA expression profile in |
SLC6A6 | 36933827 | Other | Unknown | Other | Rectal Cancer | Dissecting the heterogeneities of the tumor microenvironment between metastatic |
SLC6A6 | 34571860 | Other | Unknown | Cell lines | Rectal Cancer | A Claudin-Based Molecular Signature Identifies High-Risk, Chemoresistant |
SLC6A6 | 36933827 | Other | Unknown | Other | Rectum Cancer | Dissecting the heterogeneities of the tumor microenvironment between metastatic |
SLC6A6 | 34571860 | Other | Unknown | Cell lines | Rectum Cancer | A Claudin-Based Molecular Signature Identifies High-Risk, Chemoresistant |
HRK | 27258487 | Other | Unknown | Other | Rectal Cancer | Long-Term Survival and Local Relapse Following Surgery Without Radiotherapy for |
HRK | 27258487 | Other | Unknown | Other | Rectum Cancer | Long-Term Survival and Local Relapse Following Surgery Without Radiotherapy for |
TMEFF2 | 21559523 | Other | Downregulated | Other | Rectal Cancer | TMEFF2 is a PDGF-AA binding protein with methylation-associated gene silencing in |
TMEFF2 | 21559523 | Other | Downregulated | Other | Rectum Cancer | TMEFF2 is a PDGF-AA binding protein with methylation-associated gene silencing in |
SST | 37900691 | Other | Unknown | Other | Rectal Cancer | Can the Single-stapling Technique Following Intersphincteric Resection with |
SST | 37301966 | Other | Unknown | Other | Rectal Cancer | Reducing anastomotic leakage in TaTME by mucosal coverage of staple lines: a |
SST | 36763868 | Other | Unknown | Other | Rectal Cancer | British Association of Dermatologists guidelines for the management of people |
SST | 36638066 | Other | Unknown | Other | Rectal Cancer | Single-stapling technique versus hand-sewn anastomosis in inter-sphincteric |
SST | 36593572 | Other | Unknown | Blood | Rectal Cancer | Optimal anastomotic technique in rectal surgery to prevent anastomotic leakage. |
SST | 35704092 | Other | Unknown | Other | Rectal Cancer | The use of single-stapling techniques reduces anastomotic complications in |
SST | 34419055 | Other | Unknown | Tissue | Rectal Cancer | Identification and verification of HCAR3 and INSL5 as new potential therapeutic |
SST | 34242512 | Other | Unknown | Other | Rectal Cancer | A Transabdominal Robotic Purse-String Suture Technique for Transanal Total |
SST | 37900691 | Other | Unknown | Other | Rectum Cancer | Can the Single-stapling Technique Following Intersphincteric Resection with |
SST | 37301966 | Other | Unknown | Other | Rectum Cancer | Reducing anastomotic leakage in TaTME by mucosal coverage of staple lines: a |
SST | 36763868 | Other | Unknown | Other | Rectum Cancer | British Association of Dermatologists guidelines for the management of people |
SST | 36638066 | Other | Unknown | Other | Rectum Cancer | Single-stapling technique versus hand-sewn anastomosis in inter-sphincteric |
SST | 35704092 | Other | Unknown | Other | Rectum Cancer | The use of single-stapling techniques reduces anastomotic complications in |
SST | 35225451 | Other | Unknown | Other | Rectum Cancer | Descriptive Epidemiology of Gastrointestinal Cancers: Results from National |
SST | 35017529 | Other | Unknown | Other | Rectum Cancer | Robust differentiation of human enteroendocrine cells from intestinal stem cells. |
SST | 34419055 | Other | Unknown | Tissue | Rectum Cancer | Identification and verification of HCAR3 and INSL5 as new potential therapeutic |
SST | 34242512 | Other | Unknown | Other | Rectum Cancer | A Transabdominal Robotic Purse-String Suture Technique for Transanal Total |
SST | 37900691 | Other | Unknown | Other | Cancer Related Rectum | Can the Single-stapling Technique Following Intersphincteric Resection with |
SST | 36638066 | Other | Unknown | Other | Cancer Related Rectum | Single-stapling technique versus hand-sewn anastomosis in inter-sphincteric |
SST | 20572039 | Other | Unknown | Tissue | Cancer Related Rectum | Relation between normal rectal methylation, smoking status, and the presence or |
SST | 1588222 | Other | Unknown | Other | Cancer Related Rectum | Double versus single stapling technique in rectal anastomosis. |
SIM2 | 25908452 | Other | Unknown | Tissue | Rectal Cancer | Identification of commonly dysregulated genes in colorectal cancer by integrating |
SIM2 | 25908452 | Other | Unknown | Tissue | Rectum Cancer | Identification of commonly dysregulated genes in colorectal cancer by integrating |
ESM1 | 18680240 | Other | Unknown | Tissue | Rectum Cancer | Correlation between expression and differentiation of endocan in colorectal |
FOXQ1 | 31404997 | Other | Upregulated | Tissue | Rectal Cancer | Epigenome Mapping Identifies Tumor-Specific Gene Expression in Primary Rectal |
FOXQ1 | 31116002 | Other | Unknown | Tissue | Rectal Cancer | Screening key lncRNAs for human rectal adenocarcinoma based on lncRNA-mRNA |
FOXQ1 | 31116002 | Other | Unknown | Tissue | Rectum Cancer | Screening key lncRNAs for human rectal adenocarcinoma based on lncRNA-mRNA |
ETV4 | 18511876 | Other | Unknown | Tissue | Rectal Cancer | Association of E1AF mRNA expression with tumor progression and matrilysin in |
ETV4 | 18511876 | Other | Unknown | Tissue | Rectum Cancer | Association of E1AF mRNA expression with tumor progression and matrilysin in |
IBSP | 37746647 | Other | Unknown | Tissue | Stomach Cancer | RNA-binding protein CPSF6 regulates IBSP to affect pyroptosis in gastric cancer. |
IBSP | 15623631 | Other | Unknown | Tissue | Stomach Cancer | Small integrin binding ligand N-linked glycoprotein gene family expression in |
IBSP | 37746647 | Other | Unknown | Tissue | Gastric Cancer | RNA-binding protein CPSF6 regulates IBSP to affect pyroptosis in gastric cancer. |
IBSP | 15623631 | Other | Unknown | Tissue | Gastric Cancer | Small integrin binding ligand N-linked glycoprotein gene family expression in |
IBSP | 15623631 | Other | Unknown | Tissue | Cancer Related Stomach | Small integrin binding ligand N-linked glycoprotein gene family expression in |
HOXC8 | 26499154 | Other | Unknown | Tissue | Stomach Cancer | [Analysis of gastric cancer tissues genome methylation by DNA methylation chip]. |
HOXC8 | 35111675 | Other | Unknown | Tissue | Gastric Cancer | The Role of miR-4256/HOXC8 Signaling Axis in the Gastric Cancer Progression: |
HOXC8 | 26499154 | Other | Unknown | Tissue | Gastric Cancer | [Analysis of gastric cancer tissues genome methylation by DNA methylation chip]. |
HOXC8 | 25706881 | Other | Unknown | Other | Gastric Cancer | PAQR3 modulates H3K4 trimethylation by spatial modulation of the regulatory |
FAP | 38722804 | Other | Unknown | Other | Stomach Cancer | Updated European guidelines for clinical management of familial adenomatous |
FAP | 38707599 | Other | Unknown | Other | Stomach Cancer | Outcomes following duodenectomy in patients with familial adenomatous polyposis. |
FAP | 37943618 | Other | Upregulated | Other | Stomach Cancer | Region-specific Wnt signaling responses promote gastric polyp formation in |
FAP | 37852192 | Other | Unknown | Other | Stomach Cancer | Gastric Polyps in Familial Adenomatous Polyposis Portuguese Patients: The First |
FAP | 37713035 | Other | Unknown | Other | Stomach Cancer | Two Cases, Too Little, Too Late: Surveillance for Gastric Cancer in Patients with |
FAP | 38826990 | Other | Unknown | Tissue | Gastric Cancer | Incidental Intense Fibroblast Activation Protein Inhibitor (FAPI) Uptake in |
FAP | 38798681 | Other | Unknown | Other | Gastric Cancer | Phenotype correlations with pathogenic DNA variants in the MUTYH gene. |
FAP | 38722804 | Other | Unknown | Other | Gastric Cancer | Updated European guidelines for clinical management of familial adenomatous |
FAP | 38707599 | Other | Unknown | Other | Gastric Cancer | Outcomes following duodenectomy in patients with familial adenomatous polyposis. |
FAP | 30855821 | Other | Unknown | Other | Gastric Cancer | Familial Adenomatous Polyposis. |
FAP | 38491214 | Other | Unknown | Blood | Gastric Cancer | Early detection of anthracycline-induced cardiotoxicity using [(68) Ga]Ga-FAPI-04 |
FAP | 36805791 | Other | Unknown | Other | Cancer Related Stomach | Fundic Gland Polyps Lack DNA Content Abnormality Characteristic of Other |
FAP | 36316112 | Other | Unknown | Other | Cancer Related Stomach | Endoscopic Findings and Treatment of Gastric Neoplasms in Familial Adenomatous |
FAP | 35979026 | Other | Unknown | Other | Cancer Related Stomach | Identifying factors associated with detection of sessile gastric polyps in |
ANGPT2 | 36877445 | Other | Upregulated | Cell lines | Stomach Cancer | Helicobacter pylori infection induces abnormal expression of pro-angiogenic gene |
ANGPT2 | 36172371 | Other | Unknown | Tissue | Stomach Cancer | Immunoregulation and clinical significance of neutrophils/NETs-ANGPT2 in tumor |
ANGPT2 | 35164221 | Other | Unknown | Other | Stomach Cancer | Negative Modulation of the Angiogenic Cascade Induced by Allosteric Kinesin Eg5 |
ANGPT2 | 31452262 | Other | Downregulated | Other | Stomach Cancer | Identification of the complex regulatory relationships related to gastric cancer |
ANGPT2 | 36877445 | Other | Upregulated | Cell lines | Gastric Cancer | Helicobacter pylori infection induces abnormal expression of pro-angiogenic gene |
ANGPT2 | 36172371 | Other | Unknown | Tissue | Gastric Cancer | Immunoregulation and clinical significance of neutrophils/NETs-ANGPT2 in tumor |
ANGPT2 | 35164221 | Other | Unknown | Other | Gastric Cancer | Negative Modulation of the Angiogenic Cascade Induced by Allosteric Kinesin Eg5 |
ANGPT2 | 33758610 | Other | Unknown | Tissue | Gastric Cancer | LINC00184 involved in the regulatory network of ANGPT2 via ceRNA mediated miR-145 |
ANGPT2 | 32874130 | Other | Unknown | Other | Gastric Cancer | MiR-145-5p suppresses the proliferation, migration and invasion of gastric cancer |
ANGPT2 | 31452262 | Other | Downregulated | Other | Gastric Cancer | Identification of the complex regulatory relationships related to gastric cancer |
ANGPT2 | 36172371 | Other | Unknown | Tissue | Cancer Related Stomach | Immunoregulation and clinical significance of neutrophils/NETs-ANGPT2 in tumor |
ANGPT2 | 31452262 | Other | Downregulated | Other | Cancer Related Stomach | Identification of the complex regulatory relationships related to gastric cancer |
MMP11 | 32537806 | Other | Unknown | Tissue | Stomach Cancer | Upregulation of Tubulointerstitial nephritis antigen like 1 promotes gastric |
MMP11 | 31595150 | Other | Unknown | Tissue | Stomach Cancer | Exosomal miRNA-139 in cancer-associated fibroblasts inhibits gastric cancer |
MMP11 | 31157588 | Other | Unknown | Tissue | Stomach Cancer | Circular RNA 0047905 acts as a sponge for microRNA4516 and microRNA1227-5p, |
MMP11 | 29956735 | Other | Upregulated | Tissue | Stomach Cancer | KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and |
MMP11 | 36139587 | Other | Unknown | Tissue | Gastric Cancer | Identification of a Biomarker Combination for Survival Stratification in pStage |
MMP11 | 33204108 | Other | Unknown | Tissue | Gastric Cancer | LncRNA CTBP1-AS2 Facilitates Gastric Cancer Progression via Regulating the |
MMP11 | 33122949 | Other | Unknown | Tissue | Gastric Cancer | Circ_0000260 Regulates the Development and Deterioration of Gastric |
MMP11 | 32537806 | Other | Unknown | Tissue | Gastric Cancer | Upregulation of Tubulointerstitial nephritis antigen like 1 promotes gastric |
CST4 | 34194498 | Other | Unknown | Tissue | Gastric Cancer | miRNA-6715-5p Inhibits Cellular Proliferation and Invasion in Colorectal Cancer |
CST4 | 29218251 | Other | Upregulated | Tissue | Gastric Cancer | Overexpression of CST4 promotes gastric cancer aggressiveness by activating the |
RIPK2 | 38164277 | Other | Unknown | Other | Gastric Cancer | Receptor-interacting protein kinase 2 is associated with tumor immune |
RIPK2 | 32082487 | Other | Unknown | Other | Gastric Cancer | Identification of molecular targets for the targeted treatment of gastric cancer |
RIPK2 | 29467894 | Other | Unknown | Other | Gastric Cancer | Association between receptor interacting serine/threonine kinase 2 polymorphisms |
WNT2 | 38230407 | Other | Unknown | Other | Stomach Cancer | Repurposing celecoxib for colorectal cancer targeting via pH-triggered |
WNT2 | 36869400 | Other | Unknown | Other | Stomach Cancer | Current advances in understanding the molecular profile of hereditary diffuse |
WNT2 | 35929139 | Other | Unknown | Other | Stomach Cancer | High COL10A1 expression potentially contributes to poor outcomes in gastric |
WNT2 | 33397440 | Other | Unknown | Tissue | Stomach Cancer | Circular RNA circLMO7 acts as a microRNA-30a-3p sponge to promote gastric cancer |
WNT2 | 33015779 | Other | Unknown | Tissue | Stomach Cancer | Up-regulated ONECUT2 and down-regulated SST promote gastric cell migration, |
WNT2 | 37634009 | Other | Upregulated | Other | Gastric Cancer | WNT2-SOX4 positive feedback loop promotes chemoresistance and tumorigenesis by |
WNT2 | 37528793 | Other | Unknown | Tissue | Gastric Cancer | [IL-8 Links NF-kappaB and Wnt/beta-Catenin Pathways in Persistent Inflammatory Response |
WNT2 | 36908326 | Other | Upregulated | Tissue | Gastric Cancer | microRNA-627-5p inhibits colorectal cancer cell proliferation, migration and |
WNT2 | 36869400 | Other | Unknown | Other | Gastric Cancer | Current advances in understanding the molecular profile of hereditary diffuse |
WNT2 | 35929139 | Other | Unknown | Other | Gastric Cancer | High COL10A1 expression potentially contributes to poor outcomes in gastric |
WNT2 | 33397440 | Other | Unknown | Tissue | Gastric Cancer | Circular RNA circLMO7 acts as a microRNA-30a-3p sponge to promote gastric cancer |
WNT2 | 33015779 | Other | Unknown | Tissue | Gastric Cancer | Up-regulated ONECUT2 and down-regulated SST promote gastric cell migration, |
WNT2 | 35929139 | Other | Unknown | Other | Cancer Related Stomach | High COL10A1 expression potentially contributes to poor outcomes in gastric |
WNT2 | 33397440 | Other | Unknown | Tissue | Cancer Related Stomach | Circular RNA circLMO7 acts as a microRNA-30a-3p sponge to promote gastric cancer |
WNT2 | 33015779 | Other | Unknown | Tissue | Cancer Related Stomach | Up-regulated ONECUT2 and down-regulated SST promote gastric cell migration, |
WNT2 | 31260453 | Other | Unknown | Cell lines | Cancer Related Stomach | Umbelliprenin isolated from Ferula sinkiangensis inhibits tumor growth and |
WNT2 | 18184402 | Other | Unknown | Tissue | Cancer Related Stomach | Expression of seven gastric cancer-associated genes and its relevance for Wnt, |
WNT2 | 17611641 | Other | Unknown | Tissue | Cancer Related Stomach | Gene amplifications at chromosome 7 of the human gastric cancer genome. |
WNT2 | 15896469 | Other | Unknown | Tissue | Cancer Related Stomach | Correlation of Wnt-2 expression and beta-catenin intracellular accumulation in |
WNT2 | 15754011 | Other | Unknown | Other | Cancer Related Stomach | Comparative genomics on Wnt8a and Wnt8b genes. |
WNT2 | 12469206 | Other | Unknown | Other | Cancer Related Stomach | Expression and regulation of WNT1 in human cancer: up-regulation of WNT1 by |
E2F3 | 38194158 | Other | Unknown | Tissue | Stomach Cancer | Transcription factor E2F3 activates CDC25B to regulate DNA damage and promote |
E2F3 | 37750838 | Other | Upregulated | Tissue | Stomach Cancer | E2F3/CDCA2 reduces radiosensitivity in gastric adenocarcinoma by activating |
E2F3 | 34681596 | Other | Unknown | Other | Stomach Cancer | Epstein-Barr Virus miR-BART1-3p Regulates the miR-17-92 Cluster by Targeting |
E2F3 | 33542925 | Other | Upregulated | Tissue | Stomach Cancer | Identification of Genes Universally Differentially Expressed in Gastric Cancer. |
E2F3 | 33386518 | Other | Downregulated | Other | Stomach Cancer | Circ_PGPEP1 Serves as a Sponge of miR-1297 to Promote Gastric Cancer Progression |
E2F3 | 32953750 | Other | Unknown | Other | Stomach Cancer | RACGAP1 is transcriptionally regulated by E2F3, and its depletion leads to |
E2F3 | 32884453 | Other | Unknown | Other | Stomach Cancer | Good or not good: Role of miR-18a in cancer biology. |
E2F3 | 30914234 | Other | Downregulated | Tissue | Stomach Cancer | RNA N6-methyladenosine modification participates in miR-660/E2F3 axis-mediated |
E2F3 | 38194158 | Other | Unknown | Tissue | Gastric Cancer | Transcription factor E2F3 activates CDC25B to regulate DNA damage and promote |
E2F3 | 37750838 | Other | Upregulated | Tissue | Gastric Cancer | E2F3/CDCA2 reduces radiosensitivity in gastric adenocarcinoma by activating |
E2F3 | 35237319 | Other | Unknown | Tissue | Gastric Cancer | The lncRNA NEAT1/miRNA-766-5p/E2F3 Regulatory Axis Promotes Prostate Cancer |
E2F3 | 34681596 | Other | Unknown | Other | Gastric Cancer | Epstein-Barr Virus miR-BART1-3p Regulates the miR-17-92 Cluster by Targeting |
E2F3 | 33948359 | Other | Unknown | Other | Gastric Cancer | Decursin inhibits cell growth and autophagic flux in gastric cancer via |
E2F3 | 33542925 | Other | Upregulated | Tissue | Gastric Cancer | Identification of Genes Universally Differentially Expressed in Gastric Cancer. |
E2F3 | 33386518 | Other | Downregulated | Other | Gastric Cancer | Circ_PGPEP1 Serves as a Sponge of miR-1297 to Promote Gastric Cancer Progression |
E2F3 | 32110093 | Other | Unknown | Tissue | Gastric Cancer | Regulation of E2F Transcription Factor 3 by microRNA-152 Modulates Gastric Cancer |
E2F3 | 38194158 | Other | Unknown | Tissue | Cancer Related Stomach | Transcription factor E2F3 activates CDC25B to regulate DNA damage and promote |
E2F3 | 37750838 | Other | Upregulated | Tissue | Cancer Related Stomach | E2F3/CDCA2 reduces radiosensitivity in gastric adenocarcinoma by activating |
E2F3 | 33542925 | Other | Upregulated | Tissue | Cancer Related Stomach | Identification of Genes Universally Differentially Expressed in Gastric Cancer. |
E2F3 | 33386518 | Other | Downregulated | Other | Cancer Related Stomach | Circ_PGPEP1 Serves as a Sponge of miR-1297 to Promote Gastric Cancer Progression |
E2F3 | 32884453 | Other | Unknown | Other | Cancer Related Stomach | Good or not good: Role of miR-18a in cancer biology. |
E2F3 | 30914234 | Other | Downregulated | Tissue | Cancer Related Stomach | RNA N6-methyladenosine modification participates in miR-660/E2F3 axis-mediated |
E2F3 | 28490034 | Other | Upregulated | Tissue | Cancer Related Stomach | Long Noncoding RNA CRNDE Promotes Proliferation of Gastric Cancer Cells by |
E2F3 | 25762621 | Other | Unknown | Other | Cancer Related Stomach | miR-145 mediates the antiproliferative and gene regulatory effects of vitamin D3 |
INHBA | 37528145 | Other | Unknown | Tissue | Stomach Cancer | Identification of INHBA as a potential biomarker for gastric cancer through a |
INHBA | 35338119 | Other | Unknown | Other | Stomach Cancer | CircTHBS1 drives gastric cancer progression by increasing INHBA mRNA expression |
INHBA | 35100076 | Other | Unknown | Tissue | Stomach Cancer | Circular RNA 0000654 facilitates the growth of gastric cancer cells through |
INHBA | 34704289 | Other | Unknown | Other | Stomach Cancer | Identification of lncRNA-associated competing endogenous RNA networks for |
INHBA | 38676428 | Other | Unknown | Other | Gastric Cancer | Positive GLI1/INHBA feedback loop drives tumor progression in gastric cancer. |
INHBA | 37528145 | Other | Unknown | Tissue | Gastric Cancer | Identification of INHBA as a potential biomarker for gastric cancer through a |
INHBA | 36990906 | Other | Unknown | Other | Gastric Cancer | Retraction notice to "microRNA-6785-5p-loaded human umbilical cord mesenchymal |
INHBA | 36139587 | Other | Unknown | Tissue | Gastric Cancer | Identification of a Biomarker Combination for Survival Stratification in pStage |
INHBA | 37528145 | Other | Unknown | Tissue | Cancer Related Stomach | Identification of INHBA as a potential biomarker for gastric cancer through a |
INHBA | 34704289 | Other | Unknown | Other | Cancer Related Stomach | Identification of lncRNA-associated competing endogenous RNA networks for |
INHBA | 30963572 | Other | Unknown | Tissue | Cancer Related Stomach | INHBA gene silencing inhibits gastric cancer cell migration and invasion by |
HOXC11 | 26384301 | Other | Unknown | Tissue | Stomach Cancer | The association analysis of lncRNA HOTAIR genetic variants and gastric cancer |
HOXC11 | 35111675 | Other | Unknown | Tissue | Gastric Cancer | The Role of miR-4256/HOXC8 Signaling Axis in the Gastric Cancer Progression: |
HOXC11 | 26384301 | Other | Unknown | Tissue | Gastric Cancer | The association analysis of lncRNA HOTAIR genetic variants and gastric cancer |
COL10A1 | 35929139 | Other | Unknown | Other | Stomach Cancer | High COL10A1 expression potentially contributes to poor outcomes in gastric |
COL10A1 | 35328635 | Other | Upregulated | Other | Stomach Cancer | Collagen Family and Other Matrix Remodeling Proteins Identified by Bioinformatics |
COL10A1 | 33761685 | Other | Unknown | Tissue | Stomach Cancer | Identification of core genes and clinical outcomes in tumors originated from |
COL10A1 | 35929139 | Other | Unknown | Other | Gastric Cancer | High COL10A1 expression potentially contributes to poor outcomes in gastric |
COL10A1 | 35340765 | Other | Unknown | Tissue | Gastric Cancer | Proteomic Identification of a Gastric Tumor ECM Signature Associated With Cancer |
COL10A1 | 35328635 | Other | Upregulated | Other | Gastric Cancer | Collagen Family and Other Matrix Remodeling Proteins Identified by Bioinformatics |
COL10A1 | 35929139 | Other | Unknown | Other | Cancer Related Stomach | High COL10A1 expression potentially contributes to poor outcomes in gastric |
COL10A1 | 35328635 | Other | Upregulated | Other | Cancer Related Stomach | Collagen Family and Other Matrix Remodeling Proteins Identified by Bioinformatics |
DKC1 | 38376551 | Other | Upregulated | Tissue | Stomach Cancer | DKC1 aggravates gastric cancer cell migration and invasion through up-regulating |
DKC1 | 22935986 | Other | Unknown | Tissue | Stomach Cancer | Expressional analysis of NOLA1, NOLA2, NOLA3 and DKC1, the core proteins in H/ACA |
DKC1 | 38376551 | Other | Upregulated | Tissue | Gastric Cancer | DKC1 aggravates gastric cancer cell migration and invasion through up-regulating |
DKC1 | 30914599 | Other | Unknown | Other | Gastric Cancer | [A Case of Stage â…£Rectal Cancer with Dyskeratosis Congenita]. |
DKC1 | 28443573 | Other | Unknown | Tissue | Gastric Cancer | Normal and Tumour Tissue mRNA Expressions of Telomerase Complex Genes in Several |
DKC1 | 22935986 | Other | Unknown | Tissue | Gastric Cancer | Expressional analysis of NOLA1, NOLA2, NOLA3 and DKC1, the core proteins in H/ACA |
SEPTIN11 | 37080972 | Other | Unknown | Other | Gastric Cancer | Septin11 promotes hepatocellular carcinoma cell motility by activating RhoA to |
ADAMTS18 | 32963617 | Other | Unknown | Tissue | Stomach Cancer | High ADAMTS18 expression is associated with poor prognosis in stomach |
ADAMTS18 | 28814085 | Other | Unknown | Tissue | Stomach Cancer | Differentially regulated ADAMTS1, 8, and 18 in gastric adenocarcinoma. |
ADAMTS18 | 19806480 | Other | Unknown | Tissue | Stomach Cancer | High-resolution melting analysis of ADAMTS18 methylation levels in gastric, |
ADAMTS18 | 32963617 | Other | Unknown | Tissue | Gastric Cancer | High ADAMTS18 expression is associated with poor prognosis in stomach |
ADAMTS18 | 28814085 | Other | Unknown | Tissue | Gastric Cancer | Differentially regulated ADAMTS1, 8, and 18 in gastric adenocarcinoma. |
ADAMTS18 | 19806480 | Other | Unknown | Tissue | Gastric Cancer | High-resolution melting analysis of ADAMTS18 methylation levels in gastric, |
ADAMTS18 | 28814085 | Other | Unknown | Tissue | Cancer Related Stomach | Differentially regulated ADAMTS1, 8, and 18 in gastric adenocarcinoma. |
ADAMTS18 | 19806480 | Other | Unknown | Tissue | Cancer Related Stomach | High-resolution melting analysis of ADAMTS18 methylation levels in gastric, |
SERPINH1 | 37868053 | Other | Unknown | Tissue | Stomach Cancer | Identification and validation of key genes associated with pathogenesis and |
SERPINH1 | 31233344 | Other | Unknown | Tissue | Stomach Cancer | Screening and Survival Analysis of Hub Genes in Gastric Cancer Based on |
SERPINH1 | 24595468 | Other | Unknown | Tissue | Stomach Cancer | Heat shock protein 47 regulated by miR-29a to enhance glioma tumor growth and |
SERPINH1 | 37868053 | Other | Unknown | Tissue | Gastric Cancer | Identification and validation of key genes associated with pathogenesis and |
SERPINH1 | 31233344 | Other | Unknown | Tissue | Gastric Cancer | Screening and Survival Analysis of Hub Genes in Gastric Cancer Based on |
SERPINH1 | 37868053 | Other | Unknown | Tissue | Cancer Related Stomach | Identification and validation of key genes associated with pathogenesis and |
SERPINH1 | 31233344 | Other | Unknown | Tissue | Cancer Related Stomach | Screening and Survival Analysis of Hub Genes in Gastric Cancer Based on |
ADAMTS12 | 38167385 | Other | Unknown | Tissue | Gastric Cancer | Metformin suppresses proliferation and glycolysis of gastric cancer by modulating |
ATAD2 | 33438526 | Other | Unknown | Tissue | Stomach Cancer | Oncogenic potential of ATAD2 in stomach cancer and insights into the |
ATAD2 | 31959473 | Other | Upregulated | Tissue | Stomach Cancer | HIF1alpha-dependent upregulation of ATAD2 promotes proliferation and migration of |
ATAD2 | 31452712 | Other | Upregulated | Tissue | Stomach Cancer | Comprehensive analysis of histone modification-associated genes on differential |
ATAD2 | 27565325 | Other | Unknown | Plasma | Stomach Cancer | MicroRNA-520f suppresses growth of gastric carcinoma cells by target ATPase |
ATAD2 | 34502039 | Other | Unknown | Other | Gastric Cancer | Coordination of Di-Acetylated Histone Ligands by the ATAD2 Bromodomain. |
ATAD2 | 33438526 | Other | Unknown | Tissue | Gastric Cancer | Oncogenic potential of ATAD2 in stomach cancer and insights into the |
ATAD2 | 32462022 | Other | Downregulated | Tissue | Gastric Cancer | Integrated Bioinformatics Analysis of the Clinical Value and Biological Function |
ATAD2 | 31959473 | Other | Upregulated | Tissue | Gastric Cancer | HIF1alpha-dependent upregulation of ATAD2 promotes proliferation and migration of |
ATAD2 | 31452712 | Other | Upregulated | Tissue | Gastric Cancer | Comprehensive analysis of histone modification-associated genes on differential |
ATAD2 | 27565325 | Other | Unknown | Plasma | Gastric Cancer | MicroRNA-520f suppresses growth of gastric carcinoma cells by target ATPase |
ATAD2 | 31452712 | Other | Upregulated | Tissue | Cancer Related Stomach | Comprehensive analysis of histone modification-associated genes on differential |
ATAD2 | 27565325 | Other | Unknown | Plasma | Cancer Related Stomach | MicroRNA-520f suppresses growth of gastric carcinoma cells by target ATPase |
ZNF281 | 32194679 | Other | Upregulated | Tissue | Gastric Cancer | Long non-coding RNA-ZNF281 promotes cancer cell migration and invasion in gastric |
ESM1 | 24519050 | Other | Unknown | Blood | Stomach Cancer | [Detection of serum endothelial cell specific molecule 1 in gastric cancer |
ESM1 | 21678055 | Other | Unknown | Tissue | Stomach Cancer | Induction of cell differentiation and promotion of endocan gene expression in |
ESM1 | 38201620 | Other | Upregulated | Tissue | Gastric Cancer | ESM1 Interacts with c-Met to Promote Gastric Cancer Peritoneal Metastasis by |
ESM1 | 24519050 | Other | Unknown | Blood | Gastric Cancer | [Detection of serum endothelial cell specific molecule 1 in gastric cancer |
ESM1 | 21678055 | Other | Unknown | Tissue | Cancer Related Stomach | Induction of cell differentiation and promotion of endocan gene expression in |
CST1 | 36369321 | Other | Unknown | Blood | Stomach Cancer | CST1 inhibits ferroptosis and promotes gastric cancer metastasis by regulating |
CST1 | 34961592 | Other | Unknown | Other | Stomach Cancer | Transcriptional profiling and network pharmacology analysis identify the |
CST1 | 19463800 | Other | Upregulated | Tissue | Stomach Cancer | Upregulation of the cysteine protease inhibitor, cystatin SN, contributes to cell |
CST1 | 36369321 | Other | Unknown | Blood | Gastric Cancer | CST1 inhibits ferroptosis and promotes gastric cancer metastasis by regulating |
CST1 | 34961592 | Other | Unknown | Other | Gastric Cancer | Transcriptional profiling and network pharmacology analysis identify the |
CST1 | 33658852 | Other | Unknown | Tissue | Gastric Cancer | CST1 Promoted Gastric Cancer Migration and Invasion Through Activating Wnt |
CST1 | 34961592 | Other | Unknown | Other | Cancer Related Stomach | Transcriptional profiling and network pharmacology analysis identify the |
CST1 | 19463800 | Other | Upregulated | Tissue | Cancer Related Stomach | Upregulation of the cysteine protease inhibitor, cystatin SN, contributes to cell |
TGIF1 | 32196592 | Other | Upregulated | Tissue | Stomach Cancer | XTP8 stimulates migration and invasion of gastric carcinoma through interacting |
TGIF1 | 27528034 | Other | Upregulated | Cell lines | Stomach Cancer | Waking up dormant tumor suppressor genes with zinc fingers, TALEs and the |
TGIF1 | 16562680 | Other | Unknown | Tissue | Stomach Cancer | [Expressions of TGIF, MMP9 and VEGF proteins and their clinicopathological |
TGIF1 | 38067260 | Other | Unknown | Other | Gastric Cancer | Circular RNA CDR1as Mediated by Human Antigen R (HuR) Promotes Gastric Cancer |
TGIF1 | 33776478 | Other | Unknown | Other | Gastric Cancer | TGIF1 Knockdown Inhibits the Proliferation and Invasion of Gastric Cancer via AKT |
TGIF1 | 32196592 | Other | Upregulated | Tissue | Gastric Cancer | XTP8 stimulates migration and invasion of gastric carcinoma through interacting |
TGIF1 | 27528034 | Other | Upregulated | Cell lines | Gastric Cancer | Waking up dormant tumor suppressor genes with zinc fingers, TALEs and the |
TGIF1 | 16562680 | Other | Unknown | Tissue | Gastric Cancer | [Expressions of TGIF, MMP9 and VEGF proteins and their clinicopathological |
FOXS1 | 34825776 | Other | Unknown | Other | Stomach Cancer | TGFbeta-induced FOXS1 controls epithelial-mesenchymal transition and predicts a poor |
FOXS1 | 30500980 | Other | Downregulated | Tissue | Stomach Cancer | Overexpression of FOXS1 in gastric cancer cell lines inhibits proliferation, |
FOXS1 | 28374495 | Other | Upregulated | Tissue | Stomach Cancer | Genome-wide expression profiling and bioinformatics analysis of deregulated genes |
FOXS1 | 34825776 | Other | Unknown | Other | Gastric Cancer | TGFbeta-induced FOXS1 controls epithelial-mesenchymal transition and predicts a poor |
FOXS1 | 30500980 | Other | Downregulated | Tissue | Gastric Cancer | Overexpression of FOXS1 in gastric cancer cell lines inhibits proliferation, |
FOXS1 | 28374495 | Other | Upregulated | Tissue | Gastric Cancer | Genome-wide expression profiling and bioinformatics analysis of deregulated genes |
FOXS1 | 34825776 | Other | Unknown | Other | Cancer Related Stomach | TGFbeta-induced FOXS1 controls epithelial-mesenchymal transition and predicts a poor |
HOXC9 | 34159686 | Other | Unknown | Cell lines | Stomach Cancer | Upregulation of HOXC9 generates interferon-gamma resistance in gastric cancer by |
HOXC9 | 30205370 | Other | Upregulated | Tissue | Stomach Cancer | miR-26a/HOXC9 Dysregulation Promotes Metastasis and Stem Cell-Like Phenotype of |
HOXC9 | 35111675 | Other | Unknown | Tissue | Gastric Cancer | The Role of miR-4256/HOXC8 Signaling Axis in the Gastric Cancer Progression: |
HOXC9 | 34159686 | Other | Unknown | Cell lines | Gastric Cancer | Upregulation of HOXC9 generates interferon-gamma resistance in gastric cancer by |
HOXC9 | 30205370 | Other | Upregulated | Tissue | Gastric Cancer | miR-26a/HOXC9 Dysregulation Promotes Metastasis and Stem Cell-Like Phenotype of |
HOXC10 | 36264773 | Other | Unknown | Tissue | Stomach Cancer | HOXC10 indicates poor survival outcome in gastric cancer and promotes G1/S cell |
HOXC10 | 32552008 | Other | Upregulated | Tissue | Stomach Cancer | MiR-129-5p Restrains Apatinib Resistance in Human Gastric Cancer Cells Via |
HOXC10 | 31552684 | Other | Unknown | Other | Stomach Cancer | HOXC10 promotes cell migration, invasion, and tumor growth in gastric carcinoma |
HOXC10 | 37424812 | Other | Upregulated | Other | Gastric Cancer | Long non-coding RNA CYTOR enhances gastric carcinoma proliferation, migration and |
HOXC10 | 36264773 | Other | Unknown | Tissue | Gastric Cancer | HOXC10 indicates poor survival outcome in gastric cancer and promotes G1/S cell |
HOXC10 | 35111675 | Other | Unknown | Tissue | Gastric Cancer | The Role of miR-4256/HOXC8 Signaling Axis in the Gastric Cancer Progression: |
HOXC10 | 32552008 | Other | Upregulated | Tissue | Gastric Cancer | MiR-129-5p Restrains Apatinib Resistance in Human Gastric Cancer Cells Via |
HOXC10 | 31552684 | Other | Unknown | Other | Gastric Cancer | HOXC10 promotes cell migration, invasion, and tumor growth in gastric carcinoma |
HOXC10 | 36264773 | Other | Unknown | Tissue | Cancer Related Stomach | HOXC10 indicates poor survival outcome in gastric cancer and promotes G1/S cell |
HOXC10 | 28656883 | Other | Downregulated | Tissue | Cancer Related Stomach | MiR-136 inhibits gastric cancer-specific peritoneal metastasis by targeting |
BGN | 37128782 | Other | Unknown | Tissue | Stomach Cancer | Long noncoding RNA ZEB1-AS1 attenuates ferroptosis of gastric cancer cells |
BGN | 36632455 | Other | Unknown | Tissue | Stomach Cancer | BGN/FAP/STAT3 positive feedback loop mediated mutual interaction between tumor |
BGN | 35328635 | Other | Upregulated | Other | Stomach Cancer | Collagen Family and Other Matrix Remodeling Proteins Identified by Bioinformatics |
BGN | 35273678 | Other | Downregulated | Tissue | Stomach Cancer | The lncRNA SEMA3B-AS1/HMGB1/FBXW7 Axis Mediates the Peritoneal Metastasis of |
BGN | 37584004 | Other | Unknown | Other | Gastric Cancer | Identification of survival-associated biomarkers based on three datasets by |
BGN | 37361568 | Other | Unknown | Other | Gastric Cancer | Bioinformatics and pathway enrichment analysis identified hub genes and potential |
BGN | 37128782 | Other | Unknown | Tissue | Gastric Cancer | Long noncoding RNA ZEB1-AS1 attenuates ferroptosis of gastric cancer cells |
BGN | 36632455 | Other | Unknown | Tissue | Gastric Cancer | BGN/FAP/STAT3 positive feedback loop mediated mutual interaction between tumor |
BGN | 35328635 | Other | Upregulated | Other | Cancer Related Stomach | Collagen Family and Other Matrix Remodeling Proteins Identified by Bioinformatics |
BGN | 35273678 | Other | Downregulated | Tissue | Cancer Related Stomach | The lncRNA SEMA3B-AS1/HMGB1/FBXW7 Axis Mediates the Peritoneal Metastasis of |
BGN | 34868341 | Other | Unknown | Other | Cancer Related Stomach | Identification of Differentially Expressed Genes Reveals BGN Predicting Overall |
BGN | 34356118 | Other | Unknown | Other | Cancer Related Stomach | Extracellular Matrix-Related Hubs Genes Have Adverse Effects on Gastric |
RAD51D | 37239438 | Other | Unknown | Other | Stomach Cancer | Hereditary Gastric Cancer: Single-Gene or Multigene Panel Testing? A |
RAD51D | 32601921 | Other | Unknown | Other | Stomach Cancer | New germline mutations in non-BRCA genes among breast cancer women of Mongoloid |
RAD51D | 27734215 | Other | Unknown | Other | Stomach Cancer | Time to incorporate germline multigene panel testing into breast and ovarian |
RAD51D | 37239438 | Other | Unknown | Other | Gastric Cancer | Hereditary Gastric Cancer: Single-Gene or Multigene Panel Testing? A |
RAD51D | 34672684 | Other | Unknown | Other | Gastric Cancer | Germline Pathogenic Variants in Cancer Predisposition Genes Among Women With |
RAD51D | 32733558 | Other | Unknown | Other | Gastric Cancer | Secondary Prevention in Hereditary Breast and/or Ovarian Cancer Syndromes Other |
RAD51D | 32601921 | Other | Unknown | Other | Gastric Cancer | New germline mutations in non-BRCA genes among breast cancer women of Mongoloid |
RAD51D | 27734215 | Other | Unknown | Other | Gastric Cancer | Time to incorporate germline multigene panel testing into breast and ovarian |
RAD51D | 37239438 | Other | Unknown | Other | Cancer Related Stomach | Hereditary Gastric Cancer: Single-Gene or Multigene Panel Testing? A |
RAD51D | 32601921 | Other | Unknown | Other | Cancer Related Stomach | New germline mutations in non-BRCA genes among breast cancer women of Mongoloid |
GABRD | 36127526 | Other | Upregulated | Tissue | Stomach Cancer | Gamma-aminobutyric Acid Type A Receptor Subunit Delta as a Potential Therapeutic |
GABRD | 36127526 | Other | Upregulated | Tissue | Gastric Cancer | Gamma-aminobutyric Acid Type A Receptor Subunit Delta as a Potential Therapeutic |
SLC39A10 | 37524874 | Other | Unknown | Other | Stomach Cancer | SLC39A10 promotes malignant phenotypes of gastric cancer cells by activating the |
SLC39A10 | 36804016 | Other | Unknown | Cell lines | Stomach Cancer | Dual inhibition of MYC and SLC39A10 by a novel natural product STAT3 inhibitor |
SLC39A10 | 37524874 | Other | Unknown | Other | Gastric Cancer | SLC39A10 promotes malignant phenotypes of gastric cancer cells by activating the |
SLC39A10 | 36804016 | Other | Unknown | Cell lines | Gastric Cancer | Dual inhibition of MYC and SLC39A10 by a novel natural product STAT3 inhibitor |
SLC39A10 | 37524874 | Other | Unknown | Other | Cancer Related Stomach | SLC39A10 promotes malignant phenotypes of gastric cancer cells by activating the |
TEAD4 | 37864517 | Other | Unknown | Other | Stomach Cancer | PKNOX1 acts as a transcription factor of DHH and promotes the progression of |
TEAD4 | 37729973 | Other | Upregulated | Tissue | Stomach Cancer | Transcription factor TEAD4 facilitates glycolysis and proliferation of gastric |
TEAD4 | 36613819 | Other | Unknown | Blood | Stomach Cancer | TNF-alpha Secreted from Macrophages Increases the Expression of Prometastatic |
TEAD4 | 35062042 | Other | Upregulated | Blood | Stomach Cancer | TAZ promotes vasculogenic mimicry in gastric cancer through the upregulation of |
TEAD4 | 34396425 | Other | Downregulated | Cell lines | Stomach Cancer | HOXB13 suppresses proliferation, migration and invasion, and promotes apoptosis |
TEAD4 | 33571486 | Other | Unknown | Tissue | Stomach Cancer | Identification of novel human Wnt target genes using adult endodermal |
TEAD4 | 33069758 | Other | Unknown | Other | Stomach Cancer | VGLL1 phosphorylation and activation promotes gastric cancer malignancy via |
TEAD4 | 31559693 | Other | Unknown | Tissue | Stomach Cancer | Down-regulation of interferon regulatory factor 2 binding protein 2 suppresses |
TEAD4 | 38804704 | Other | Unknown | Other | Gastric Cancer | PKP2 induced by YAP/TEAD4 promotes malignant progression of gastric cancer. |
TEAD4 | 37741096 | Other | Upregulated | Tissue | Gastric Cancer | YAP/TEAD-induced PRIM1 contributes to the progression and poor prognosis of |
TEAD4 | 37729973 | Other | Upregulated | Tissue | Gastric Cancer | Transcription factor TEAD4 facilitates glycolysis and proliferation of gastric |
TEAD4 | 36830634 | Other | Unknown | Cell lines | Gastric Cancer | Lnc-uc.147 Is Associated with Disease Stage of Liver, Gastric, and Renal Cancer. |
TEAD4 | 36613819 | Other | Unknown | Blood | Gastric Cancer | TNF-alpha Secreted from Macrophages Increases the Expression of Prometastatic |
TEAD4 | 35366053 | Other | Unknown | Other | Gastric Cancer | Vestigial-like family member 3 stimulates cell motility by inducing high-mobility |
TEAD4 | 35062042 | Other | Upregulated | Blood | Gastric Cancer | TAZ promotes vasculogenic mimicry in gastric cancer through the upregulation of |
TEAD4 | 34396425 | Other | Downregulated | Cell lines | Gastric Cancer | HOXB13 suppresses proliferation, migration and invasion, and promotes apoptosis |
TEAD4 | 37729973 | Other | Upregulated | Tissue | Cancer Related Stomach | Transcription factor TEAD4 facilitates glycolysis and proliferation of gastric |
TEAD4 | 35062042 | Other | Upregulated | Blood | Cancer Related Stomach | TAZ promotes vasculogenic mimicry in gastric cancer through the upregulation of |
TEAD4 | 34396425 | Other | Downregulated | Cell lines | Cancer Related Stomach | HOXB13 suppresses proliferation, migration and invasion, and promotes apoptosis |
TEAD4 | 33571486 | Other | Unknown | Tissue | Cancer Related Stomach | Identification of novel human Wnt target genes using adult endodermal |
TEAD4 | 31559693 | Other | Unknown | Tissue | Cancer Related Stomach | Down-regulation of interferon regulatory factor 2 binding protein 2 suppresses |
TEAD4 | 31489619 | Other | Unknown | Tissue | Cancer Related Stomach | Verteporfin targeting YAP1/TAZ-TEAD transcriptional activity inhibits the |
TEAD4 | 31175271 | Other | Unknown | Tissue | Cancer Related Stomach | A novel YAP1/SLC35B4 regulatory axis contributes to proliferation and progression |
TEAD4 | 29367737 | Other | Unknown | Tissue | Cancer Related Stomach | miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric |
TUBB3 | 29125480 | Other | Unknown | Other | Stomach Cancer | Methods and significance of the combined detection of HER2 gene amplification and |
TUBB3 | 28056823 | Other | Unknown | Tissue | Stomach Cancer | Clinical significance of UGT1A1 polymorphism and expression of ERCC1, BRCA1, |
TUBB3 | 25016949 | Other | Unknown | Other | Stomach Cancer | Combination of microtubule associated protein-tau and beta-tubulin III predicts |
TUBB3 | 24722794 | Other | Unknown | Tissue | Stomach Cancer | The relationships between the chemosensitivity of human gastric cancer to |
TUBB3 | 38744818 | Other | Unknown | Cell lines | Gastric Cancer | dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas |
TUBB3 | 29125480 | Other | Unknown | Other | Gastric Cancer | Methods and significance of the combined detection of HER2 gene amplification and |
TUBB3 | 28078044 | Other | Unknown | Other | Gastric Cancer | Tumor profiling of co-regulated receptor tyrosine kinase and chemoresistant genes |
TUBB3 | 28056823 | Other | Unknown | Tissue | Gastric Cancer | Clinical significance of UGT1A1 polymorphism and expression of ERCC1, BRCA1, |
TUBB3 | 28056823 | Other | Unknown | Tissue | Cancer Related Stomach | Clinical significance of UGT1A1 polymorphism and expression of ERCC1, BRCA1, |
TUBB3 | 22546220 | Other | Unknown | Cell lines | Cancer Related Stomach | Synergistic anti-proliferative effects of gambogic acid with docetaxel in |